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ABSTRACT
The inherited intensity of the hypoxic ventilatory
response may be important in determining the severity of
hypoxaemia in chronic obstructive pulmonary disease
(COPD). However, existing methodology does not allow
adequate quantification of peripheral chemoreceptor
sensitivity in conscious humans. The aim of this project
was to validate a new mathematical model and apply this
model to investigate the hypoxic ventilatory response of
healthy offspring of patients with COPD. The
mathematical model (consisting of two linear
differential equations in parallel, each with either a
fast or slow time constant component, both using the
fall in Sa02 as the stimulus and with the equation
outputs summed to give the rise in ventilation above the
normoxic baseline value) was used to analyse the
ventilatory response to transient and step change
hypoxic stimuli in normal conscious human volunteers.
Ten repeated measurements of the hypoxic ventilatory
response in four subjects showed that the model
parameter estimation was reproducible within a subject,
and capable of distinguishing between subjects. Studies
at rest and increasing levels of exercise showed that
the hypoxic ventilatory response expressed both as the
VEinst/Sa02 relationship and as the model gain
parameters increased with increasing exercise level.
No significant effect could be demonstrated upon the
ventilatory response of varying the rate of onset of the
7
hypoxic stimulus to give a time course for the fall in
Sa02 from 17 to 50 seconds. The central adenosine
blocker theophylline given as a slow-release oral
preparation did not consistently affect the hypoxic
ventilatory response expressed either as the VEinst/Sa02
relationship or as the model gain parameters of six
normal subjects.
Thus, the mathematical model appears to quantitate the
hypoxic ventilatory response in normal subjects and is
capable of reflecting true physiological changes. It
may also provide further information regarding the
components of the response than conventional methods of
analysis.
Studies in 35 offspring of patients with COPD showed a
significant relationship between the Pa02 of a group of
patients with COPD and the hypoxic ventilatory response
of their offspring in response to step change hypoxia.
However the Pa02 of the patients was best predicted by a
combination of the model gain parameters of their
offspring (where gain 1 may represent the peripheral
chemoreceptor response , and gain 2, the central or
combined hypoxic response) . Hence the Pa02 of the
patients may be determined by hereditary
characteristics of the peripheral chemoreceptor and
central components of the hypoxic ventilatory response.
The hypoxic ventilatory response of the offspring group
was no different from that of a group of 26 age and sex-
matched control subjects whose parents did not have
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COPD, suggesting that the offspring group were within
the wide range of the normal hypoxic ventilatory
response. The studies in the offspring of patients with
COPD suggest that the Pa02 in COPD seems to depend on a
genetically determined normal variation of both




In order to adapt to the respiratory requirements during
exercise or at altitude, the respiratory control system
is capable of regulating arterial 02 , C02 and pH
concentrations. In man, the increase in ventilation due
to a fall in arterial oxygen saturation is mediated
mainly by the peripheral carotid chemoreceptors
(Lugliani et al 1971 ) . The ventilatory response to a
rise in arterial PC02 or a fall in pH is mediated by
peripheral and central chemoreceptors on the surface of
the ventral medulla.
In man, the hypoxic and hypercapnic ventilatory drives
to breathing vary between healthy individuals (Hirshman
et al 197 5) and the intensity of the drive may be
O f temp I iCoitvoN'S
important in the pathogenesis /\of chronic obstructive
pulmonary disease (COPD). It has been suggested by
Dornhorst (1955) that patients suffering from COPD may
be divided into two groups: the "pink puffers" who have
relatively well preserved arterial blood gases, and the
"blue bloaters" who have low Pa02, high PaC02, cor
pulmonale and pulmonary hypertension. However it was
later shown that the two groups could not be
distinguished on the basis of the pathology or the
degree of airways obstruction (Burrows et al 1966).
Flenley et al (1970) showed that patients with the "blue
and bloated" form of COPD had a low hypoxic ventilatory
drive and this has been shown to be at least partly
inherited (Hudgel et al 1974 ; Scoggin et al 1978 ;
1 0
Kawakami et al 1982a). An accurate method of assessing
the carotid body mediated hypoxic ventilatory drive in
conscious humans may enable quantification of the
mechanisms responsible for the regulation of ventilation
by hypoxia.
The adaptation of ventilation to meet the respiratory
requirements during exercise or at altitude is
controlled by both neural and chemical mechanisms.
I Neural control of breathing
Spontaneous respiration is produced by rhythmic
discharge of the motor neurons that innervate the
respiratory muscles (intercostal muscles and diaphragm).
This discharge is totally dependent on nerve impulses
from the brain and breathing stops if the spinal cord is
transected above the origin of the phrenic nerves.
Respiration is regulated by two separate neural
mechanisms, one being responsible for voluntary control
and the other for autonomic control (Berger 1977). The
voluntary system is located in the cerebral cortex and
sends impulses to the respiratory motor neurons via the
corticospinal tracts. The autonomic system is located in
the pons and medulla, and the motor outflow from this
system to the respiratory motor neurons is located in
the lateral and ventral portions of the spinal cord. The
motor neurons to the expiratory muscles are inhibited




Rhythmic discharge of neurons in the medulla oblongata
produces autonomic respiration. Respiratory neurons are
of 2 types: those that discharge during inspiration (I
neurons) and those that discharge during expiration (E
neurons). The I neurons are actively inhibited during
expiration and E neurons during inspiration.
The area in the medulla that is concerned with
respiration, classically known as the respiratory
centre, consists of two groups of respiratory neurons.
The dorsal group of neurons in and near the nucleus of
the tractus solitarius is the source of rhythmic drive
to the contralateral phrenic motor nerves and hence the
muscles of the diaphragm (Berger 1979) . The ventral
group has two divisions: the cranial division is made up
of neurons in the nucleus ambiguus that innervate the
ipsilateral accessory muscles of respiration,
principally via the vagus nerves. The caudal division is
made up of neurons in the nucleus retroambigualis that
provide the inspiratory and expiratory drive to the
motor neurons supplying the intercostal muscles. The
carotid sinus nerve afferents project to the nucleus
tractus solitarius (Berger 1979) which is near the
dorsal surface of the medulla, and is likely to be the
first synapse of the carotid chemoreceptor afferents.
Superimposed on this basic neural control of
respiration, other afferents provide the "fine
adjustments" that affect breathing in particular
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situations eg. afferents from pons, hypothalamus and
limbic system; afferents from proprioceptors; afferents
from pharynx, trachea and bronchi for sneezing, coughing
and swallowing; vagal afferents from inflation and
deflation receptors in the lungs; afferents from
baroreceptors: arterial, atrial, ventricular and
pulmonary.
ii) Pontine and vagal influences
The rhythmic discharge of the neurons in the respiratory
centre is spontaneous, but it is modified by centres in
the pons and by afferents in the vagus nerves from
receptors in the lungs (Larrabee and Hodes 1948).
Studies of nerve and brain section in anaesthetised cats
have shown that complete transection of the brain stem
below the medulla stops all respiration. When all of the
cranial nerves (including the vagi) are cut and the
brain stem is transected above the pons, regular
breathing continues. However, when an additional
transection is made in the inferior portion of the pons,
the inspiratory neurons discharge continuously and there
is a sustained contraction of the inspiratory muscles.
The area of the pons that prevents the arrest of
respiration in inspiration (apneusis) is known as the
pneumotaxic centre and is located in the nucleus
parabrachialis and the Kolliker Fuse nucleus. The area
in the Cauda pons responsible for apneusis is called the
apneustic centre. When the brain stem is transected in
the inferior portion of the pons and the vagus nerves
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are left intact, regular respiration continues. In an
apneustic animal, stimulation of the proximal stump of
one of the cut vagi produces a relatively prolonged
inhibition of inspiratory neuron discharge (Pitts 1942).
Stretch receptors situated in the lung parenchyma relay
to the medulla via afferents in the vagi and rapid
inflation of the lung inhibits inspiratory discharge
(Hering-Breuer inflation reflex). Therefore stretching
of the lungs during inspiration reflexly inhibits
inspiratory drive, reinforcing the action of the
pneumotaxic centre in producing intermittency of
inspiratory neuron discharge. Respiration continues
even when all pontine tissue is separated from the
medulla, whether or not the vagi are intact. This
respiration is rhythmic although irregular and gasping
and its occurrence demonstrates that the respiratory
centre neurons are capable of spontaneous rhythmic
discharge. The precise physiologic role of the pontine
respiratory areas is uncertain, but they apparently make
the rhythmic discharge of the medullary neurons smooth
and regular. It appears that there are tonically
discharging neurons in the apneustic centre which drive
inspiratory neurons in the medulla, and these neurons
are intermittently inhibited by impulses in afferents
from the pneumotaxic centre and vagal afferents.
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iii) Hypothalamic influences
The reticular activating system within the hypothalamus
determines the state of wakefulness of an individual and
as the carotid chemoreceptors have projections to the
hypothalamus, hypothalamic influences may cause the fall
in hypoxic ventilatory drive observed during sleep
(Berthon-Jones and Sullivan 1982 ).
In humans the hypoxic ventilatory drive to breathing
has been shown to increase due to a rise in body
temperature (Natalino et al 1977). The carotid
chemoreceptors have been shown to react to temperature
changes in cats (McQueen and Eyzaguirre 1974) and
afferent fibres project from the carotid chemoreceptors
to the hypothalamus (Caleresu and Ciriello 1980 ) which
is the temperature regulating centre of the body.
iv) Cortical influences
Cortical influences regulate the voluntary control of
ventilation. Saunders et al (19.72) showed that
personality may affect hypercapnic ventilatory drive in
normal man with more extrovert people having higher
hypercapnic ventilatory drives. The effects of
personality, mood, anxiety or fatigue upon hypoxic
ventilatory drive have not been studied.
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II Chemical control of breathing
In normal subjects, a rise in the PC02 or H+
concentration of arterial blood or a fall in its P02
result in an increase in the level of respiratory centre
activity and changes in the opposite direction have a
slight inhibitory effect. Respiratory chemoreceptors,
receptor cells in the medulla and carotid and aortic
bodies sensitive to changes in blood chemistry initiate
impulses to stimulate the respiratory centre producing a
change in ventilation. The regulatory mechanisms adjust
ventilation in such a way that the arterial PC02 is
normally held constant, the effects of a fall in blood
pH are combated and the Pa02 is raised when it falls to
a potentially dangerous level.
i) Carotid chemoreceptors
Chemoreceptors sensitive to changes in the PC02 and P02
of arterial blood are found in the carotid bodies which
are ellipsoidal structures situated at the bifurcation
of the common carotid artery on each side. The carotid
bodies were first described anatomically by Winslow in
1732, and in 1928 DeCastro suggested that they may be
sensors for chemicals in the blood (DeCastro 1928) . Each
carotid body has a volume of about one cubic millimetre
and consists of islands of two types of cells, type I
(glomus) cells and type II (sustenacular) cells. Each
carotid body receives an extremely high blood flow of
about two litres per minute per 100 grammes of tissue
(Daly et al 1954 ) via the glomic artery which can be
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controlled by a sphincter of smooth muscle in the glomic
artery. Both afferent and efferent nerves supply the
carotid bodies with the afferent pathway being mainly
via fibres in the ganglioglomerular nerve which synapse
with the type I cells (DeCastro 1928; Hess and Zapata
1972; and McDonald and Mitchell 1975). The type I cells
may also be innervated by ganglion cells within the
carotid body, by projections frpm the retrofacial
nucleus and the nucleus ambiguus (Hess and Cassady
1983), by preganglionic sympathetic fibres (McDonald and
Mitchell 1975) or by postganglionic sympathetic fibres
(Verna 1981). The efferent nerve supply consists of pre-
and postganglionic sympathetic fibres (O'Regan 1977 and
1981) and vagal parasympathetic fibres (Neil and O'Regan
1971; Sampson 1971b). The sympathetic nerve endings and
the afferent synapses on the type I cells are situated
very near one another (Verna 1971) and therefore the
type I cells may be inactivated by uptake of
catecholamines by the sympathetic nerve cells. The
sympathetic efferents may modify the activity .of the
type I cells due to the release of other chemicals.
Their sensitivity was shown by Heymans et al (1930,
1931; Heymans and Neil 1958).
Interaction of hypoxia and hypercapnia at the carotid
chemoreceptors has been demonstrated in whole nerve and
single fibre preparations in animals (Eyzaguirre and
Lewin 1961; Lahiri and Delaney 1975). In human subjects,
Nielson and Smith first recognised that a combination of
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hypoxia and hypercapnia produced an increase in
ventilation which was greater than that caused by either
stimulus alone (1951).
The catecholamines contained in the carotid body have
been considered to be putative neurotransmitters
although this is currently a point of contention (Alfes
et al 1977 ) . The type I (glomus) cells of the carotid
body are known to contain dopamine which may have both
excitatory and inhibitory effects on the carotid
chemoreceptors. Bisgard et al (1979) showed that a large
dose of dopamine had an excitatory effect upon carotid
chemoreceptor activity, whereas a small dose resulted in
chemosensory inhibition.
Sampson demonstrated that intra-carotid injection of
adrenaline, dopamine or noradrenaline caused inhibition
of spontaneous discharge of the carotid chemoreceptors
(1971a), whereas O'Regan observed an increase of carotid
chemoreceptor activity after injection of adrenaline or
noradrenaline (1981). Thus any "flight or fright"
situation which causes a release of catecholamines from
the adrenal glands into the bloodstream could therefore
affect the measurement of hypoxic ventilatory drive.
In man, the aortic bodies situated in the arch of the
aorta seem to contribute little to the hypoxic
ventilatory drive to breathing as removal or denervation
of the carotid chemoreceptors abolished the ventilatory
response to both steady state hypoxia (Guz et al 1966;
and Lugliani et al 1971) and to transient hypoxia
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(Wasserman et al 1975; and Whipp and Wasserman 1980).
The aortic bodies may however contribute to the
ventilatory response to hypercapnia (Swanson et al
1978) .
ii) Central chemoreceptors
An area within the ventro-lateral medulla, thought
previously to be sensitive only to pH (Mitchell et al
1963 ; Loeschke 1982), has recently been shown to cause
changes in ventilation in response to pH or C02 (Teppema
et al 1983 ; Eldridge et al 1985) . In both animals and
man a multiplicative interaction of the chemoreceptor
input and the medullary response to C02 and pH has been
described (Lee et al 1975; Kao and Mei 1978) although it
is assumed by most that the interaction of C02 and 02 in
humans can be entirely accounted for by the carotid
chemoreceptors (Whipp et al 1976) . There is no evidence
for direct central stimulation of ventilation by hypoxia
and hypoxia may act centrally to depress ventilation
(Weiskopf and Gabel 1975; Easton et al 1986, 1988). This
depression of ventilation may be an indirect effect due
to increasing cerebral blood flow during hypoxia leading
to central hypocapnia (Weiskopf and Gabel 1975).
However, Easton et al (1986, 1988) have shown that
during sustained hypoxia, the decline in ventilation
which occurs in normal adults may be related to central
accumulation of a neurochemical, possibly adenosine,
with a net inhibitory effect on ventilation.
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Ill Measurement of the chemoreceptor response to hypoxia
Several methods may be used to assess the carotid
chemoreceptor response to various time courses of
hypoxic stimuli:
In animal preparations it is possible to make direct
recordings of the chemoreceptor afferent activity in the
carotid nerve. This method provides a direct measurement
of carotid chemoreceptor activity but of course cannot
be used in conscious human subjects. The significant
trauma involved in the procedure and the anaesthetics
used in these animal studies may themselves affect the
chemoreceptor discharge (Biscoe and Millar 1968).
The second method is by measurement of the ventilatory
response to an hypoxic stimulus in conscious healthy
human subjects. Several methods have been used to
demonstrate and attempt to quantitate the hypoxic drive
to breathing expressed as a change in minute ventilation
for a fall in arterial oxygen saturation, including
steady state, progressive and transient hypoxia
techniques.
i) steady state hypoxia
The first method was described by Nielson and Smith
(1952) . They measured the steady state ventilatory
response to C02 at two levels of P02 (40 and 150mmHg)
and expressed hypoxic sensitivity as the ratio of the
slopes of the C02 responses at the two levels of
oxygenation (S40/S150). Severinghaus et al (1966) used a
similar experimental technique, constructing two C02
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response lines, one at a steady state Pa02 of 200mmHg
and the other at 4OmmHg. They then defined their measure
of hypoxic sensitivity, /\V40 as the rise in ventilation
produced from a fall in Pa02 from 200 to 40mmHg at a
standardised "normal" PaC02 for each subject (the PaC02
at which the hyperoxic response line intersected a
ventilation of 4 litresmin-1, the normal resting
ventilation). A similar method was used by Flenley and
Millar (1967) who compared the ratio of the slopes of
the C02 response lines at a P02 of 70mmHg and 120mmHg,
giving the ratio S70/S120. Lloyd et al (1958) used a
similar experimental method involving at least four
different levels of PA02 but analysed the results in a
different manner. They expresed the linear part of the
V/PAC02 relationship by the equation
V = S ( PaC02 - B )
where S is the slope of the V/PAC02 line and B its
intercept on the x axis. They noted that the intercept
did not change with a change in PA02 but the slope, S
did ie. the lower the PA02, the greater the slope. They
derived the following equation to describe the
relationship between S and PAC02
S = D ( 1 + A }
PA°2 " P
where D is the slope of the V/PAC02 line at infinite
PA02, A is the shape of the hyperbola and C is the PA°2
at which V tends to infinity. They concluded that A can
be regarded as a measure of the hypoxic ventilatory
drive.
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There are several disadvantages of the steady state
technique. The method is very time consuming and it may
take up to several hours to measure ventilation at
several levels of steady state paco2 against a
background of several levels of steady state Pa°2• The
hyperbolic relationship between ventilation and PA°2 ^as
limitations as the shape parameter of the hyperbola, A
is affected by changes in C, the Pa°2 which
ventilation tends to infinity. Lloyd et al (1958) used a
constant value of 32 to represent C in all their
calculations but Cunningham et al (1964) showed that C
may vary between individuals, hence the assumption of a
constant C will lead to error. The hyperbolae are not
always the same shape for the same value of A, hence the
other parameters in the equation must be determined for
accurate calculation of hypoxic ventilatory drive.
Another disadvantage of the steady state technique is
that some subjects with a particularly high hypoxic
ventilatory drive may find a steady state level of
ventilation very uncomfortable due to the multiplicative
action of hypoxia and hypercapnia (Nielson and Smith
1951) , thus producing few data points at the low PA02
end of the hyperbola.
A major disadvantage of the /\V40 technique is that a
Pa02 of 40mmHg lies on the steep part of the V/PA02
response curve, therefore a small change in P02 results
in a large change in ventilation. A small experimental
inaccuracy could therefore cause a large variation in
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the results.
ii) progressive isocapnic hypoxia
Methods using progressive isocapnic hypoxia were
introduced by Weil et al (1971) and involved the gradual
addition of N2 to the inspired gas to reduce PET02 from
12 0mmHg to approximately 4 0 mmHg over a period of 15-2 0
minutes. Carbon dioxide was also gradually added to the
inspired gas mixture in order to keep PETC02 constant.
The shape of the curve relating VE and PA02 could be
described by the equation
VE = VEO + A / ( PA02 - 32 )
where VEO is the asymptote for ventilation at infinite
Pa°2 ' ^ ;'-s s^ape parameter of the curve, and 3 2 is
the constant PA02 at which the ve/pA°2 sl°Pe tends to
infinity as used by Cunningham et al (1964) in the
calculation of the ventilatory response to steady state
hypoxia. A similar progressive isocapnic hypoxia method
was used by Kronenberg et al (1972) in which the PET02
was reduced from 120 to 40 mmHg over a period of 3-4
minutes.
Rebuck and Campbell (1974) developed a rebreathing
method based on that of Read (1967) in which subjects
rebreathed from a six litre bag containing 7% C02 and
24% 02. A rapid fall in PET02 from 140-160mmHg to 30-
40mmHg was produced within four minutes. Rebuck
maintained isocapnia, keeping PETC02 at mixed venous
level by drawing a stream of the gas through a soda lime
CO 2 absorber. Ear oxygen saturation was measured
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continuously during the procedure and the hypoxic
ventilatory drive was expressed as the slope of the
linear regression relationship between minute
ventilation and ear oxygen saturation. The major
criticisms of this technique relate to the use of ear
oximetry in that the delay between the change in Pa02
and the response of the oximeter at that time may affect
the results and that Sa02 is probably not the actual
chemoreceptor stimulus (Chiodi et al 1941 and Hatcher et
al 1973). A disadvantage of both the steady state and
progressive isocapnic hypoxia is that the prolonged
hypoxia may result in a central depression of
ventilation in some subjects even if the duration of the
hypoxic stimulus is only 3-4 minutes (Weiskopf and Gabel
1975 ; Easton et al 1986, 1988) , thus causing an
underestimation of the peripheral chemoreceptor
response.
iii) transient hypoxia
Transient hypoxic stimuli lasting only a few breaths
have been used to avoid central hypoxic depression seen
in some subjects during steady state or progressive
isocapnic hypoxia experiments. It was suggested that the
short duration of the stimulus involved would avoid
central depression of ventilation (Weiskopf and Gabel
1975; Easton et al 1986, 1988) and that the ventilatory
response would therefore more accurately reflect
chemoreceptor activity alone. The transient method of
assessing chemoreceptor drive was first used by Dejours
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et al, in which the subject inhaled one or two breaths
of either an hypoxic or hyperoxic gas (1957b, 1958 ;
Dejours 1953, 1963 ). In order to reduce adequately the
PaC>2 at rest, the subject was required to take a vital
capacity breath of the gas mixture, and this manoeuvre
in itself affected the subjects' breathing pattern and
made them aware of the measurement being made
(Kronenberg et al 1972 ; Gabel et al 1973 ). This
technique was modified by Lahiri and Edelman (1969) who
gave the subjects 100% C>2 to breathe for 3-5 breaths
without their knowledge. Flenley et al (1973) used a
similar test during exercise, giving 2 or 3 tidal
breaths of 100% 02 • In the studies of Kronenberg et al
(1972) only the change in ventilation was measured hence
the stimulus of 02 or N2 at the chemoreceptors was not
taken into account. Edelman et al (1973) used an ear
oximeter to measure oxygen saturation as the hypoxic
stimulus and expressed the hypoxic ventilatory drive as
the slope of the linear regression relationship between
VE and SaC>2. The VE value used in this case was the mean
of the two breaths with the largest VE after each
hypoxic stimulus. Calverley et al (1974) and DeCort et
al (1988) have shown that there was no significant
difference in the ventilatory response to transient
hypoxia whether or not the P^CC^ was controlled. The
absolute changes measured during a transient hypoxic
stimulus can be increased by giving it during exercise,
just as exercise will potentiate the increase in
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ventilation observed during steady state hypoxia
(Flenley et al 1973).
The method of analysis of the transient hypoxic
stimuli was improved by Flenley et al (1979). Subjects
were studied walking at a moderate speed on a level
treadmill breathing 14% 02 as the background gas and
given five tidal breaths of 30% 02 on six occasions.
Hypoxic ventilatory drive was expressed as the slope of
the VE/PET02 relationship for the pooled data and this
analysis included all breaths during the transient
relief of hypoxia and the return to the hypoxic gas
mixture. The analysis used an iterative process thus
avoided any subjectivity in selecting the peak VE,
included more data points and therefore gave improved
statistical power compared with the method of Edelman et
al (1973). One criticism of this technique is that PET02
was used in the analysis as a measure of Pa02. However
this may not be true due to an increase in the arterial-
alveolar difference upon exercise (Whipp and Wasserman
1969). Gould et al (1985) modified the data analysis
method of Flenley et al (1979) and demonstrated that
analysis of the VE/PET02 relationship using all data
points for the increase in minute ventilation with
hypoxia and the return to normoxic baseline VE gave
different results to a method using only the points
during the rise in VE.
The ventilatory response to hypoxia may be measured as
the pressure generated by the insiratory muscles (PQ ^)
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in response to airway obstruction 100msec after the
onset of inspiration from residual capacity (Whitelaw et
al 1975). This method is simple and non-invasive and is
not affected by lung mechanics. However in some
subjects, even a very short occlusion time (eg. 150msec)
may influence the breathing pattern. The PQ ^ may be
measured during the first 60msec of every breath even
during sleep (Gugger et al, in press).
Comparisons between the three methods of quantitating
the hypoxic ventilatory drive to breathing have been
made by several investigators. In normal subjects at
rest, Kronenberg et al (1972) found a significant
correlation between the response to the steady state and
progressive methods and also between the steady state
and transient tests but no correlation between the
progressive and transient methods. Edelman et al (1973)
compared the transient and steady state hypoxia methods
at rest. They found that the ventilatory responses to
transient hypoxia were qualitatively similar to the
responses to steady state hypoxia although they were
quantitatively significantly greater by an average of
18%. Shaw et al (1982) compared progressive isocapnic
and transient hypoxia at rest and found a significant
correlation between the two techniques in a group of 18
normal subjects (1982). Warren et al (1984) compared
the three methods in normal subjects and found a
significant correlation between progressive isocapnic
and transient hypoxia techniques. However absolute
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comparisons could not be made as steady state and
progressive isocapnic hypoxia were studied at rest
whereas transient hypoxia was studied during exercise.
Airlie et al (1989) have recently shown that the
specific peripheral chemoreceptor stimulant almitrine
bismesylate significantly increased the hypoxic
ventilatory drive (expressed as the VEinst/Sa02
relationship) in six out of seven normal men at rest for
progressive isocapnic hypoxia. However there was no
consistent change in the ventilatory responses to
transient hypoxia measured during exercise. They
therefore concluded that the response to transient
hypoxic stimuli did not accurately reflect peripheral
chemoreceptor activity alone. This group also found
that the VEinst/Sa02 relationship in response to rapid
onset, short duration transient stimuli was less than
that to slower onset, more prolonged hypoxia, and the
two responses could not be described adequately by a
single linear system (Warren et al 1987). The smaller
ventilatory response to transient hypoxic stimuli may be
due to the time course of the ventilatory response to
hypoxia (air to 9% 02) shown by Reynolds and Millhorn
(1973) to have a mean half-time of 78 seconds ie.
significantly greater than the time course of the
transient hypoxic stimuli.
As the ventilatory response to transient hypoxia
appears to depend upon the rate of onset and the
duration of the stimulus, Kirby et al have developed a
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mathematical model (Appendix A; Warren et al 1989) which
allows a dynamic analysis of the ventilatory response to
both transient and sustained hypoxia.
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CHAPTER 2: A MATHEMATICAL MODEL FOR ANALYSIS OF THE
DYNAMIC VENTLATORY RESPONSE TO HYPOXIA
Mathematical models have been used to describe the
dynamic ventilatory response to 02 (Sarhan et al 1988)
and C02 (Belville et al 1979 ; Grodins et al 1967 ;
Saunders et al 1980) . However modelling techniques have
not previously been used to investigate the dynamics of
the peripheral and central chemoreceptor controllers of
the ventilatory response to hypoxia. Kirby et al
therefore developed a mathematical model which described
the dynamic ventilatory response to both transient
(inspired gas changed to 2 breaths N2) and step change
hypoxia (inspired gas changed abruptly to 15% or 12% 02
for a 3 minute period; Appendix A, Warren et al 1989) .
The model was systematically developed to fit the
observed ventilatory responses both to transient and to
step change hypoxia in 10 normal subjects. The simplest
model relating VEinst to Sa02 which used the minimum
number of parameters, and which adequately described the
experimental data obtained in the 10 subjects was
derived empirically. The final model structure, shown in
Fig 2.1 consisted of two linear differential equations
(1 and 2) in parallel. The fall in Sa02 during hypoxia
(S) was taken as the input to both equations. The
outputs of both equations (Y-^ and Y2). were summed to
give the rise in ventilation above the normoxic baseline
value (V) and added to the ventilation during normoxia
to give Vcalc.
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The time constant of equation 1 (tau 1) was found to
be fast ie. less than 3 sec, and was therefore set to
0.1 sec since the time constant of the ear oximeter (1.6
sec, Douglas et al 1979 ) prevented this parameter from
being measurable. The non-linear terms included in the
final model were an inhibition parameter and a
saturating effect parameter. The output of equation 1
may be "inhibited" (positive I), or "potentiated"
(negative I) by the output of equation 2 (Fig 2.1). The
saturating effect parameter allowed the gain to
"saturate" in a way analogous to the Michaelis-Menten
equation by replacing the gain G with the term
G/(sigma + S) . Equation 2 has a longer time constant
(tau 2) and its gain is allowed to be saturated.
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The model depends on three assumptions: arterial
oxygen saturation was taken as a measure of the stimulus
and VEinst as the output. The P02 within the carotid
glomus was considered to be the stimulus to the
peripheral carotid chemoreceptors (Eyzaguirre and Zapata
1984) and while Sa02 was not the actual chemoreceptor
stimulant, it is related to arterial P02 and provides
the only non-invasive measure of arterial oxygenation.
The final assumption was that arterial PC02 was constant
and equal to end-tidal PC02 although some evidence
suggests that as tidal volume increases during exercise,
a small difference develops between end-tidal and
arterial PC02 values (Cummins et al 1986; Jones et al
197 9) . The program was written in Fortran IV and
assembler on a DEC PDP 11/73 computer and allowed for
any arrangement of one or two differential equations,
with or without the non-linear terms described above. An
input file contained a sequence of values for an
individual of Sa02, time and Vginst, including both
transient and step change events. To reduce processing
time, only 15 normoxic breaths before and after each
period of hypoxia were included in the file. A standard
Runge-Kutta integration routine (a standard mathematical
minimisation process, Press et al 1986) was used to
calculate values of ventilation for a given set of
equation parameters, and the parameters were adjusted to
minimise the sum of weighted squared differences between
the calculated and observed ventilation using the
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"Simplex" method (a standard stepwise multidimensional
minimisation method, Press et al 1986). The weighting
prevented the fitting process being biased towards the
step changes (due to their greater number of
experimental points contributing to the sum of squares)
by multiplying the squared differences during step
changes by the factor W, where
W = sum of durations of transients
sum of durations of steps
To allow the use of delays within the model and
compensate for the delay in response of the ear oximeter
(about 2 sec) , the Sa02 was interpolated to one second
intervals within the program using the method of
Lagrange (a classical polynomial interpolation formula,
Margenau et al 1956).
At each stage of the model parameter estimation, the
best fit to the data was found, and the process stopped
at the level when the addition of further terms did not
give a statistically significant decrease in the
residual deviations of V^inst from the values for
ventilation calculated by the model. A decrease on
addition of one new parameter was considered to be
significant if the quantity:
F = (RSSbefore - RSSafter)
(RSSafter/(n-(p+l)
was greater than the 5% level of Snedecor's F
distributed with 1 and (n-(p+l)) degrees of freedom,
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where RSSt>efore an<1 RSSafter were the residual sum of
squares before and after inclusion of additional
parameters, p was the original number of parameters, and
n was the number of data points being fitted. This is a
form of Analysis of Variance.
The starting points for the iterative process were
arbitrarily chosen as tau 1: 0.1 sec; gain 1: 2 lmin"
1%-1; and gain 2: 2 lmin-1%-1 and the parameters for
inhibition (0.1 lmin-1) and sigma (0.1 %) were added
individually and then in combination until the model of
best fit was derived. The repeatibil ity of the
minimisation procedures were tested by starting the
parameter estimation from four different sets of points
in ten subjects. The parameter estimation generally
began with only values for the two time constants and
the two gains, then the values for inhibition and
saturating effect were introduced individually and then
in combination in a stepwise manner. Repeatibility of
the model was assessed by starting parameter estimation
at the following points, I, II, III and IV
Starting Point I II III IV
tau 1 0.1 0.1 0.1 0.1
gain 1 2 0 5 10
inhibition 0 . 1 0 1 2
tau 2 50 0 50 100
gain 2 2 0 5 10
sigma 0.1 0 1 2
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In all ten cases tested the final parameter values were
identical irrespective of the starting points used . The
set I starting points were therefore used for all
subsequent estimations. Chapter 4 describes in detail
the reproducibility of both the hypoxic ventilatory
response and the mathematical model parameters for four
subjects and suggests that the model gives a
quantitative and reproducible measure of the hypoxic
ventilatory response in normal subjects.
The form of the model was developed on a purely
mathematical basis, and physiological interpretation
therefore needs validation. It can be postulated that
the components of the fast differential equation (1)
represent the activity of the carotid chemoreceptors and
that of equation (2) with the longer time constant
represent a central component. The studies described in
this thesis aimed to assess the repeatability of the
model parameter values obtained in an individual, to
investigate the physiological interpretation of the
model structure and to use the model in a large
familial study. The ventilatory stimulant theophylline,
considered to act centrally, has been used to assess and
attempt to separate out the peripheral and central
components of the model. Several different levels of
exercise have been used to investigate the potentiation
of the hypoxic ventilatory response and its effect upon
the model parameters. The effect of different rates of
onset of the hypoxic stimulus upon the model analysis of
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the ventlatory response have also been studied. The
relationship between the ventilatory response to hypoxia
and the model parameters of a group of offspring with
the PaC>2 of their parents with COPD has been used to
investigate the suitability of the model for use in an
epidemiological study.
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CHAPTER 3: GENERAL METHODS AND EQUIPMENT USED TO MEASURE
THE HYPOXIC VENTILATORY RESPONSE IN NORMAL MAN
I EQUIPMENT AND DATA ACQUISITION
Fig 3.1 shows the breathing circuit used for transient
and step change hypoxia throughout the following
studies. Subjects breathed through a mouthpiece
connected to a low-resistance custom-built valve (range
0-4.9 cmH20 over a flow range 0-110 lmin-1, Fig 3.2)
with a dead space of 90ml. The valve had two inlet ports
although only one was used in the following studies.
Mouth pressure was measured via a port between the
inspiratory and expiratory flaps of the valve and the
mass spectrometer probe was positioned 7cm from the
mouth for continuous inspired and expired gas analysis.
In order to provide more than two inspiratory ports, a
five-way valve (Hans-Rudolph 2440 series, five-way
Gatlin shape valve) with a dead space of 95ml was
connected to one inspiratory port of the custom-built
valve (Fig 3.3). The Hans-Rudolph valve had a similar
pressure-flow relationship to the custom-bu'ilt valve
(Fig 3.2). Each of the ports of the five-way valve was
closed by a pneumatically operated silicone rubber
balloon which could be inflated or deflated very rapidly
by means of a remote controller (Hans-Rudolph series
2430), operated from behind the subject. The combination
of the custom-built and five-way valves allowed very
abrupt changes in inspired gas. Addition of the five-way
valve to the custom-built valve did not affect the mouth
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pressure measured over a flow range of 0-110 lmin 1
hence inspiratory resistance was not increased (Fig
3.4) .
Gas mixtures of 10, 12 or 15% 02 used for step change
hypoxia were made from room air and 100% N2 supplied
from a cylinder of primary gas. The mixtures were made
up using a system of rotameters (Rotameter Manufacturing
Co. ltd.) connected to a 10.5 litre mixing box. Room air
was supplied by a pump through a 0 to 200 lmin-1
rotameter, 100% N2 through a 0 to 50 lmin-1 rotameter
and 100% C02 through a 0 to 10 lmin-1 rotameter. C02 was
then supplied directly to the inspiratory tube close to
the Hans-Rudolph valve. Gas mixtures from the rotameters
were supplied at a total flow rate of 100 lmin-1. The
gas from the rotameters passed through a T-piece
connected to one inspiratory port of the Hans-Rudolph
valve (figs 3.1 and 3.3). Excess gas passed via a T-
piece along a 2 metre tube of 5cm diameter (fig 3.3) ,
ensuring that the gas supply from the rotameters
exceeded respiratory requirements, that positive
pressure was not applied to the inspiratory side of the
circuit and that room air was not entrained into the
inspiratory mixture.
To produce transient hypoxic stimuli, either 100% N2
or 1% 02 in N2 was supplied from a Douglas bag connected
to one port of the Hans-Rudolph valve (Fig 3.1). A
second valve, a mechanical foot pedal was positioned
between the Douglas bag and the Hans-Rudolph valve.
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Simultaneous operation of both the foot pedal and the
remote controller of the Hans-Rudolph valve was required
before the subject could inhale from the Douglas bag,
thus preventing accidental inhalation of 100% N2.
Expired gas passed from the respiratory valve along a
straight metal tube via a pneumotachograph (Fleisch No.
2) to a 3.2 litre mixing chamber. It was then dried and
passed through a dry gas meter (Parkinson-Cowan CD4) .
Mixed expired gas was sampled from the mixing chamber at
— 1
500mlmin and analysed for 02 (Sybron-Taylor Servomex
Oxygen Analyser 570A) and C02 (Gould-Godart Capnograph
Mark III) concentrations as required for calculation of
steady state gas exchange.
i) Recording Devices
Inspired and expired gas concentration was sampled
continuously 7cm from the mouth by a heated mass
spectrometer probe (VG-Medical Spectralab M) with a
sampling rate of 20-25mlmin-^ and a typical transit time
of 100-200ms. The 10-90% response time was 65ms
(calculated as a mean of ten measurements of the
response to abrupt changes from air to gas mixtures
containing 8% C02 and 5% C02) . Before each study the
mass spectrometer was calibrated for N2, 02, C02 and
Argon with six gases of known composition. The gas
mixtures used were 100% N2, cylinder air and four 02/C02
mixtures (02 range 5-21%, C02 range 2-8%). The 02/C02
mixtures used were obtained from the British Oxygen
Company with certificates of analysis and analysed to a
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tolerance within the range +2.5% of the analysed value.
The software operating the mass spectrometer calculated
the average difference between the measured and expected
concentrations for each gas and the calibration was
accepted if the average error was less than 1%. The mass
spectrometer calibration was stable over a period of
three hours which was the duration of the longest study
(table 3.1).
Mouth pressure was recorded using a micromanometer
(Furness Controls FCO/4) from a port between the
inspiratory and expiratory flaps of the custom-made
respiratory valve.
Expiratory gas flow was recorded using an heated
pneumotachograph (Fleisch No. 2), the differential
pressure across which was measured using a Furness
Controls ltd FCO/4 micromanometer and the pressure/flow
relationship of the expiratory pneumotachograph is shown
in Fig 3.5. Ear oxgen saturation was recorded
throughout all studies using an Hewlett-Packard 47201A
ear oximeter with fibreoptic earprobe. The oximeter was
always used in the fast mode with a delay time of 0.34
sec and a time constant of 1.61 sec (Douglas et al
1979). The electrocardiogram (ECG) and heart rate
(measured from the r-r interval) were also recorded
throughout all studies using an Hewlett-Packard 78351A
Electrocardiogram monitor.

























Schematic representation of the breathing circuit used
for all studies.
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Fig 3.2 : Pressure-flow relationships for the custom-
made and Hans-Rudolph five-way respiratory valves.
0 20 40 ' 60 ■' 80 100 120
Air Flow (lmm~1)
Pressure-flew relationships were determined by passing
known constant flows of room air supplied from the
rotometers at 20°C through the valves and measuring the
pressure difference between the inlet and outlet parts
using a Fumess Controls FCO/4 micromanometer. Open
circles (0) represent pressure-flow relationship for
the custom-made valve, and closed circles (•) that for
the Hans-Rudolph five-way valve.
A3
Fig 3.3 : Apparatus
Subjects walked on a level treadmill and breathed
through the custom-made and Hans-Rudolph five-way
valves in combination.
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Fig 3.A : Pressure-flow relationships of the respiratory
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Pressure-flow relationships were measured by passing
constant flows of room air at 20°C through the custom-
made valve alone, and then in combination with the
Hans-Rudolph five-way valve, and measuring the pressure
difference across the valves using a Furness Controls
FCO/4 micromanometer. The open circles (0) represent
the pressure-flow relationship of the custom-made valve
and inspiratory pneumotachograph, and the closed circles
(•) represent that of the Hans-Rudolph five-way valve,
the custom-built valve plus the pneumotachograph.
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Table 3.1 Stability of the mass spectrometer
Gas Concentration (%) Concentration (%)




COo 0. 04 0. 03
Composition of room air measured by the mass
spectrometer immediately after calibration (time 0 min)
and after three hours (time 180 min).
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The pressure-flow relationship was calculated by
passing known constant flows of room air from the
rotameters through the pneumotachograph and
measuring the differential pressure using a Furness
Controls FCO/4 micromanometer. Each point represents
the change in pressure at a constant air flow.
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ii) On-line Data Acquisition
Analogue signals from the recording devices were sampled
every 16.67 milliseconds by a PDP 11/73 computer
(Digital Equipment Corporation) using custom-written
programs.
The beginning and end of the respiratory phase of each
breath was identified by the computer using the mouth
pressure signal. High frequency noise generated by
movement was reduced in the mouth pressure signal by
adding a resistance (a needle, the diameter of which was
empirically chosen) in the sampling line close to the
custom-built valve. The beginning of inspiration was
determined as the time at which the mouth pressure fell
below a negative threshold, and the beginning of
expiration as the time at which mouth pressure rose
above a positive threshold equal in size to the negative
threshold. Inspiratory and expiratory times (Tj and TE)
were derived for each breath and respiratory frequency
(fR) was then calculated as 60/(Tj+Te).
The output of the expiratory pneumotachograph was
integrated to give expired volume which was then
corrected using a calibration factor derived every 10
litres from the output of the dry gas meter. The flow
integrator was reset every breath (using the mouth
pressure signal as a marker), thus giving a breath-by-
breath measurement of tidal volume (Vt) . Instantaneous
minute ventilation (VE inst) was then calculated for
each breath from respiratory frequency multiplied by
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tidal volume.
The analogue signal from the mass spectrometer was
calibrated for N2, 02, C02 and Argon onto the computer
on each study day using five gas mixtures (100% N2,
cylinder air, and three 02/C02 gas mixtures, 02 range 5-
21%, C02 range 2-8%) . Each was sampled by the mass
spectrometer and the least squares linear regression
relationship was calculated between the analogue signal
and the expected gas concentration. The residual root
sum squared for N2, 02 and C02, the largest individual
variation in N2, 02 and C02 and the gas mixture for
which it occurred, the delay time of the mass
spectrometer probe and the measured composition of room
air were displayed. The calibration was accepted only if
the delay time was less than 800ms and the largest
individual variation was less than 0.25% for N2, 02 and
C02. The delay time was used to offset all other
variables to synchronise the measurements.
The ear oximeter analogue signal was also calibrated
onto the computer using the electrical signals for 0 and
100% saturation, and assumed linearity of the
relationship between ear oxygen saturation and the
analogue signal between these two extremes. Ear oxygen
saturation (Sa02) was recorded as a mean over each
breath. Mean heart rate of the previous 8 breaths was
recorded breath-by-breath at the end-tidal point.
Inspired gas composition was calculated as an average
over 150 ms, 750ms after the onset of inspiration (to
avoid analysis of dead space gas) . End-tidal PC02
(PETC02) was determined as the maximal value during each
expiration and end-tidal P02 was recorded
simultaneously.
At the end of each study, data was archived onto
floppy disks for subsequent off-line analysis.
iii) Analogue and Digital Displays
On the computer screen were displayed five breath mean
values for inspired and end-tidal %02 , %C02, tidal
volume, minute ventilation, respiratory frequency, ear
oxygen saturation, heart rate, breath number and stored
time. A four channel time based recorder (Watenabe
Linear Corder Mark VII) gave a continuous analogue
display of PC02, tidal volume, expiratory gas flow and
mouth pressure. The same information was also displayed
on an oscilloscope (Lan-Electronics Ltd.) throughout
each study. Ear oxygen saturation, heart rate (in
digital form) and ECG were also displayed throughout all
studies.
II GENERAL PROCEDURES
i) Subjects and lung function measurements
The subjects studied included laboratory personnel, the
offspring of patients with chronic obstructive pulmonary
disease and volunteers drawn from the general public.
All subjects were healthy and taking no medication at
the time of the studies and gave informed consent to the
procedures. The studies were approved by the Lothian
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Health Board Medicine and Clinical Oncology Ethics of
Medical Research Sub-Committee. Anthropomorphic and lung
function measurements were made in all subjects. Forced
vital capacity (FVC) and forced expiratory volume in one
second (FEV-^) were measured using a Vitalograph
spirometer (model s, number 20.400). Total lung
capacity (TLC), functional residual capacity (FRC),
residual volume (RV) and transfer factor (diffusing
capacity;TLCO) were all measured using a Gould 2400
Pulmonary Function Laboratory system driven by an IBM
PC/AT computer. Total lung capacity and its
subdivisions were measured by the closed circuit helium
dilution method (Cotes 1979). The TLCO was measured by
the single breath method (Cotes 1979) using an 8 second
breath holding time.
For men, the predicted normal values for FEV^, FVC,
and FEV1/FVC% were taken from Crapo et al (1981) and
FRC, RV, TLC and RV/TLC% predicted values were taken
from Crapo et al (1982) . Predicted normal values for
TLCO were those given by Cotes (1965).
For women, the predicted normal values for FEV-,, FVC,
FEV1/FVC%, RV, TLC and RV/TLC% were taken from Hall et
al (1979). Predicted normal values for TLCO were taken
from Billiet et al (1963). Predicted body surface area
values for all subjects were taken from Documenta Geigy
(1962) .
All subjects completed the Medical Research Council's
questionnaire on respiratory symptoms, 1986 (a revised
and updated version of the 1965 questionnaire on
respiratory symptoms approved by the Medical Research
Council's committee on research into chronic
bronchitis).
ii) Measurement of gas exchange
Expired gas volume was measured over a period of 2
minutes from the digital output of the Parkinson Cowan
. ■ * — I
CD4 dry gas meter and minute ventilation (VE; lmm
BTPS) calculated. During the same 2 minute period,
oxygen and carbon dioxide concentrations were measured
in the mixed expired gas drawn from the mixing chamber
at 500 mlmin . Oxygen concentration was analysed with a
Servomex 02 analyser (model 570A) and recorded as an
average of three digital measurements taken at time 45,
75 and 105 seconds after the start of the mixed expired
gas collection. Carbon dioxide concentration was
measured using a Gould Capnograph (Mark III) . The
concentration was recorded as millimetres deflection of
the trace on the chart paper during the last 15 seconds
of the gas collection and read off the calibration curve
drawn that day for the analyser. Both analysers were
calibrated on each study day with four gas mixtures of
known 02 and C02 concentrations. Oxygen consumption
(V02; lmin-1 STPD) and carbon dioxide output (VC02;
lmin-1 STPD) were calculated off-line using standard
steady state equations (Rahn et al 1955 ) . The
respiratory exchange ratio (RQ) was also calculated.
• • •
The V02, VC02 and VE were measured between 5-7 and
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7.15-9.15 minutes after the onset of either rest or
exercise periods and between 5-7 minutes after the last
hypoxic episode to confirm that steady state gas
exchange had been achieved. Steady state gas exchange
was considered to have been achieved if the initial two
measurements of V02 were within 100ml. If this was not
achieved, then further two minute collections of mixed
expired gas were made until two consecutive values of
V02 were within 100ml.
iii) Measurement of the hypoxic ventilatory response
Hypoxic ventilatory drive was determined either at rest
(Chapter 6) or during exercise (Chapters 4,5,6,7,8),
under conditions of steady state gas exchange using
either transient or step change hypoxic stimuli.
iv) Transient hypoxia
The inspired gas was changed abruptly during an
expiration from room air to either 100% N2 or 1% 02 in
N2 for between 1 and 3 breaths ( depending on the tidal
volume) to cause a fall in ear oxygen saturation (Sa02)
to 80-90%. Inspired gas was then returned to room air
during an expiration. The transient hypoxic stimulus
was repeated at intervals of at least 40 breaths until
at least three acceptable stimuli were given (causing a
fall in Sa02 to 80-90%) with a maximum of 6 transient
stimuli being given. Isocapnia was maintained by the
addition of C02 close to the Hans Rudolph valve in the
inspiratory limb of the circuit to keep end-tidal C02
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constant.
v) Step change hypoxia
The inspired gas was abruptly changed during an
expiration to an hypoxic mixture which was sustained for
three minutes. The first inspired oxygen concentration
was selected to reduce Sa02 to 90-93% (usually Fj02 0.12
at rest, 0.15 on exercise ). The inspired gas was then
returned to room air, again during an expiration. The
subject breathed room air for at least 5 minutes before
the inspired gas was changed abruptly to a second
hypoxic mixture selected to reduce Sa02 to 85-88%
(usually Fj02 0.10 at rest, 0.12 on exercise) for three
minutes. Inspired gas was then returned to room air
during an expiration. Isocapnia was maintained during
the periods of hypoxia by the addition of C02 close to
the Hans Rudolph valve to keep end-tidal C02 constant.
Ill OFF-LINE DATA ANALYSIS
Analysis of data recorded breath-by-breath
Data was analysed off-line using custom-written programs
with a PDP 11/73 computer.
i) Elimination of spurious breaths
Breaths during which the subject swallowed, coughed or
sighed produced spurious values for inspiratory and
expiratory timing, and thus unusually large or small
values for VE inst. Such breaths were therefore
eliminated using a custom-written computer program if
54
they did not conform to the following criteria:
a) 2kPa < PErj,C02 < lOkPa
b) PETC>2 >2kPa
c) Vt > 0.151
d) T£ > 300ms
e) Tj > 500ms
However, not all spurious breaths could be identified by
this program especially those associated with
swallowing. The analogue trace of mouth pressure and
expiratory flow (simultaneously zero during a swallow)
were therefore used to identify a swallow which was then
deleted from the computer file along with the previous
and following breath (Fig 3.6).
ii) Calculation of hypoxic ventilatory response
Hypoxic ventilatory response was expressed as the slope
of the linear regression relationship between VEinst and
SaC>2.
For transient hypoxic stimuli, the data from the
breath before the onset of hypoxia and all breaths up to
and including the breath with the lowest Sa02 (ie. the
"on-phase" of the ventilatory response) were included in
the calculation. Data from acceptable transient hypoxic
stimuli (no spurious breaths for 10 breaths either side
of the onset of hypoxia and a fall in Sa02 to between 80
and 90%) were pooled. To take into account physiological
and instrumental lag, an iterative process was used to
calculate the best relationship between VEinst and Sa02
during the response to transient hypoxia, using the
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equation:
V£inst (breath n+z) = a+b (Sa02, breath n)
where z was allowed to vary from -5 to +5. Correlation
coefficients (r) of these relationships were calculated
and the slope of the VEinst/Sa02 relationship at the
most negative correlation was used to describe hypoxic
ventilatory drive to transient hypoxia (Fig 3.7).
The ventilatory response to step change hypoxia was
calculated from data ten breaths before the onset of
each hypoxic period and all breaths during each three
minute period of step change hypoxia. Data were then
analysed by least squares linear regression to produce a
slope for the VEinst/Sa02 relationship which were
generally negative (Fig 3.8).
iii) Calculation of baseline and hypoxic PETCC>2 values
Baseline PErpC02 was calculated as the mean of 20 breaths
before each hypoxic stimulus and 20 breaths five minutes
after the end of the last period of hypoxia. Step change
hypoxia PE-nC02 was calculated as the mean of 10 breaths
before and all breaths during the step change periods of
hypoxia. Transient hypoxia PETC02 was calculated as the
mean of all breaths included in the calculation of
transient hypoxic ventilatory response.
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Analogue traces drawing tidal volume, P]?tC02,
mouth pressure and expiratory flow. Mouth pressure
and expiratory flow are simultaneously zero during
a swallow.
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Fig3.7:Calculationofthesl peoftheVEinst/Sa02relation ipfollowing transienthypoxia. Lefthandside:hypoxicventil toryresponseexpr ssedasthslopeofthelinear regressionlin(),a d95%confidencelimits(),oftheVEinst/Sa02relatio hip atthemostsignificantnegativecorrelationatl g0,asshownitherig thandp ne . Righthandside:t ecorrelationcoeffi ient(r)forthelinearregressionre ationsh p betweenthSa02andtyginstforeacbr athcalculatedbt eequa iontfgi st(breath n+z)=ab(S 02ofbreathn)forthp ol ddata,fromthreebreathsbe ore,upo andincludingthebreathwiththlowesrecordedSa02.Thlagzincludesbot physiologicalandinstrumentalre ponsetim .
Fig 3.8 : Calculation
to step change hypoxic
for the ventilatory response
s timuli.
Sqq2 (%)
The hypoxic ventilatory response to step change
hypoxia expressed as the slope of the linear regression
line ( ). Each point represents the corresponding
values for Vginst and SaC^ for 10 breaths before and
all breaths during each three minute period of step
change hypoxia in subject 2. The 95% confidence limits
are given by the broken lines ( ).
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CHAPTER 4; REPRODUCIBILITY OF THE HYPOXIC VENTILATORY
RESPONSE AND MATHEMATICAL MODEL PARAMETER ESTIMATION
I INTRODUCTION
The ventilatory response to hypoxia varies widely
between individual normal subjects (Forster et al 1971,
Hirshman et al 1975, Kronenberg et al 1973, Rebuck et al
1973, Weil et al 1972, Anderton et al 1964). This may be
partly due to differences in body size since the hypoxic
ventilatory drive measured using progressive isocapnic
hypoxia has been shown to correlate with height, weight,
and body surface area (Hirshman et al, 1975). However,
studies in cats suggest that there is a between
individual difference in carotid body chemoreceptor
sensitivity to oxygen (Black et al 1971, Eyzaguirre et
al 1961). This difference in peripheral chemosensitivity
may be genetically determined (Moore et al 1976, Collins
et al 1978, Kawakami et al 1982a), and the inherited
intensity of the drive may be important in the
pathogenesis of some respiratory diseases (Flenley et al
1970, Mountain et al 1978, Fleetham et al 1984).
However, comparisons between individuals is
complicated by both the within day and between day
variability in the hypoxic ventilatory drive in an
individual. Both Anderton et al (1964) and Kronenberg et
al (1972) measured the ventilatory response to hypoxia
on two occasions within twenty minutes. Anderton et al
noted a greater increase in minute ventilation for the
same alveolar oxygen tension, whereas Kronenberg et al
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found no significant difference between the two
measurements in each subject. It has been suggested that
prior exposure to hypoxia potentiates the hypoxic
ventilatory drive (Davidson et al 1983, Jennett et al
1984) , and this may therefore influence measurements of
hypoxic ventilatory drive repeated within thirty
minutes. However, a diurnal variation in the sensitivity
to CC>2 and the C02 threshold has been reported (Koepchen
et al 1953 , 1954) and a similar variation to 02
sensitivity may affect measurements of hypoxic
ventilatory drive. This diurnal variation in hypercapnic
ventilatory drive may be due to the diurnal variation
in adrenocorticotrophic hormone (ACTH) which has been
shown to potentiate the ventilatory response to C02
(Koepchen et al 1954). Within day variability will also
be affected by meals as Zwillich et al (1977) have shown
that ingestion of carbohydrates potentiates the hypoxic
ventilatory drive.
The only study of between day variability in the
hypoxic ventilatory drive (Sahn et al 1977) showed a
greater between day than within day variability in the
ventilatory response to hypoxia. Sahn et al recorded
the ventilatory response to progressive isocapnic
hypoxia in eight normal subjects on 5 occasions 30
minutes apart on the same day, and over a period of
seven months. They reported a mean co-efficient of
variation of 19.4% for measurements made on the same
day, but found that the between day variability was more
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than 4 times as variable as the within day variability
in 5 of the 8 subjects. Thus there is a wide variability
in the measured hypoxic ventilatory response between
days even within an individual. Many physiological
changes may account for this variability. Sahn et al
noted that the between day variability could be
partially accounted for by variations in arterial pH
measured prior to each study. In women, hypoxic
ventilatory drive has been shown to vary with the
menstrual cycle, with an increased drive in the luteal
phase compared to the follicular phase (White et al
1983), probably due to the increased level of
progesterone at this time, which is known to increase
ventilatory responsiveness (Sutton et al 1975). Between
day variations in metabolic rate may also affect the
ventilatory response to hypoxia. Factors such as
exercise (Weil et al 1972), hyperthermia (Natalino et al
1977), hyperthyroidism (Zwillich et al 1976) and
ingestion of food (Zwillich et al 1977) which increase
metabolic rate have been shown to cause a rise in
hypoxic ventilatory drive, whereas myxoedema (Zwillich
et al 1975) or semi-starvation (Doekel et al 1976) which
decrease metabolism are associated with a fall in
hypoxic ventilatory responsiveness.
Thus if comparisons are to be made between
individuals, some estimate of the variability of the
method for assessing hypoxic ventilatory drive must be
known. The aim of this study therefore was to determine
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the between day variability of the ventilatory response
to transient and step-change hypoxic stimuli expressed
both conventionally as the minute ventilation/oxygen
saturation relationship, and by parameter estimation




The subjects were two male (2 and 4) and two female (1
and 3), aged 23-40 years. Their anthropomorphic and lung
function measurements are given in Appendix table 1.
Subjects 1,2 and 3 were non-smokers but subject 4
occasionally smoked cigarettes. None were taking any
medication at the time of the study.
ii) Protocol
Subjects 1,2, and 4 were studied at the same time of day
on ten consecutive weeks. Subject 3 was studied at the
same time of day on ten occasions over a period of 34
weeks, with an interval of at least a week between
studies. The total duration and day of the current
menstrual cycle was recorded for each study for the
female subjects. All fasted for at least four hours
before each study.
The subjects walked on a level treadmill at speeds of
1.35-1.55msec-1 which had previously been selected for
each individual and the same speed was used for the ten
studies. The subjects initially walked for 10 minutes
breathing room air to establish steady state gas
exchange. Mixed expired gas was collected between 5-7
and 7.15-9.15 minutes after the start of exercise, and
from 5-7 minutes after the last step change hypoxic
stimulus for calculation of V£, V02, VC02 and RQ to
confirm steady state conditions.
The ventilatory response was measured first to
transient hypoxia and then to step change hypoxia.
iii) Transient hypoxia
Inspired gas was abruptly changed during an expiration
from room air to 1% 02 in N2 for 1-3 breaths to cause a
fall in Sa02 to between 80-90%. Inspired gas was then
returned to room air during an expiration. The transient
hypoxic stimulus was repeated at 2 minute, or at least
40 breath, intervals until at least three acceptable
stimuli were given (Sa02 falling to between 80-90%). A
maximum of 6 transient hypoxic stimuli were given during
each study. Isocapnia was maintained by the addition of
C02 close to the Hans-Rudolph valve in the inspiratory
limb of the circuit to keep PETC02 constant.
iv) Step change hypoxia
Following the last transient hypoxic stimulus the
subjects breathed room air for at least 3 minutes.
The ventilatory responses to two levels of step change
hypoxia (Fj02 0.15 and 0.12) were then studied. Inspired
gas was abruptly changed during an expiration from room
air to 1% 02 in N2 for one breath. In the subsequent
expiration, inspired gas was changed to 15% 02 for the
remainder of the 3 minute period. The subjects then
breathed room air for at least 5 minutes. Inspired gas
was then abruptly changed during an expiration to 1% 02
in N2 for two breaths followed by 12% 02 for the
remainder of the 3 minute period. Inspired gas was then
returned to room air during an expiration. Isocapnia
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was maintained by the addition of C02 close to the Hans-
Rudolph valve in the inspiratory limb of the circuit to
keep PETC02 constant.
v) Analysis
The results of the transient hypoxic stimuli were pooled
and the response expressed as the slope of the VE
inst/Sa02 relationship as described in Chapter 3. The
results for the step change hypoxic stimuli were also
pooled and the response expressed as the slope of the
linear regression relationship between VEinst and Sa02
for 10 breaths before and all breaths during each 3
minute hypoxic period.
Baseline normoxic end-tidal C02 (PETC02) was
calculated as the mean of the 20 breaths before the
first transient stimulus, 20 breaths before each of the
step change hypoxic stimuli and 20 breaths five minutes
after the end of the last hypoxic period. The mean
PETC02 during transient hypoxia was calculated for all
breaths used in the analysis of the ventilatory
response. The mean PETC02 during step change hypoxia was
calculated for 10 breaths before each, and all breaths
during both 3 minute periods of hypoxia. Baseline
respiratory freguency (fR) and tidal volume (Vt) values
were calculated for each study as the mean of 20 breaths
before the first, transient stimulus, 20 breaths before
each of the step change hypoxic stimuli and 20 breaths
five minutes after the end of the last hypoxic period.
The ventilatory response to both transient and step
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change hypoxia was also analysed using the mathematical
model and the parameters derived which best described
the ventilatory response on each study day.
The Kruskal-Wallis one-way analysis of variance was
used to compare each set of ten baseline values for VE,
V02, VC02 and PETC02 for each subject between study
days, and also the PETC02 values during transient and
step change hypoxia with the corresponding baseline
normoxic values for each subject. Simple least squares
linear regression analysis was used to assess the effect
of baseline values for VE, V02, VC02 and PETC02 upon
• 9
transient VEinst/Sa02 slope, step change VEinst/Sa02
slope, gain 1 or gain 2. The coefficients of variation
were calculated for transient and step change




The values for baseline normoxic VE, V02 and VC02 for
each subject on the ten study days are given in Appendix
table 2. Although there was between day variability in
all three variables within a subject, none of these
differences were significant. The RQ value remained
below 1.0 for all studies in all subjects.
There was no significant difference in the mean
baseline PETC02 on the ten occasions in the four
subjects, although the differences between the means in
any one subject ranged from 0.10 kPa to 0.37 kPa
(Appendix table 3). Breath-by-breath variation in
PETC02, as indicated by the standard deviation, varied
from 0.07 to 0.32 kPa during normoxia. There was no
significant difference in any subject on any occasion
between mean PETC02 during transient or step change
hypoxia and the mean baseline normoxic value (Appendix
table 3). Breath by breath variation in PETC02 during
transient (sd 0.15 to 0.34 kPa) and step change (sd 0.09
to 0.23 kPa) hypoxia was similar to that seen during
baseline normoxic ventilation. There was a significant
correlation between baseline PETC02 and Vt or fR (p<0.02
and p<0.001, respectively).
Similar maximal falls in Sa02 were achieved on the ten
occasions in each individual subject in response to
either transient hypoxia, a step change hypoxic stimulus
using 15% 02, or a step change hypoxic stimulus using
12% 02 (Appendix table 4). There was also no significant
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difference between the mean lowest Sa02 achieved in
response to transient hypoxia or in response to a 12% 02
step change stimulus in an individual on any occasion.
Day to day variability in the ventilatory response to
transient and to step change hypoxia expressed as the
VEinst/Sa02 relationship is illustrated in Fig 4.1, with
the results summarised in Appendix tables 5 and 6. The
coefficient of variation for the response to transient
hypoxia varied from 22 to 32%, and for the response to
step change hypoxic stimuli from 19 to 37% (Table 4.1).
The between day variability in the parameters derived
using the mathematical model for the four subjects is
illustrated in Fig 4.2 with the results summarised in
Appendix tables 7 to 11 and the model of best fit for
subject 1 on three study days is given in Fig 4.3. The
co-efficients of variation ranged from 19 to 34% for
gain 1 and from 20 to 45% for gain 2. There was a
significant difference (p<0.001) between subjects for
gain 1 and gain 2 but not for tau 2. A positive value
for the inhibition parameter (I) was consistently needed
to obtain the best fit in subjects 2 and 4, although the
absolute value varied between days (Fig 4.2, Appendix
table 8) . In subjects 1 and 3, a negative value for I
(ie. potentiation) was generally needed to obtain the
best fit, with between day variation in the absolute
value for I. However, in subject 1 a positive value for
I was needed on study day 8, and in subject 3, the
parameter was not needed to obtain the best fit on study
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day 1 whereas a positive value for I was needed on study
day 3. The use of parameter sigma (the "saturating"
effect acting on gain 2) was less consistent. In subject
1, sigma was consistently needed to obtain the best fit,
but the absolute value for sigma was substantially lower
on study days 8, 9 and 10 compared to days 1 to 7. In
subject 4, sigma was only needed on one occasion (day
eight). In subjects 2 and 3, varying values for sigma
were reguired on six and four days respectively (Fig
4.2, Appendix table 11). The slow time constant, tau 2,
showed the greatest between day variation (Fig 4.2,
Appendix table 9), with co-efficients of variation
ranging from 75 to 121% in the four subjects (table
4.1). There was no correlation between the VEinst/Sa02
slope measured in response to transient or to step
change hypoxia or parameters gain 1 and gain 2 with
• • •
baseline normoxic VE, V02, VC02, or PErpC02.
Subject 1 had a regular 28 day menstrual cycle and
there appears to be a trend of a lower ventilatory
response in the follicular phase of the .menstrual cycle
than in the luteal phase (Fig 4.4). No similar trend
could be demonstrated in subject 3 but she did not have
a regular 28 day menstrual cycle. However, both male and
female subjects studied showed a similar variability in
either the VEinst/Sa02 slopes or the model gain
parameters.
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transient (--0--) and step change (—•—) hypoxia,
given for each subject on each study day.
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Table 4.1 Coefficient of variation values for transient
and step change hypoxia ^Einst/Sa02 slopes, gain 1, gain
2 and tau 2 (%)
Subj ect
transient VEinst/Sa02 23 22 25 32
step change VEinst/Sa02 19 37 30 37
gain 1 29 34 19 29
gain 2 20 45 40 40
tau 2 90 75 79 121
Coefficient of variation calculated as ( standard
deviation / mean ) x 100. Transient and step change
hypoxia VEinst/Sa02 slopes and gain 1 expressed as lmin-1%-1, gain 2 as lmin if sigma also required or as
lmin-1%-"1" if sigma not included and tau 2 in sec.
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Between-day variability of the model parameters for each
subject on each of ten study days. Gain 1 expressed as
lmin~1%_1; gain 2 as lmin-l if sigma also required or
as lmin~1%~1 if sigma not required; I as (lmin;
sigma as % and tau 2 as sec.
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Fig A.3 : Best fit model traces for subject 1 on
three study days.
For each study (1, 6 and 9) the upper trace shows the
model output (Vcalc) and the lower trace, the
experimental Vginst for subject 1. The model output,
the dotted line, is also superimposed on the
experimental data in the lower trace for each study
day.
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Fig 4.4 : Change of hypoxic ventilatory response with
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Day of menstrual cycle
The hypoxic ventilatory response expressed as the slope
of the Vj?inst/Sa02 relationship for transient and step
change hypoxia, and as the model gain parameters are
plotted against the day of the menstrual cycle. The
cross-hatched areas indicate the predicted (Best and
Taylor 1985) follicular and luteal phases of the cycle.
Each point represents the value obtained on a single
study day. Units for gain 2 are lmin~1 if sigma also
required or lmin~1%~1 if sigma not required to produce
the model of best fit.
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IV DISCUSSION
This study has shown that in four subjects studied at
the same metabolic rate on 10 occasions over a period of
10-34 weeks, the within-subject variability of the gain
parameters derived using the mathematical model was
similar to that of the VEinst/Sa02 relationships for the
responses to both transient and step change hypoxia. In
addition, there was a significant between-subject
difference in the model gain parameters.
The coefficients of variation for between-day
variability in the VEinst/Sa02 relationships of 22-32%
for transient hypoxic stimuli and 19-37% for step change
stimuli are similar to those reported by Sahn et al
(1977) . They found that the mean coefficient of
variation in response to progressive isocapnic hypoxia
was 19% for each subject over a two hour period, but the
between-day variability of this measurement was 1-15
times greater than the within-day variability.
The values for gain 1 showed a similar variability as
the VEinst/Sa02 relationships with the coefficients of
variation ranging 19-35%. Values for gain 2 showed a
similar variability with a range of coefficients of
variation of 19-45%. The time constant of equation 2,
tau 2 , was highly variable within each subject, with a
range of coefficients of variation from 75 to 121%. The
"inhibition" and "saturating effect" parameters of the
model showed some within-subject variability but were
generally either required or not required to produce the
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model of best fit for each subject. The similar
variability of the VEinst/Sa02 slopes and the model gain
parameters suggests that the variability of the model
gains is probably due to daily physiological changes
rather than random error of the parameter estimation.
The experimental values for VEinst/Sa02 found in this
study are comparable with a normal range of values
demonstrated by Rebuck and Campbell (1974) by a similar
method. The mathematical model showed significant
differences between the gain parameters of the four
subjects studied and may therefore be used to study
individual differences within a population.
This study did not aim to determine the causes of the
day-to-day variability of the hypoxic ventilatory
response. However, the effect of some factors were
minimised by the study design. The hypoxic ventilatory
response has been shown to increase with the level of
exercise (Weil et al 1972, Martin et al 1978). In this
study, the V02 did not vary significantly between the
ten studies in an individual, and in all studies the RQ
remained below 1.0 suggesting that the subjects
exercised below their anaerobic threshold (Buchfuhrer et
al 1983) . Thus it is unlikely that day-to-day
differences in the level of exercise were responsible
for the variations in the hypoxic ventilatory response.
Potentiation of the ventilatory response to hypoxia by
ingestion of carbohydrates (Zwillich et al 1977) was
avoided because all subjects fasted for at least four
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hours before each study. For all subjects, the fall in
SaC>2 produced by either transient or step change hypoxic
stimuli were consistent over the ten studies. Thus the
day-to-day variability in the hypoxic ventilatory
response cannot be attributed to variation in the size
of the stimuli.
Diurnal variation in the hypercapnic ventilatory
response due to a change in ACTH has been demonstrated
(Koepchen et al 1954), and may therefore also contribute
to the variability of the hypoxic ventilatory response.
Diurnal variation in the response was avoided by
studying all subjects at the same time of day (to within
one hour) on each occasion. A circadian rhythm of
wakefulness has been demonstrated (McFadden 1988), with
dips in wakefulness at around 2pm and 10pm. The periods
of increased drowsiness during mid-afternoon (when all
studies took place), would therefore have had a similar
effect on each study.
Both pH and PC02 interact with hypoxia at the
peripheral chemoreceptors to potentiate the hypoxic
ventilatory response (Eyzaguirre and Lewin 1961). Sahn
et al (1977) reported that the between-day variability
in the hypoxic ventilatory response in an individual was
at least partly due to a change in arterial pH. However,
they measured the pH of arterialised venous blood
which may not represent a true arterial pH. Arterial pH
was not measured in this study.
Although the differences between baseline normoxic
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PETC02 between study days were not statistically
significant for each subject, there was some variation
and this may partly account for the variability of the
response. For all four subjects studied, there was a
significant correlation between baseline PETC02 and
either fR or Vt. This suggests that between-study
changes in the baseline PETC02 were due to changes in
breathing pattern, which varies considerably between
days (Tobin et al 1988). Furthermore, throughout this
study, PETC02 is assumed to equal PaC02. End-tidal PC02
has been directly compared with simultaneously measured
PaC02 in normal subjects at rest and during exercise and
a small positive difference has been shown in PETC02 -
PaC02 as tidal volume and respiratory frequency increase
during exercise (Jones et al 1979, Cummins et al 1986).
Thus manual addition of C02 into the apparatus to keep
PETC02 constant may have introduced the possibility of a
slight variable degree of hypercapnia. However, several
studies indicate that at mild to moderate exercise
levels (as in this study) , (A-a) PC02 differences are
either unchanged or only very slightly changed from
resting values (Jones et al 1966, Whipp and Wasserman
1969) . Therefore the difference between PETC02 and
PaC02 was probably small and contributed little to the
between-day variability of the hypoxic ventilatory
response within an individual. Between-day changes in
normoxic baseline PETC02 probably therefore reflect
small changes in arterial PC02 initiated by a
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fluctuation in pH (Gabel and Weiskopf 1975).
Two of the four subjects studied ( 1 and 3) were
female. Progesterone, which is known to potentiate the
hypoxic ventilatory response (Sutton et al 1975), is
considered to be the cause of the increased response
during the luteal phase of the menstrual cycle (White et
al 1983, Regensteiner et al 1989). Subject 1 had a
regular 28 day menstrual cycle and demonstrated a trend
of a lower hypoxic ventilatory response during the
follicular phase of the menstrual cycle than in the
luteal phase. Subject 3 did not demonstrate such a trend
but did not have a regular 28 day menstrual cycle. Since
only two complete cycles were studied and the
progesterone levels in the blood were not measured, no
conclusions can be drawn from a trend in only one
subject. Nevertheless, changes in progesterone levels
may have contributed to the variability of the response
in the female subjects. However, it is unlikely that
these hormonal changes are the sole cause of the
variability, as the hypoxic ventilatory responses of the
male subjects (2 and 4) were no less variable than those
of the females.
Several other factors may be responsible for the
between-day variability in the hypoxic ventilatory
response. A variation in sympathetic activity may alter
peripheral chemoreceptor sensitivity (Briggs 1920,
Hickham et al 1951, Asmussen and Nielson 1957, 1958,
Biscoe and Purves 1967, Bhattacharyya et al 1970,
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Lugliani et al 1971, Weil et al 1972, Masson and Lahiri
1974, Leitch et al 1976, Martin et al 1978, Flenley et
al 1979) . A decrease in CNS activity during sleep has
been shown to cause a fall in the hypoxic ventilatory
reponse (Douglas et al 1982, Berthon-Jones and Sullivan
1982, Hedemark and Kronenberg 1982). The effect of
personality (Saunders et al 1972) and mental stimuli
(Morgan and Cameron 1984) upon the hypercapnic
ventilatory response in normal subjects has been
demonstrated and may also influence the hypoxic
ventilatory response.
In spite of a wide between-day variability of the
hypoxic ventilatory response and model parameters, there
were distinct differences between subjects, suggesting
that the model is capable of differentiating between
individuals and reflects true between-day physiological
variation in the ventilatory response. The mathematical
model therefore appears to be a reliable method for
estimation of the hypoxic ventilatory response in normal
subjects and may allow further investigation of factors
such as mood, central nervous system or sympathetic
activity which may be responsible for day-to-day
variability in the response.
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CHAPTER 5; THE EFFECT OF RATE OF ONSET OF HYPOXIA UPON THE
HYPOXIC VENTILATORY RESPONSE
I INTRODUCTION
In order to avoid central hypoxic depression of
ventilation (Weiskopf and Gabel 1975, Easton et al
1986), the transient hypoxic stimulus has often been
used specifically to measure peripheral chemoreceptor
mediated ventilatory drive (Dejours et al 1953, 1957b,
1958, 1963). However, the ventilatory response to
transient hypoxia may be attenuated as the time to reach
stable ventilation during step change hypoxia exceeds
the duration of the transient stimulus (Reynolds and
Millhorn 1973). A close correlation has been reported
between the ventilatory response to transient and either
steady state hypoxia (Kronenberg et al 1972, Edelman et
al 1973), or progressive isocapnic hypoxia (Shaw et al
1982, Warren et al 1984). However, Shaw et al (1982)
found the ventilatory response (expressed as the
VEinst/Sa02 slope) to transient hypoxia was
approximately half that to progressive isocapnic
hypoxia. Furthermore, Warren et al (1987) found that,
during moderate exercise, the slope of the VEinst/Sa02
relationship in response to transient hypoxic stimuli
was significantly lower than to 3 minute isocapnic step
change hypoxic stimuli produced by abruptly changing
inspired gas from air to 15% 02 and air to 12% 02. They
found that the half time of the response to 12% 02 was
on average three times the duration of the transient
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stimulus and therefore concluded that this contributed
to the underestimation of the hypoxic ventilatory drive
since insufficient time was available for the response
to develop. However, they also found that Fourier
deconvolution of the VEinst/Sa02 relationship showed a
difference between the amplitude/frequency plot of the
convolution function derived from the transient data,
and that derived from the step change data. These
results suggest that the response to transient or step
change hypoxia may not adequately be described by a
single linear system. They therefore concluded that the
ventilatory response was dependent on the rate of onset
of the stimulus.
Only two groups have studied the effects of differing
time courses of hypoxic stimuli upon the ventilatory
response. Dutton et al (1973) investigated the effects
of different perfusion rates of hypoxic blood into the
carotid bodies of 24 anaesthetised dogs using step,
ramp, pulse and pulse train hypoxic forcing functions.
In contrast to the abrupt increase in ventilation
observed during step forcing with hypoxic blood at the
carotid bodies, ramp forcing resulted in a ventilatory
response which developed more slowly than the decrease
in PC>2, especially during the first second of perfusion.
They observed that the large increase in tidal volume
within the first second occurred too rapidly to be
explained by even the fastest increase in neural
activity observed by Black et al (1971). They therefore
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concluded that at some site in the respiratory control
system central to the chemoreceptor, the initial change
in chemoreceptor activity triggered a signal for a
substantial ventilatory response, followed by little
further rise in ventilation despite a subsequent
increase in sinus nerve input. Hence an element of rate
sensitivity appeared to be present during step hypoxia,
even though there was no overshoot in ventilation.
Dutton et al also analysed the hypoxic ventilatory
response using a mathematical model which consisted of
two parallel pathways, each containing linear second-
order dynamics, one with fast pathway dynamics (time
constant 2.9 sec), and the second, a slow pathway (time
constant 13.9 sec). The input for the model was the fall
in PC>2, and the output, the ventilation ratio (hypoxic
ventilation divided by control ventilation) . They found
that an additional feed forward pathway with linear
dynamics and a time constant of 1 sec was required to
account for the initial rapid change in ventilation but
which was not responsive to subsequent rapid changes in
arterial oxygen tension. They concluded that the abrupt
increase in respiratory centre output at the onset of
severe hypoxia could provide an emergency mechanism for
rapidly raising alveolar oxygen tension in an intact
animal.
Bertholon et al (1989) are the only group to have
studied the effect of the rate of onset of an hypoxic
stimulus upon the ventilatory response in humans. They
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investigated stepwise increases and decreases of four
different levels of hypoxia with varying time courses in
7 healthy subjects. They found that the maximum
ventilatory responses were found at times 8 and 24
minutes after the start of hypoxia and these results
were similar to those obtained using a similar protocol
and C02 stimulation by the same group (Bertholon et al
1988). Measuring the difference between normoxic resting
V£ and that at a P^02 of 50 mmHg for each subject
(/\V50), they demonstrated that hypoxic sensitivity was
rate dependent with two preferential rates of rise for
the stimulus. They also used a mathematical model to
describe the ventilatory response which included a
central neural controller with no dynamics of its own
and a linear response to chemoreceptor inputs. However,
they found that the single compartment model could not
describe the two maxima of the ventilatory response
produced at times 8 and 24 minutes after the start of
hypoxia. They therefore suggested the existence of an
hypoxic threshold of activation for the regulatory
system, the value of which depended on the rate of rise
of the stimulus. They also hypothesised that the central
neural controller displays differential sensitivity
properties.
Bertholon et al (1989) investigated the ventilatory
response to hypoxic stimuli with longer time courses
than those studied by Warren et al (1987). Therefore,
the aim of this study was to investigate the effect of
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the rate of onset of an hypoxic stimulus when varied
between that of transient and step change hypoxic
stimuli (giving a mean time course of the fall in Sa02




The subjects were six healthy volunteers (3 male, 3
female), aged 22-39 years drawn from laboratory staff.
Their anthropomorphic and normal lung function details
are given in Appendix table 12. All subjects were non-
smokers apart from subject 3 who occasionally smoked
cigarettes and none were taking any medication at the
time of the study.
ii) Protocol
The subjects exercised for four 40 minute periods, each
separated by 15 minutes rest. They walked on a level
treadmill at a speed of between 1.35-1.60 msec-1 which
had previously been selected to produce a V02 of 10-
12mlmin-1kg-1, and the same speed was used for all four
exercise periods in an individual. The subjects
initially walked for 12 minutes breathing room air to
establish steady state gas exchange conditions. Mixed
expired gas was collected between 7-9 and 9.15-11.15
minutes after the start of exercise and from 5-7 minutes
after the end of the last hypoxic stimulus for
calculation of V^, V02, VC02 anc^ R(2 *-° confirm steady
state conditions.
The ventilatory response was measured either to
transient hypoxia or to one of three rates of onset of
step change hypoxia during exercise. The order of the
types of hypoxic stimuli were randomised.
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iii) Transient hypoxia
Inspired gas was abruptly changed from air to 100% N2
for two breaths to cause a fall in Sa02 to between 80-
90%. Inspired gas was then returned to room air during
an expiration. The transient hypoxic stimulus was
repeated six times at 60 breath intervals. Isocapnia was
maintained by the addition of C02 close to the Hans-
Rudolph valve in the inspiratory limb of the circuit to
keep PETC02 constant.
iv) Step change hypoxia
Three forms of step change hypoxia were given:
a) 1%+12% C>2 Inspired gas was abruptly changed during
an expiration from room air to 1% 02 in N2 for two
breaths followed by 12% 02 for the remainder of a three
minute period. Inspired gas was then returned to room
air during an expiration and the procedure was repeated
five minutes later.
b) 6%+12% 02 Inspired gas was abruptly changed during an
expiration to 6% 02 in N2 for two breaths followed by
12% 02 for the remainder of the three minute period.
Inspired gas was then returned to room air during an
expiration and the procedure was repeated five minutes
later.
c) 12% C>2 Inspired gas was abruptly changed during an
expiration to 12% 02 for three minutes. Inspired gas was
then returned to room air during an expiration and the
procedure was repeated five minutes later.
Isocapnia was maintained during the onset and duration
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of all step change hypoxic stimuli by the addition of
C02 close to the Hans-Rudolph valve in the inspiratory
limb of the circuit.
v) Analysis
Baseline normoxic PETC02 was calculated for each
section of the study as the mean of 20 breaths before
each hypoxic stimulus and 20 breaths five minutes after
the end of the last hypoxic stimulus. The mean PETC02
during transient hypoxia was calculated for all breaths
used in the analysis of the ventilatory response. The
mean PETC02 for each type of step change hypoxia was
calculated for 10 breaths before each and all the
breaths during both 3 minute periods of step change
hypoxia. The rate of onset of each type of stimulus was
calculated as the mean value for the Sa02 to fall to a
minimum for transient stimuli, or to the mean value for
step change hypoxic stimuli from the onset of hypoxia,
for each subject.
The results of the acceptable transient hypoxic
stimuli (Sa02 falling to between 80-90%) were pooled and
the response expressed as the slope of the VEinst/Sa02
relationship as described in Chapter 3. The data from
the two periods of step change hypoxia for each onset
type were also pooled for calculation of the hypoxic
ventilatory drive expressed as the negative VEinst/Sa02
slope.
The half-time of the ventilatory response for step
change hypoxia was calculated as the time from the onset
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of hypoxia for half the mean final minute Vginst to be
reached. The duplicate measurements at each rate of
onset of step change hypoxia were pooled with the
responses to transient stimuli for each subject. The
mathematical model was then used to derive a set of
unique parameters which best described the ventilatory
response for each rate of onset of step change hypoxia
for each subject.
Variables were compared using the Kruskall-Wallis one
way analysis of variance test (Colquhoun 1971) .
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Ill RESULTS
There was no significant difference between baseline gas
collection values for V£, V02 and VC02 for each section
of the study for each subject (Appendix table 13). The
respiratory quotient (RQ) was less than 1.0 throughout
the study for all subjects. Baseline PETC02 was not
significantly different for any subject during the four
exercise periods, and the maximal standard deviation
about the mean in PETC02 during hypoxia was 0.21kPa
(Appendix table 14).
Transient hypoxia caused a rapid fall in Sa02
accompanied by a brief rise in Vginst (fig 5.1) . Step
change hypoxic stimuli of 1% +12% 02, 6%+12% 02 and 12%
02 caused progressively slower rates of onset of hypoxia
with sustained rises in V£inst (fig 5.1).
The times for Sa02 to fall to a minimum value for
transient stimuli and to the mean value for step change
hypoxic stimuli are given in table 5.1. The rate of
onset of the transient hypoxic stimuli was significantly
shorter than that of the 6%+12% 02 or 12% 02 step change
hypoxic stimuli (p<0.05) but was similar to that of the
1%+12% 02 step change hypoxic stimuli. There was no
significant difference between the lowest Sa02 values
reached during transient hypoxia and any of the types of
step change hypoxia for each individual subject (table
5.2) .
To determine whether a steady state of ventilation had
been achieved for each type of step change hypoxia for
91
each subject, mean values of VEinst were calculated for
each 30 second block during the hypoxia. There was no
significant difference between mean V^inst values for
the periods 2-2.5 and 2.5-3 minutes after the start of
hypoxia for any subject during any type of step change
hypoxia.
The VEinst/Sa02 relationship ranged -0.70 to -4.29
— 1—1 . . . — 1—1
lmm % for transient hypoxia, -0.60 to -3.491mm %
for 1%+12% C>2 step change hypoxia, -0.47 to -3.60
— 1 — 1
lmm % for 6%+12% 02 step change hypoxia, and -0.72
— 1 — 1
to -3.481min % for 12% 02 step change hypoxia (table
5.3). The VEinst/Sa02 slope in response to transient
hypoxia was consistently greater than that for any rate
of onset of step change hypoxia in 3 subjects (2, 3 and
5), less in 2 subjects (1 and 6), and in one subject (4)
the responses to all four types of stimuli were similar
(figs 5.2 and 5.3). There was no significant difference
between the VEinst/Sa02 slope for transient hypoxia and
any rate of onset step change hypoxia for the group as a
whole (table 5.3, fig 5.2). There was no systematic
order effect upon the VEinst/Sa02 responses measured.
Mean half-times for the ventilatory response were 29
sec (range 14-44 sec) for 1%+12% 02 step change
hypoxia, 28 sec (range 21-44 sec) for 6%+12% 02 step
change hypoxia and 28 sec (range 17-42 sec) for 12% 02
step change hypoxia (table 5.4). There were no
significant differences between the half-times for the
ventilatory response to any of the rates of onset of
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hypoxia. Due to large breath-to-breath variability in
the hypoxic ventilatory response, the mean Vginst values
were calculated for each 30 second block throughout the
three minute period following the onset of each type of
hypoxia for each subject (fig 5.4) . There was no
significant difference between the corresponding mean 30
sec values for each type of hypoxia for each subject.
However, calculating the 30 sec mean of V£inst values
may smooth the transient ventilatory response, therefore
the VEinst/SaC>2 slope in response to the first 7 breaths
of each type of hypoxia was calculated for each subject.
There was no significant difference between the initial
7 breath VEinst/Sa02 slopes for each type of hypoxia.
The values for the mathematical model parameters at
each rate of onset of step change hypoxia are summarised
in table 5.5. In an individual, no consistent change in
gain 1 or gain 2 due to a change in the rate of onset of
hypoxia could be detected (table 5.5, fig 5.5). A wide
variation in tau 2 was demonstrated (table 5.5). There
was no systemmatic effect of the rate of onset of the
hypoxic stimulus upon the non-linear terms of the model.
Positive values for the inhibition parameter I were
consistently required by four subjects (1, 3, 4 and 5).
Negative values for I were consistently required by
subject 6. It was not always necessary to incorporate an
inhibition parameter to produce the model of best fit in
subject 2 (table 5.5). The saturating effect parameter
sigma was always required by subject 6 and never
required by subjects 2 and 3. For the remaining
subjects, the sigma parameter was sometimes necessary to
produce the model of best fit. Subjects 3 and 5 who
showed a greater slope for transient than for any type
of step change hypoxia also had a consistently greater
value for gain 1 than for gain 2. Subjects 1 and 6 who
showed a greater slope for step change than for
transient hypoxia also had consistently greater values
for gain 2 than for gain 1.
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Fig 5.1 : Effect of the four types of hypoxic







Breath-by-breath values are plotted against time for
Sa02 and Vginst. The upper trace shows the fall in
Sa02 in response to transient hypoxia ( ) and step
change stimuli of 1% + 12%C>2 ( ), 6% + 12%C>2 ( )»
and 12%C2 (....). The lower four traces show the
ventilatory response to a single stimulus of each type,
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Table 5.1 Onset time for hypoxic stimuli
Subject
number
Time for Sa02 to fall (s)
Stimulus type
Transient 1%+12% 02 6%+12% 02 12% 02
16. 7 21.5 32 . 4 34 . 4
14 . 0 14.8 30.5 30.3
16. 4 17.4 42 . 9 46.6
17 . 3 26 . 8 35.2 49 . 4
20.3 48 . 5 47 . 9 73 . 7













Mean duration for Sa02 to fall to a minimum value for
transient stimuli and to the mean value for step change
hypoxic stimuli. * represents a significant difference
(p<0.05) between the time for Sa02 to fall for the
different rates of onset of hypoxia.
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Table 5.2 Mean Sa02 values for transient hypoxic
stimuli and the minimum values during each
type of step change hypoxia for each subject
Mean Minimum step change Sa02 (%)
Subject transient
number Sa02 1%+12% 02 6%+12% 02 12% 02
1 80 86 85 85
2 87 87 85 88
3 84 82 82 85
4 86 83 83 85
5 87 82 81 82
6 86 84 82 81
There was no statistical difference between the fall in









































Fig 5.2 : Slope of Vginst/SaC^ for each subject at









Hypoxia Step Change Hypoxia
Each point represents the Vginst/Sa02 slope derived in
an individual at each rate of onset of hypoxia and the
symbols represent different subjects (1O? 2#; 3D;
'•fl: 5A ; 6^). There was no statistical difference
between the ventilatory responses at any rate of onset
of hypoxia.
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Fig 5.3 : Comparison of the ventilatory responses
to transient and 1% + 12%C>2 step change hypoxic
stimuli in two subjects.
Breath-by-breath values for Vginst (upper traces) and
SaC>2 (lower traces) are plotted against time for the
responses to transient hypoxia ( ) and 1% + 12%C>2
step change hypoxia ( ) for subjects 3 and 1. In
both subjects the initial abrupt fall in SaC>2 was
similar, however the ventilatory responses_differed.
Subject 3 showed an initial large rise in Vginst in
response to 1% + 12%C>2 which then fell to a lower steady
state level. Subject 1 showed a small initial rise in
Vginst in response to 1% + 12%02 which then increased
to a steady state level.
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Table 5.4 Mean half-times for the ventilatory response
to each type of step change hypoxia
Half-time (s)
Subject 1%+12% 02 6%+12% 02 12% 02
number
1 22 21 24
2 19 22 24
3 44 23 17
4 34 34 34
5 14 25 29
6 42 44 42
mean 29 28 28
s.d. 13 11 9
The half-time of the ventilatory response for each type
of step change hypoxia was calculated as the time in
seconds from
t the onset of hypoxia for half the mean
final minute V£inst to be reached.
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Fig 5.4 : Mean Vginst and SaO^ responses to the
four types of hypoxic stimuli in one subject.
Time (s)
Time (s)
Mean values for Vginst and Sa02 calculated over
consecutive 30 sec blocks are plotted against time
for the responses to transient (□—O) , and step
change hypoxic stimuli of 1 % + 12%C>2 (A A),
6% + 12%02 (0 -0), and 12%02 (t •). The
ventilatory response to the transient stimulus was
greater than to any of the step change stimuli in
spite of similar falls in SaC>2 . However, there
was no difference in the ventilatory response to
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Fig 5.5 : Model gain values for each subject at






















Each point represents the gain 1 or gain 2 parameter
derived in one subject at each rate of onset of
step change hypoxia (key as for Fig 5.2). There
was no statistical difference between either gain 1
or gain 2 at any rate of onset of step change
hypoxia. Units for gain 2 are lmin-1 if sigma
also included or lmin_1%-1 if sigma not required to
produce the model of best fit.
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IV DISCUSSION
The fall in Sa02 in response to transient hypoxia was
significantly faster than those due to 6%+12% 02 or 12%
02 step change hypoxic stimuli but similar in intensity.
However, no significant differences could be detected in
the ventilatory responses to these stimuli with
different rates of onset when expressed as either the
VEinst/Sa02 slopes, the final half minute steady state
ventilation values, the half-time for the ventilatory
response, mean 30 second Vginst values during hypoxia,
first 7 breaths of hypoxia VEinst/Sa02 slopes, or as the
model parameter values. The response to transient
hypoxia and the initial response to 1%+12% 02 step
change hypoxia were also similar for each subject.
However, although this study does not show significant
differences in the ventilatory responses to different
rates of onset of hypoxia for the group as a whole, the
results are qualitatively similar to those of Warren et
al (1987). They found that 12% 02 step change hypoxia
produced a greater ventilatory response than transient
hypoxia in 8 out of 10 subjects (personnal
communication), but the reverse in other subjects. In
this study, three subjects showed a greater ventilatory
response to transient hypoxia than to step change
hypoxia, two subjects showed the reverse and one subject
showed similar responses to all types of hypoxia
studied. A similar trend was seen in the model gain
parameters although not for tau 2 or the non-linear
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terms inhibition and sigma. This may suggest that the
mechanisms of the response may vary between subjects
although a statistically significant difference was not
possible due to the small number of subjects studied.
The results of this study cannot be compared directly
with the only previous study in humans by Bertholon et
al (1989), as their rates of onset of hypoxia were
— 1
generally slower ranging from 77 to 5 mmHgmin ,
compared to rates of approximately 165 to 32 mmHgmin-1
(calculated using the Severinghaus slide rule
[Severinghaus 1966] from the fall in Sa02 and assuming a
pH of 7.38) used in this study. However, they found that
the ratio of (Vg during hypoxia) / (Vg during rest) was
greater for the first 3 minute period of steady state
hypoxia than for the first 20 second period of step
change hypoxia, implying a rate of change of stimulus
effect. Their results suggest that the three minute step
change hypoxic stimuli used in this study would cause a
greater ventilatory response than the transient hypoxic
stimuli and this occurred in 2 of the 6 subjects in
this study.
The results of this study are similar to those
reported in dogs by Dutton et al (1973) who were also
unable to demonstrate a statistically significant
difference between the ventilatory responses to ramp and
pulse hypoxic stimuli. Dutton et al (1973) concluded
that an element of rate sensitivity was present during
step change hypoxia and at some site in the respiratory
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control system central to the chemoreceptors, the
initial change in chemoreceptor activity triggered a
signal for a substantial ventilatory response, followed
by little further increase in ventilation, despite a
subsequent rise in sinus nerve input. The initial rapid
increase in ventilation due to step change stimuli may
suggest some form of unique input to the control system
at the initiation of a change from control steady state.
Possible sources for this input may be rapidly adapting
vagal receptors in the bronchi (Knowlton and Larrabee
1946), or inspiratory neurons in the medulla facilitated
by lung inflation (Cohen 1969). Evidence that a rapidly
adapting augmentation of ventilation may be operating
during the first breath of step change hypoxia is
supported by the finding that vagotomy abolishes the
initial overshoot in tidal volume (Casaburi 1972) .
However, reductions in input to the respiratory centre
other than by vagotomy may have a similar effect on the
hypoxic ventilatory response.
The structure of the mathematical model derived by
Kirby et al (Warren et al 1989) which is used in this
study is similar to that of Dutton et al (1973) ,
consisting of two linear differential equations with
non-linearities although their model also incorporates
an additional linear feedforward pathway to account for
the rapid change in ventilation with a time constant of
1 second. Kirby et al (personal communication) also
attempted to incorporate a feed forward pathway into the
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model structure but found that inclusion of two non¬
linear terms instead produced a more capable model. The
model of Dutton et al (1973) also requires a non-linear
switching device to model the respiratory control system
adequately which may mimic the physiological central
facilitation of ventilation. Although the mathematical
model did not give any statistically significant
differences between the parameters at the different
rates of onset of hypoxia, a trend was shown with the
two subjects having a larger VEinst/Sa02 slope for
transient hypoxia than for step change hypoxia also
having consistently larger values for gain 1 than gain
2, and two subjects demonstrated the reverse. If the
rate of onset of the hypoxic stimuli were to affect the
ventilatory response, then the model parameters expected
to be affected are tau 2 and the inhibition parameter,
I. This effect could not be demonstrated in this study
although several factors may account for this. As
discussed in Chapter 4, the non-linear terms and tau 2
values tend to be very variable within a subject between
days hence any systematic change in these variables due
to a change in the rate of onset of the hypoxic stimulus
may be difficult to detect. Also, the model structure
was empirically derived to fit the data for transient
and 15 and 12% 02 step change hypoxic stimuli and it may
therefore not be applicable to analyse the ventilatory
responses to hypoxic stimuli with differing rates of
onset. Several experimental factors may have
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contributed to the failure to demonstrate changes in the
ventilatory responses to hypoxic stimuli with different
rates of onset. The duration of each study was at least
two hours and thus problems of subject fatigue may have
affected the results, particularly for the less fit
subjects, although this effect was minimised by
administering the tests in random order and allowing all
subjects to rest for at least 15 minutes between each
section of the study.
The large rise in ventilation in response to transient
hypoxia or two breaths of 1% 02 in N2 demonstrated
especially by subjects 2, 3 and 5 may be due to cortical
influences, with the subjects reacting to the sensation
of arterial oxygen desaturation, even though they were
distracted by music. However, it is egually likely that
cortical influences would also affect the response to
step change stimuli. Also, the oximeter value for Sa02
is not the actual chemoreceptor stimulus therefore the
exact rate of change of the stimulus at the carotid body
is unknown. However Sa02 is closely related to arterial
P02 (and therefore to carotid glomus P02), and provides
the only non-invasive measure of arterial oxygenation.
As only six subjects were studied, type II statistical
error may have contributed to the lack of any difference
in the ventilatory responses to different rates of onset
of hypoxia.
Although this study has not been able to demonstrate
an effect of the rate of onset of an hypoxic stimulus
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upon the ventilatory response, two patterns of response
are apparent. The physiological mechanisms for the
transient hypoxic response being less than step change
hypoxia response may be due the time course of the
transient stimulus being insufficient for the response
to develop, or due to central facilitation of
ventilation. The mechanism for the step change hypoxia
response less than the transient response may be
central depression of ventilation or a feed forward
pathway as suggested by Dutton et al ( 1973 ) . A
difference in the ventilatory response due to different
rates of onset of hypoxia may also be affected by the
peripheral chemoreceptor response time. However Black et
al (1971) have shown that the peripheral chemoreceptor
response to hypoxia (recorded from single or few fibre
strands of the carotid sinus nerve) was fast, reaching a
maximum within 1-5 seconds. Also, DeCort et al (1987)
showed in cats that the chemoreceptor discharge during
transient hypoxia was not significantly different from
that achieved at the same SaC^ during step change
hypoxia, either before or after treatment with the
specific chemoreceptor stimulant almitrine. This may
suggest that chemoreceptor discharge is independent of
the rate of onset of the hypoxic stimulus.
Evidence of central facilitation or inhibition of the
hypoxic ventilatory reponse comes from studies in
anaesthetised cats. Tenney and Ou (1977) showed that in
decerebrate cats, the ventilatory responses to hypoxia
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and hypercapnia were indistinguishable from control
studies. However, in decorticate cats, the occurrence of
tachypnea and slight hyperventilation on room air
suggest the existence of a tonic facilitatory influence
from the diencephalon (Redgate and Gellhorn 1958) on the
brainstem. As removal of the cortex exposes this effect,
there must normally be a tonic descending cortical
inhibitory influence which holds the system in balance.
The presence of a mechanism of peripheral chemoreceptor
excitation and a direct depression of the brain stem
respiratory complex by hypoxia was demonstrated by St.
John and Wang (1977) in decerebrate cats. They concluded
that central chemoreceptor afferent influences are
widely distributed throughout the medullary respiratory
complex, whereas peripheral chemoreceptor afferents
produce only a discrete and unequal excitation of
respiratory units. Dutton et al (1973) also found that a
non-linear switching device was required to model the
respiratory control system and suggested that this may
mimic the central facilitation of ventilation.This study
has not been able to demonstrate.any effect of the rate
of onset of an hypoxic stimulus upon the ventilatory
response, although previous evidence has suggested that
such an effect be important in determining the
ventilatory response. Further work is required to
investigate the central controller of ventilation,
looking at the central depression and facilitation of
ventilation and the recovery phase after hypoxia.
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CHAPTER 6: THE EFFECT OF EXERCISE LEVEL UPON THE HYPOXIC
VENTILATORY RESPONSE
I INTRODUCTION
It has long been recognised that the ventilatory
response to hypoxia is increased during exercise in
humans. Several groups (Briggs et al 1920, Hickham et al
1951, Asmussen and Nielson 1957, Flenley et al 1979)
have shown that the depression of ventilation during
inhalation of 100% O2 was greater during exercise than
at rest, and concluded that exercise potentiated the
peripheral chemoreceptor mediated hypoxic ventilatory
drive. A similar conclusion was drawn by Bhattacharyya
et al (1970) and Masson and Lahiri (1974) who
demonstrated a left upward shift of the VE/PAC02
relationship at a given level of hypoxia during mild
exercise as compared to rest in normal male subjects. A
rise in the threshold for the ventilatory response to
hypoxia has also been demonstrated by Hornbein and Roos
(1962) who found that whilst at rest ventilation did not
increase until P^02 fell below 60mmHg (8kPa) but during
exercise a reduction in PA02 to only 94mmHg (12.5 kPa)
was sufficient to cause a significant increase in
ventilation.
The potentiation of the ventilatory response to
hypoxia increases with the level of exercise. Two groups
(Weil et al 1972, Martin et al 1978) , using the
progressive isocapnic technigue, demonstrated an
increase in the shape parameter A with increasing V02
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measured at four levels from 0.25 lmin-1 (rest) to 1.20
lmin-1 in 8 normal men (Weil et al 1972) , or when
measured at rest, and at 1/3 and 2/3 V02max in 16 male
athletes (Martin et al 1978). However there may not be a
simple linear relationship between V02 and the hypoxic
ventilatory response. Flenley et al (1979) studied the
effect of transient relief of hypoxia (14% 02) by 30% 02
at rest and at two levels of exercise in four normal
males. Their data shows a greater increase in hypoxic
ventilatory sensitivity expressed as the VEinst/Sa02
relationship, for a rise in V02 from 1 to 2 lmin-1 than
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for an increase in V02 from rest to 1 lmm .
Furthermore, the data of Weil et al (1972), replotted as
the slope of the VEinst/Sa02 relationship (Flenley and
Warren 1983), shows a curvilinear rise in the hypoxic
ventilatory response with increasing V02 suggesting that
the degree of potentiation is greater at higher levels
of V02.
The mechanism of the potentiation of the hypoxic
ventilatory response during exercise remains unclear.
Mechanisms which have been proposed include increased
sensitivity of the peripheral chemoreceptors,
circulating chemical mediators, and muscle afferent
activity interacting centrally with chemoreceptor input.
Asmussen and Nielson (1958) first suggested that
exercise potentiated the hypoxic ventilatory response in
man due to an enhancement of carotid chemoreceptor
sensitivity. Other groups have drawn the same conclusion
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since they showed that the ventilatory response to
transient hypoxia (Leitch et al 1976) or transient
relief of hypoxia (Flenley et al 1979) , both of which
were considered to be measures of peripheral
chemoreceptor activity (Dejours et al 1957a), increased
with exercise. This hypothesis was supported by the work
of Lugliani et al (1971) who found that the ventilatory
response to hypoxia during exercise was abolished in
carotid body resected subjects, although their steady
state ventilatory response to exercise was intact. Thus
carotid chemoreceptor input is required for the
ventilatory response to hypoxia. However, these
receptors are not necessarily the site at which
potentiation of the response occurs. The evidence from
direct carotid sinus nerve recordings in animals is
conflicting. Biscoe and Purves (1967) found that passive
exercise of the hindlimbs caused a rapid increase in
carotid chemoreceptor activity during normoxia in
anaesthetised cats. However, Davies and Lahiri (1973)
were unable to demonstrate a rise in chemoreceptor
activity in response to passive hindlimb exercise in
either anaesthetised or decerebrate cats despite an
increase in ventilation. They therefore concluded that
exercise and hypoxia interact as ventilatory stimulants
at a central location rather than at the carotid
chemoreceptors. Hypermetabolism in cats induced by
intravenous administration of 2,4-dinitrophenol (DNP)
has been shown to have no effect upon peripheral
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chemoreceptor activity, however it did enhance the
central transduction of the carotid afferent nerve
resulting in an increased hypoxic ventilatory response
at any given level of hypoxia (Adams et al 1983). This
may be due to stimulation of muscle receptors
sensitive to metabolic rate. Changes in the
concentration of a circulating chemical mediator may be
responsible for the potentiation of the hypoxic
ventilatory response on exercise. One such possible
mediator is the catecholamine noradrenaline.
Catecholamines exist within the glomus cells of the
carotid bodies and are putative neurotransmitters for
the hypoxic stimulus (Alfes et al 1977). Noradrenaline
is known to potentiate the hypoxic ventilatory response
at rest in normal subjects (Cunningham et al 1963) and
circulating levels increase during exercise (Christensen
et al 1979). Furthermore plasma noradrenaline levels and
ventilation have both been shown to be higher during
hypoxic than during normoxic exercise (Clancy et al
1975), and are both reduced during inhalation of 100% 02
(Hesse et al 1981).
Central interaction may result from an increase in
muscle afferent feedback from either muscle stretch
receptors or from nociceptors stimulated by an increase
in metabolites in the hypoxic exercising muscle. A
local build up of anaerobic metabolites in exercising or
hypoxic muscle, or an increase in muscle stretch
receptor activity may cause an increase in muscle
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afferent activity leading to an increase in hypoxic
sensitivity. Sergeant et al (1981) showed that the
increase in ventilation which accompanied leg exercise
was maintained if the muscle venous outflow circulation
was occluded using cuffs around the thighs both during
and after exercise. This supports the hypothesis that
the increase in muscle afferent activity as a result of
metabolite build up, rather than release of chemical
stimulants from the muscle into the circulation may be
responsible for the potentiation of the ventilatory
response to hypoxia during exercise, especially since an
increase in blood lactate was observed following release
of the cuffs.
Since carotid chemoreceptor activity does not appear
to increase during hypoxic exercise in anaesthetised
cats (Davies and Lahiri 1973), the muscle afferents are
likely to interact centrally rather than by causing a
reflex increase in peripheral chemosensitivity perhaps
via sympathetic efferents. Conflicting evidence
regarding the role of muscle afferent activity acting
centrally to produce the ventilatory response comes from
the work of Duncan et al (1981) and Adams et al (1984a).
Both groups demonstrated a normal ventilatory response
to isometric arm exercise or electrical muscle
stimulation in patients with either sensory neuropathies
affecting forearm afferent nerves, or with traumatic
spinal cord transection respectively. Adams et al
(1984a) concluded that in spite of spinal cord
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transection with a presumed loss of muscle afferents
there was still a rapid ventilatory response to
electrically induced exercise which cannot be explained
by classical chemoreception, therefore suggesting an, as
yet, undetermined chemical stimulus.
Separation of peripheral and central mechanisms in
conscious humans has been difficult with previously
existing methodology and hence it has been difficult to
elucidate the site of potentiation. The aim of this
study, therefore, was to a) investigate further the
increase in the hypoxic ventilatory response at several
levels of exercise, and b) use the mathematical model to
analyse the hypoxic ventilatory response to investigate





The subjects were nine healthy volunteers (4 male, 5
female), aged 23-40 years (Appendix table 15) , drawn
from laboratory staff. The subjects were non-smokers
apart from subject 3 who occasionally smoked cigarettes.
All subjects had normal lung function (Appendix table
15) and none were taking any medication at the time of
the study apart from subject 7 who was taking
Terfenadine for mild hayfever.
ii) Protocol
Hypoxic ventilatory drive was measured using step change
hypoxia at rest and at three levels of exercise, apart
from subject 8 who was studied at rest and at two levels
of exercise, and subject 7 who was studied at rest and
at four levels of exercise. The levels of exercise at
which hypoxic ventilatory drive was measured ranged
between rest and the fastest speed at which each subject
could walk comfortably for at least half an hour (the
approximate duration of each section of the study).
Hypoxic ventilatory drive was always measured initially
at rest with the subject seated comfortably in an
armchair and then at the various levels of exercise in
random order. The subjects rested for 15 minutes between
each level of exercise.
At rest and at each exercise level the subjects
initially breathed room air in order to establish
conditions of steady state gas exchange. Mixed expired
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gas was collected between 7-9 and 9.15-11.15 minutes
after the start of either the rest period or each
exercise level, and from 5-7 minutes after the last step
change hypoxic stimulus for calculation of VE, V02, VC02
and RQ.
For the rest measurements an abrupt onset, sustained
fall in Sa02 to about 90% was achieved by changing
inspired gas to 1% 02 in N2 for two breaths and then to
12% 02 for the remainder of a three minute period. The
subjects then breathed room air for five minutes after
which an abrupt onset, sustained fall in Sa02 to about
80% was achieved by changing inspired gas to 1% 02 in N2
for two breaths and then to 10% 02 for the remainder of
three minutes. On exercise, similar falls in Sa02 were
achieved by changing inspired gas to 1% 02 in N2 for one
breath followed by 15% 02 for the remainder of three
minutes to achieve a stable Sa02 of about 90% and , five
minutes later to 1% 02 in N2 for two breaths followed by
12% 02 for the remainder of three minutes to achieve a
Sa02 of about 80%. All changes in inspired gas were made
during an expiration. Isocapnia was maintained by the
addition of C02 close to the Hans-Rudolph valve in the
inspiratory limb of the circuit to keep PETC02 constant.
iii) Analysis
Baseline normoxic PETC02 at rest and at each exercise
level was calculated as the mean of the 20 breaths
before each step change hypoxic stimulus and 20 breaths
five minutes after the end of the second hypoxic period.
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The mean PETC02 during step change hypoxia was
calculated from 10 breaths before and all breaths during
both three minute periods of hypoxia at rest and at each
exercise level.
The method for calculation of the slope of the
VEinst/Sa02 relationship is described in detail in
Chapter 3. The data from the two levels of step change
hypoxia at rest and at each exercise level were pooled
for calculation of the hypoxic ventilatory drive
expressed as the negative VEinst/Sa02 slope.
The ventilatory response to the two periods of step
change hypoxia at rest and each level of exercise were
also analysed using the mathematical model and the
parameters derived which best described the ventilatory
response at each exercise level. A double weighting was
applied to the start of each period of step change
hypoxia in order to compensate for the lack of transient
stimuli.
Differences between variables at rest and at the
various levels of exercise were tested using the
Kruskal-Wallis one-way analysis of variance.
Correlations between variables were calculated using
least squares linear regression. The increase in the
VEinst/Sa02 relationship from rest to light exercise was
compared with that from light to moderate exercise for




In all subjects V£, V02 and VC02 increased with
increasing exercise level (table 6.1). The mean values
for V02 at rest and during exercise were: rest 0.18+0.04
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lmm (range 0.09-0.24 1mm ); exercise level 1,
0.51+0.09 lmin-1 (range 0.40-0.67 lmin-1); level 2,
0 . 67 +0.lOlmin-1 (range 0.53-0.87 lmin-1); level 3,
0.91+0.15 lmin-1 (range 0.71-1.04 lmin-1). The
respiratory quotient (RQ) was equal to or less than 1.0
at all exercise levels except for subject 9, in whom it
was above 1.0 at the two higher exercise levels (1.15 at
level 2 and 1.04 at level 3).
Baseline PgrpC02 was not significantly different for
rest and the three levels of exercise (Appendix table
16) , although in one subject (subject 5) the mean value
during the highest exercise level was approximately
0.6kPa less than that at rest. There was no significant
difference between mean PETC02 values during step change
hypoxia and the corresponding exercise level baseline
values for any subject, and the standard deviation of
PErpC02 about the mean during hypoxia ranged from 0.07 to
0.21 kPa in the nine subjects.
Inspiration of 12% 02 at the different levels of
exercise or 10% 02 at rest produced similar maximal
falls in Sa02 (Appendix table 17), with the mean and
range for rest being 83% (81-87%), exercise level 1, 85%
(78-89%); level 2, 84% (81-87%); and level 3, 81% (77-
85%) .
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At rest, the VEinst/Sa02 relationship ranged +0.02 to
-1.85 lmin-1 (table 6.2) in the 9 subjects. The
VEinst/SaC>2 slope tended to increase (ie. to become more
negative) with increasing exercise level (fig 6.1, table
6.2), and was significantly different from rest at
levels 2 (p<0.02) and 3 (p<0.01) for the group as a
whole. Also for the group there was a significant
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correlation between VEinst/Sa02 and V02 (p<0.02, fig
6.2), V02/BSA (p< 0.0 5, fig 6.2), VC02 (p<0.01) and
baseline normoxic VEinst (p<0.01). When the increase in
VEinst measured as a result of step change hypoxia at a
Sa02 of 85% at each exercise level was expressed as a
proportion of the baseline V£inst, the increase at rest
ranged -2 to 219%, and during exercise the
proportional increase ranged 14 to 168%. There was no
correlation between the order in which the workloads
were studied and the corresponding hypoxic ventilatory
response measured. There was wide variation in V02
between subjects at each exercise level. In order to
investigate differences in the degree of potentiation of
the ventilatory response to hypoxia between subjects,
comparisons were made on the basis of V02 at rest, and
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during light (V02 0.4-0.67 1mm ) and moderate (V02
— 1 • • •
0.7-0.92 lmin ) exercise. The increase m VEinst/Sa02
from rest to light exercise ranged -0.15 to 0.70
lmin-1%-1 (mean -0.21 lmin-1%-1) , and from light to
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moderate exercise ranged 0 to 1.93 lmin %
(mean -0.46 lmin-1%-1). However, there was no
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significant difference between the percentage increase
from rest to light exercise (range 0 to 119%) and light
to moderate exercise (range 14 to 168%), for the group
(Fig 6.3) .
At rest, gain 1 ranged from 0.03 to 2.83 lmin-1%-1,
gain 2 from -0.56 to 5.33 lmin~^%-^ and tau 2 from 36 to
313 sec (Fig 6.4, table 6.3). A positive value for the
inhibition parameter was needed in 4 subjects, a
negative value in one subject, and the parameter sigma
was needed in 7 subjects (table 6.3). For the group as a
whole, both gain 1 and gain 2 tended to increase with
exercise (fig 6.4, table 6.3) and this increase was
significantly different from rest for both gains at
exercise levels 2 and 3 (gain 1, p<0.02; gain 2,
p<0.01). A positive value for the inhibition parameter
was consistently needed at rest and all exercise levels
in four subjects, but was not always required in the
remaining five subjects (table 6.3). A negative
inhibition parameter was not needed in any subject
during exercise . There appeared to be a trend with the
inhibition parameter decreasing as the exercise level
increased but this was not significant. Two subjects
consistently did not require the parameter sigma at rest
or on exercise, but in the remaining seven, sigma was
required to obtain the best fit on some occasions (table
6.3). A wide variation in tau 2 was demonstrated both
within and between subjects with resting values ranging
36 to 313 sec and exercise values ranging 1 to 329 sec
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(table 6.3). However, tau 2 did not consistently change
within an individual as the level of exercise increased.
For the group there was a significant correlation
between gain 1 and V02 (p<0.02), V02/BSA (p<0.05), VC02
(p<0.02), VEinst (p<0.01) and VEinst/Sa02 (p<0.001).
Gain 2 correlated with V02 (p<0.01), V02/kg (p<0.05),
V02/BSA (p<0.01), VC02 (p<0.01), V£inst (p<0.01) and
VEinst/Sa02 (p<0.001). Expression of V02 for each
9
subject per kg or m body surface area did not improve
the significance of the relationship with VEinst/Sa02
(Fig 6.2), gain 1 or gain 2.
To compare differences between individuals in the
effect of exercise on the gain parameters, the
exercise levels were divided into light and moderate on
the basis of V02 as described above. The mean rise in
— 1 — I
gam 1 from rest to light exercise was 1.04 lmm %
(range -0.45 to 2.57 lmin~"'"%~"'" ) and from light to
moderate exercise 0.38 lmin_^"%-^ (range -2.26 1 to 1.78
lmin-1%-1, Fig 6.5). The mean increase in gain 2 from
rest to light exercise was 0.74 lmin-1%-1 (range -2.59
to 1.98 lmin-1%_1 ) and from light to moderate exercise
was 0.15 lmin-"^-1 (range -2.57 to 1.61 lmin-"1"%-1, Fig
6.6).
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Table 6.2; y„ inst/SaO^ slopes at rest and
during steady state exercise.
V£ inst/Sa02 (lrain~^%~^)
Subject Rest level 1 level 2 level 3 level
1 -0.75 -0.77 -1.57 -1.32 -
2 -1.85 -1.70 -3.63 -4.66 -
3 -0.23 -0.45 -0.56 -0.35 -
4 +0.02 -0.22 -0.06 -0.50 -
5 -0.26 -0.96 -0.73 -0.96 -
6 -0.32 -0.37 -0.53 -0.49 -
7 -0.33 -0.46 -0.70 -0.62 -0.79
8 -0.25 -0.65 -1.12 - -
9 -0.19 -0.49 -0.57 -0.94 -
Hypoxic ventilatory drive expressed as the slopes of the
VEinst/Sa02 relationship at rest and at various levels
or steady state exercise arranged in order of increasing
*°2-
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0-2 0*4 0*6 0-8 1:0 12
Vq2 Umin"1)
The Vginst/Sa02 relationship is plotted against VO2 for
all levels of exercise in the 9 subjects. Each point
represents the value obtained in a subject at a given
level of exercise and the symbols denote individual
subjects (1 O; 3(^|; 4 Q; 5A 5 6A 5 90).
The hypoxic ventilatory response expressed as the
Vginst/Sa02 relationship increased with increasing
exercise level.
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Fig 6.3 : The VEinst/SaC>2 relationship at rest and
during light and moderate levels of exercise.
0-7-0 920-09-0-24 04-067
V02 dmin"1)
The hypoxic ventilatory response expressed as the
VEinst/Sa02 relationship is plotted for each subject
for rest, light (V02 0.A-0.67 lmin-1) and moderate
exercise (V02 0.7-0.92 lmin"1). Each point represents
the value obtained at that level in an individual.
The symbols denoting individual subjects are the same
as in Fig 6.1 .
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Fig 6.4 : The effect of increasing exercise level upon
the model gain parameters.
Each point represents the model gain 1 or gain 2
parameter for each subject (as illustrated in Fig 6.1)
during rest and at the different levels of exercise.
Both model gain parameters increased with increasing
exercise level. Units for gain 2 are lmin-1 if sigma
also required, or lmin-1%-1 if sigma not required to
produce the model of best fit.
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Fig 6.5 : The effect of increasing exercise level on
gain 1.
0 09-0-24 0-4-0-67 07-0 92
Vq^ (L min"1)
Gain 1
The hypoxic ventilatory response expressed as the
model gain 1 parameter value is plotted for each subject
for- rest, light (VO2 0.4 - 0.67 lmin"^) and moderate
exercise (VO2 0.7 - 0.92 lmin-1 ) . Each point represents
the value obtained at that level in an individual. The
symbols denoting individual subjects are the same as in
Fig 6.1.
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The hypoxic ventilatory response expressed as the model
gain 2 parameter value is plotted for each subject for
rest, light (VO2 0.4 - 0.67 lmin-1), and moderate
exercise (VO2 0.7 - 0.92 lmin-1). Each point represents
the value obtained at that level in an individual. The




The hypoxic ventilatory response expressed as the
VEinst/SaC>2 relationship was greater during exercise
than at rest and significantly correlated with baseline
normoxic V02, VC02 and Vginst. This increase in the
hypoxic ventilatory drive with exercise confirms the
findings of Weil et al (1972) and Martin et al (1978).
The hypoxic ventilatory response expressed as the model
gain parameters was also greater during exercise than at
rest and both gain 1 and gain 2 also correlated with the
normoxic exercise V02, VC02 and VEinst. In this study,
the proportional rise in VEinst during hypoxia
(expressed as a percentage of the normoxic baseline
value) varied widely with increasing exercise level
within an individual (range 74 to 159%) . However, Martin
et al (1978) found that the percentage rise in V£inst to
be constant at approximately 20 + 2% above the baseline
normoxic value over a wider range of exercise, although
hyperoxia (ie. no chemoreceptor input) preceded
progressive isocapnic hypoxia in that study.
There was riot a consistent increase in VEinst/Sa02
slope or the gain parameters as the intensity of
exercise rose in each individual subject. Subject
fatigue may have contributed to the variability of the
increase in hypoxic ventilatory response with increasing
exercise level although this was reduced by giving the
workloads in random order and allowing the subjects to
rest for 15 minutes between each exercise level.
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Furthermore, there was no correlation between the order
in which the workloads were studied and the hypoxic
ventilatory response. Other factors must therefore
account for the observed variability in the ventilatory
response. Measurements of hypoxic ventilatory response
are known to vary widely within an individual over a
period similar to this study. Sahn et al (1977) have
demonstrated a coefficient of variation for the hypoxic
ventilatory response ranging from 8 to 64% over a period
of 2 hours.
As 02 and CC>2 interact at the peripheral
chemoreceptors, any change in PaC02 may also affect the
hypoxic ventilatory response (Nielson and Smith 1951,
Eyzaguirre and Lewin 1961, Lahiri and Delaney 1975).
Although the differences between baseline normoxic
PETC02 at each exercise level were not statistically
significant for the group, there was some individual
variation which may partly account for the variability
of the response. A further problem is that in this
study, PETC02 is assumed to equal PaC02 and this
assumption may not be correct. However, as discussed in
Chapter 4, Jones et al (1966) and Whipp and Wasserman
(1969) have shown that at mild to moderate exercise
levels, as in this study, the differences between PETC02
and PaC02 probably contribute little to the variation in
the hypoxic ventilatory response.
The increase in the VEinst/Sa02 slope at a given level
of exercise varied widely between subjects hence there
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was individual variation in the potentiation of the
hypoxic ventilatory response. If population studies are
to be made at a particular level of exercise, eg. V02=1
lmin"1, this variation in the degree of potentiation
between individuals may influence the comparison of the
hypoxic ventilatory response between individual
subjects. In this study of only 9 subjects, the
correction of V02 for subject weight or body surface
area did not improve the significance of the
relationship with VEinst/Sa02 slope or the gain
parameters. However, in a population study with a wider
range of subject age, body size and fitness, the level
of exercise may contribute a varying level of exercise
potentiation to the hypoxic ventilatory response between
subjects, hence it may be more appropriate to correct
V02 for subject weight or body surface area.
The above factors probably also contribute to the high
variability of the gain parameters with increasing
exercise level. However, the model structure may not be
applicable at different levels of exercise as the model
was developed to describe the ventilatory response to
both transient and step change hypoxic stimuli at an
exercise level of approximately 1 lmin-1. In this study,
although transient hypoxic stimuli were not given, the
step change hypoxic stimuli incorporated an abrupt fall
in Sa02 (one or two breaths 1% 02 in N2) to allow
calculation of the short time constant component. Also,
the lack of transient hypoxic stimuli was compensated by
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the application of a double weighting to the start of
each of the periods of step change hypoxia. Use of this
double-weighting method to compensate for the lack of
transient hypoxic stimuli appears to be valid as
subjects 1, 2 and 3 also completed a repeatability
study, involving both transient and step change hypoxic
stimuli (Chapter 4, subjects 1, 2 and 4) and similar
results were obtained during moderate exercise for
VEinst/SaC>2 slope, gain 1 and gain 2. A quantitative
analysis of the model goodness of fit is not possible,
however similar F values were obtained at all levels of
exercise for an individual, indicating that the fit was
as good at all exercise levels.
The mechanism of the observed increase in hypoxic
ventilatory response remains unclear but proposed
mechanisms include increased sensitivity of the
peripheral chemoreceptors, circulating chemical
mediators, and increased muscle afferent activity
interacting centrally with chemoreceptor input. Both
gain 1 and gain 2 increased with increasing exercise
level. If gain 1 is assumed to represent the peripheral
chemoreceptor response (with a time constant of less
than 3 sec), and gain 2, the central response, then the
involvement of a combination of both mechanisms is
implied. Enhancement of carotid chemosensitivity during
mild exercise as shown by the increase in gain 1, is in
agreement with previous suggestions of Briggs et al
(1920), Hickham et al (1950), Asmussen and Nielson
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(1957, 1958), Biscoe and Purves (1967), Bhattacharyya et
al (1970), Lugliani et al (1971), Weil et al (1972),
Masson and Lahiri (1974), Leitch et al (1976), Martin et
al (1978) and Flenley et al (1979). Some form of central
interaction from muscle afferent activity, as shown by
an increase in gain 2, would be consistent with the
proposal by Davies and Lahiri (1973) who were unable to
demonstrate an increase in peripheral chemoreceptor
activity in response to passive hindlimb exercise in
either anaesthetised or decerebrate cats despite an
increase in ventilation and Sergeant et al (1981).
However, this hypothesis has been refuted by Duncan et
al (1981) and Adams et al (1984a). Thus, both peripheral
and central mechanisms are probably involved in the
potentiation of the hypoxic ventilatory response with
mild exercise.
This study has demonstrated an increase in hypoxic
ventilatory response with increasing exercise level and
suggests that the parameter analysis using the
mathematical model can quantify physiological changes
affecting both the peripheral and central mechanisms of
the ventilatory response. Further studies are required
to elucidate the precise mechanism of ventilatory
stimulation such as the measurement or noradrenaline
levels in the blood before, during and after hypoxia and
investigation of the effect of lack of muscle afferent
activity in patients with spinal cord lesions upon the
ventilatory response to hypoxia.
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CHAPTER 7; THE EFFECT OF ORAL THEOPHYLLINE UPON THE
HYPOXIC VENTILATORY RESPONSE
I INTRODUCTION
The methylxanthines caffeine, theophylline and
aminophylline can cause an increase in ventilation when
given systemically. Aminophylline is a complex of two
molecules of theophylline and the simple diamine,
ethylenediamine which is used to increase solubility. It
is assumed that only theophylline, which contributes 85%
of the complex, causes the respiratory effect. This
stimulation of ventilation has been shown to occur with
either caffeine or aminophylline in normal adults
(Lakshminarayan et al 1978), adults with, pulmonary
emphysema or Cheyne-Stokes respiration (Dowell et al
1965) , human neonates (Gerhardt et al 1977) and in a
variety of animal species including dogs, cats, sheep
and rabbits (Eldridge et al 1983) .
Methylxanthines have also been shown to increase the
hypoxic ventilatory response in man. Lakshminarayan et
al (1978) demonstrated an increase in hypoxic
ventilatory response to progressive isocapnic hypoxia,
resting V02 and VC02 in six normal subjects after
intravenous administration of aminophylline (mean plasma
level 9.41ugml-1, range 7 . 7-11.3ugml_1) . Similarly,
Sanders et al (1980) found an increase in the
ventilatory response to progressive isocapnic hypoxia
but only after P^C02 was raised to the control level
before the administration of either intravenous or oral
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theophylline (oral aminophy11ine mean plasma level
8.8ugml-1, standard deviation about the mean 1.7ugml-1).
Georgopoulos et al (1989) showed that the ventilatory
decline due to prolonged hypoxia could be prevented by
pretreatment with intravenous aminophylline in 10 normal
subjects. However, an increase in the ventilatory
response to hypoxia was not shown by Swaminathan et al
(1989) with oral theophylline in 15 normal subjects
(mean plasma level 11.3ugml-1, range 5.3-22.lugml-1),
although several subjects were below the therapeutic
range of 10-2Ougml-"'".
The bronchodilator effects of the methylxanthines have
been attributed to the inhibition of phosphodiesterase
(Butcher and Sutherland 1962), cellular uptake of
calcium ( Kolbek et al 1979), and adenosine antagonism
(Ally and Nakatsu 1976) . The central stimulation of
ventilation by methylxanthines may be due to the
alteration of dopamine (Lundberg et al 1981) and
serotonin levels (Mueller et al 1981) or a change in the
receptor activity in the brain of these compounds.
However the stimulation of ventilation by theophylline
is largely attributed to its action as an adenosine
antagonist. This was demonstrated by Lagercrantz et al
(1984), who showed that the respiratory depression due
to administration of adenosine analogues to rabbit pups
could be reversed by theophylline. Animal studies have
indicated that the action of the methylxanthines is
central (Eldridge et al 1985, 1983; Millhorn et al
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1984). Eldridge et al (1985) showed that adenosine given
systemically or injected directly into the third
cerebral ventricle of 19 cats depressed respiration and
systemically administered theophylline reversed this
depression of ventilation. They therefore suggested that
adenosine acts as a tonic modulator of respiration and
that theophylline stimulates respiration by competitive
antagonism of adenosine at neuronal receptor sites.
Furthermore, cerebral adenosine has been shown to
increase during hypoxia (Winn et al 1981, Daly et al
1981).
In humans, the evidence for the central stimulatory
action of aminophylline upon the hypoxic ventilatory
response comes mainly from the work of Easton et al
(1988a). They found that the ventilatory decline during
sustained hypoxia was not completely abolished by
pretreatment with aminophylline but most of the
ventilatory depression was due to changes in breathing
pattern.
This aim of this study was to investigate the effects
of oral theophylline, a proposed central stimulant of
respiration, upon the hypoxic ventilatory response and
to investigate whether the slow time constant equation
of the mathematical model represents the central




The subjects were 6 healthy volunteers (3 male, 3
female), aged 23 to 65 years. Their anthropomorphic and
normal lung function details are given in Appendix table
18. All subjects were non-smokers apart from subject 1
who was an occasional cigarette smoker.
ii) Protocol
The subjects initially took oral theophylline (Astra,
Theodur slow release preparation, Weinberger and
Hendeles 1984) , 12 hourly at 8am and 8pm in order to
establish the reguired dose to produce a plasma
theophylline level of 10-20 ugrnl-^. This dosage was used
in the subsequent study. The trial period was followed
by a washout period of at least two weeks after which
the subject took either theophylline or placebo for 15
days. The order was randomised and double-blind. All
subjects abstained from taking coffee throughout the
five week study period. The two limbs of the study were
separated by at least one week, during which neither
drug nor placebo were taken. Measurements were made on
day 15 of each limb of the study and each individual was
studied at the same time of day on both occasions. The
subjects did not fast on day 15 but all took a light
breakfast at least one hour before the measurement of
hypoxic ventilatory response. The FEV^ and specific
airways conductance (SGaw) were initially recorded. SGaw
was calculated from (1/Raw)/VG measured using a Fenyves
1 4 2
body plethysmography A blood sample was then taken from
the antecubital vein (2 to 4 hours after the last dose),
and subsequently analysed for plasma theophylline
concentration using a high performance liquid
chromatographic method (Evenson and Warren 1976).
Ventilation and gas exchange were then measured at rest,
followed by the hypoxic ventilatory response during
exercise using both transient and step change methods.
a) Measurement of resting ventilation and gas exchange
Resting ventilation and gas exchange were measured with
the subject seated in an armchair and breathing room air
through the apparatus described in Chapter 3 . They
rested initially for 10 minutes to establish steady
state gas exchange. Mixed expired gas was then collected
between 10-12 and 12.15-14.15 minutes after the start of
the rest period for calculation of VE, V02, VC02 and RQ.
Minute ventilation, tidal volume, respiratory frequency,
inspired and expired gas concentrations and heart rate
were also recorded breath-by-breath over the same 15
minute period.
b) Measurement of the hypoxic ventilatory response
The subjects walked on a level treadmill at speeds of
_ 1
0.90-1.35 msec which had previously been selected to
*
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produce a V02 of about 10 mlmin kg , and the same
speed was used for each subject for both treadmill
studies. They initially walked for 10 minutes breathing
room air. Mixed expired gas was collected between 5-7
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and 7.15-9.15 minutes after the start of exercise, and
from 5-7 minutes after the last step change hypoxic
stimulus for calculation of VE, V02, VC02 and RQ to
confirm that steady state conditions existed during the
measurement of the hypoxic ventilatory response.
The ventilatory response was measured first to
transient hypoxia and then to step change hypoxia.
Transient hypoxia
Inspired gas was abruptly changed during an expiration
from room air to 1% 02 in N2 for 1-3 breaths to cause a
fall in Sa02 to between 80-90%. Inspired gas was then
returned to room air during an expiration. The transient
hypoxic stimulus was repeated at 2 minute or at least 40
breath intervals until at least three acceptable stimuli
were given (Sa02 falling to between 80-90%). A maximum
of 6 transient hypoxic stimuli were given during each
study. Isocapnia was maintained during the transient
stimuli by the addition of C02 close to the Hans-Rudolph
valve in the inspiratory limb of the circuit to keep
PETC02 constant.
Step change hypoxia
Following the last transient hypoxic stimulus the
subjects breathed room air for at least 3 minutes.
The ventilatory responses to two levels of step change
hypoxia (fj°2 0-15 and 0.12) were then measured.
Inspired gas was abruptly changed during an expiration
from room air to 1% 02 in N2 for one breath. In the
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subsequent expiration, inspired gas was changed to 15%
02 for the remainder of the 3 minute period. The
subjects then breathed room air for at least 5 minutes.
Inspired gas was then abruptly changed during an
expiration to 1% 02 in N2 for two breaths followed by
12% 0>2 f°r t^ie remainder of the 3 minute period.
Inspired gas was then returned to room air during an
expiration. Isocapnia was maintained during the onset
and duration of the step change hypoxic stimuli by the
addition of C02 close to the Hans-Rudolph valve in the
inspiratory limb of the circuit to keep PETC02 constant.
iii) Analysis
Resting respiratory frequency (fR) , tidal volume (Vt)
and baseline PE^C02 values were calculated as the mean
of 20 breaths, eight minutes after the start of the rest
period.
Baseline normoxic PETCC>2 during exercise was
calculated as the mean of the 20 breaths before the
first transient stimulus, 20 breaths before each of the
step change hypoxic stimuli and 20 breaths five minutes
after the end of the last hypoxic period. The mean
PETC02 during transient hypoxia was calculated for all
breaths used in the analysis of the ventilatory
response. The mean PETC02 during step change hypoxia was
calculated using 10 breaths before and all breaths
during both 3 minute periods of hypoxia.
The results of the transient hypoxic stimuli were
pooled and the response expressed as the slope of the
1 45
VE inst/SaC>2 relationship as described in Chapter 3.
The results for the step change hypoxic stimuli were
also pooled and the response expressed as the slope of
the linear regression relationship between Vginst and
SaC>2 for 10 breaths before and all breaths during each 3
minute hypoxic period.
The ventilatory response to both transient and step
change hypoxia was also analysed using the mathematical
model and the parameters derived which best described
the ventilatory response on each study day.
The Kruskal-Wallis one way analysis of variance test
was used to compare normoxic baseline PETC02 with the
corresponding values during transient and step change
hypoxia for each subject. Other variables were compared
using Wilcoxon's signed rank test.
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Ill RESULTS
Theophylline was not detected in the plasma in any
subject when taking placebo. When taking theophylline,
plasma levels ranged from 4.4 to 11.4 ugml-1, with two
subjects (2 and 3) being outside the therapeutic range
of 7-20 ugml-1 (table 7.1). There were no significant
differences in the resting baseline measurements of
FEV-l, SGaw, VE, V02, V02/kg, VC02, fR, Vt and PETC02
when the subjects were taking placebo or theophylline
(Appendix table 19). Due to technical problems, the SGaw
could not be measured in subject 5 on the theophylline
limb of the study. At rest, the RQ value was equal to,
or less than 1.0 for all subjects taking either placebo
or theophylline. There were no significant differences
between the exercise baseline measurements of VE, V02,
V02/kg and VC02 when the subjects were taking either
placebo or theophylline (Appendix table 20) . During
exercise, the RQ value was less than or equal to 1.0 in
all subjects taking either placebo or theophylline,
except for subject 1 in whom it was 1.01 when taking
placebo (Appendix table 20).
Baseline normoxic PETC02 values during exercise were
not significantly different on theophylline or placebo,
although the greatest difference between the two mean
values was 0.99 kPa in subject 5 (Appendix table 21).
There was no significant difference between the mean
PErpC02 during either transient or step change hypoxia
and the corresponding baseline values for each subject
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on either limb of the study (Appendix table 21).
The mean values for the fall in Sa02 due to the
transient hypoxic stimuli or the minimum value of Sa02
during step change hypoxia, did not differ significantly
when the subjects took either placebo or theophylline
(table 7.2).
The ventilatory response to transient hypxia
(expressed as the VEinst/Sa02 relationship) ranged from
-0.68 to -2.67 lmin-1%-1 on placebo (although this
measurement could not be made in subject 3 due to
technical problems), and from -0.33 to -1.85 lmin-1%-1
on theophylline (table 7.3). On theophylline the
ventilatory response to transient hypoxia was increased
in two subjects and was decreased in three subjects (Fig
7.1). The ventilatory response to step change hypoxia
(expressed as the VEinst/Sa02 relationship) ranged from
-0.33 to -1.38 lim-^-1 on placebo, and -0.46 to -1.35
lmin-1%-1 on theophylline (table 7.3). On theophylline
the ventilatory response to step change hypoxia was
increased in four subjects and decreased in two subjects
(Fig 7.1). There was no significant difference between
the VEinst/Sa02 slopes in response to either transient
or step change hypoxia when the subjects took either
placebo or theophylline (Fig 7.1).
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Table 7.1 Plasma theophylline levels for all subjects
taking either placebo on one limb of the
study and oral theophylline on the other, in
a randomised order
PLASMA THEOPHYLLINE LEVEL (ugml -1)
Subject






6 0 10. 5
The plasma theophylline level considered to be
therapeutic is 7 to 20 ugml-1.
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Table 7.2 Mean Sa02 values for transient hypoxic
stimuli and the minimum values during 12%
02 step change hypoxia for each subject







































There was no statistical difference between the fall in
Sa02 due to either type of hypoxia for any subject
taking either placebo or theophylline.
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Table 7.3 Vginst/Sa02 slopes in response to transient
(trans) and step change hypoxia (step) for




trans step trans step
1 -1.22 -0.44 -1.64 -0.46
2 -0.83 -0.33 -0.33 -0.74
3 - -0. 61 -0.91 -1. 07
4 -1.22 -1.15 -1.18 -0.51
5 -2.67 -1.38 -1.85 -0. 56
6 COVO•01 -1.25 -1.01 -1.35
VEinst/Sa02 slopes expressed as lmin"1%"1
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Fig 7.1 : Effect of theophylline upon the hypoxic
ventilatory response.
Each point represents the Vginst/Sa02 relationship
in response to transient (upper panel) and step change
hypoxia (lower panel) for each of 6 subjects. For
each subject, the ventilatory responses on placebo and
theophylline are joined by a line. Closed circles on
the theophylline limb of the study represent a plasma
theophylline level within the therapeutic range and open
circles, a level outside the range of 7-20ugml-^.
1 52
The gain 1 parameter values ranged from 0.02 to 4.15
lmin-1%-1 on placebo, and -0.02 to 2.94 lmin-1%-1 on
theophylline (table 7.4). On theophylline, the gain 1
parameter was increased in two subjects and decreased in
four subjects (Fig 7.2). Gain 2 ranged from -2.7 0 to
3.71 lmin-1%-1 on placebo, and 1.26 to 3.65 lmin-1%-1 on
theophylline (table 7.4). On theophylline, the gain 2
parameter increased in three subjects and decreased in
three subjects (Fig 7.2). There was no significant
difference between either the gain 1 or gain 2 values
when the subjects took either placebo or theophylline
(Fig 7.2). On placebo, the values for tau 2 ranged from
25 to 339 sec and on theophylline this range was 25 to
268 sec, with no consistent changes apparent (table
7.4). The inhibition parameter was reguired in three
subjects (1, 2 and 4) on the placebo limb of the study
— 1 — 1
(range 0.05 to 0.51 (lmm ) ), and in two subjects (1
and 5) on the theophylline limb of the study (range 0.04
to 0.19 (lmin-1), table 7.4). The saturating effect
parameter was required in three subjects on placebo (2,
4 and 6, range 0.05 to 0.24%), and in three subjects on
theophylline (1,3 and 4,range 0.07 to 0.53%, table 7.4).
There was no obvious relationship between the plasma
theophylline level of each subject during the
theophylline limb of the study and the hypoxic
ventilatory response expressed as either the Vginst/Sa02
relationship, or as the model parameters gain 1 or gain
2 (Figs 7.1 and 7.2).
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Each point represents the value derived for gain 1
(upper panel) or gain 2 (lower panel) for each of
6 subjects. For each subject, the gain values derived
on placebo and theophylline are joined by a line.
Closed circles on the theophylline limb of the study
represent a plasma theophylline level within the
therapeutic range and open circles, a level outside
the range. Units for gain 2 are lmin-1 if sigma
also required, or lmin-1%-'' if sigma not required to
produce the model of best fit.
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IV DISCUSSION
This study has been unable to demonstrate any effect of
oral theophylline upon the hypoxic ventilatory response
expressed as either the VEinst/Sa02 relationship or as
the model gain parameters. However, only six subjects
were studied, and in two of them the level of
theophylline measured was outside the therapeutic range.
Previous evidence suggests that theophylline increases
both resting normoxic ventilation and that during
hypoxia by specific central adenosine antagonism
(Eldridge et al 1983, 1985 ; Millhorn et al 1984;
Lagercrantz et al 1984; Lakshminarayan et al 1978;
Sanders et al 1980 ; Easton et al 1988b) . Such an
increase in the hypoxic ventilatory response due to
intravenous aminophylline was demonstrated by
Lakshminarayan et al (1978), and Sanders et al (1980) at
similar plasma levels to those achieved in this study.
However, an increase in the hypoxic ventilatory response
could not be demonstrated by Swaminathan et al (1989),
also with oral theophylline at plasma levels similar to
those in this study.
Several reasons could account for this failure to
demonstrate a consistent effect of theophylline upon the
hypoxic ventilatory response. Previous hypoxic
ventilatory response reproducibility studies by Sahn et
al (1977) and Chapter 4 of this thesis have shown that
the between-day variability of the response is at least
20% in normal subjects. Thus this variability may have
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masked the effect of theophylline upon the hypoxic
response. Furthermore, three of the subjects (3, 4 and
6) were female, and each were studied after a 15 day
interval, hence potentiation of the hypoxic ventilatory
response by progesterone (Sutton et al 1975, White et al
1983, Regensteiner et al 1989) may have contributed to
the lack of any effect of theophylline upon the hypoxic
ventilatory response in these subjects.
It is unlikely that the failure to demonstrate a
consistent effect of theophylline was due to differing
degrees of potentiation of the hypoxic ventilatory
response by exercise on the two limbs of the study (Weil
et al 1972, Martin et al 1978). In this study the
subjects walked at the same speed on both limbs of the
study and the V02 did not vary significantly between
placebo and theophylline days. Also, all subjects
exercised below their anaerobic threshold (Buchfuhrer et
al 1982) . Also, although all subjects took a light
breakfast approximately two hours before each study, the
degree of potentiation of the hypoxic ventilatory
response due to the ingestion of carbohydrates (Zwillich
et al 1977) would have been similar on the two days.
Each subject was studied at the same time of day (to
within one hour), hence any diurnal variation in the
response (as demonstrated for the hypercapnic
ventilatory response, Koepchen et al 1954) was avoided.
For all subjects, the fall in Sa02 produced by either
transient or step change hypoxic stimuli were consistent
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between the two studies. Therefore the lack of a change
in the hypoxic ventilatory response due to theophylline
cannot be attributed to variation in the size of the
stimuli. Although the differences between baseline
normoxic PETC02 either at rest or during exercise were
not statistically significant between the two limbs of
the study, the variation may partly account for the lack
of a response. An increase in the hypoxic ventilatory
response could be demonstrated by Sanders et al (1980)
only after P^C02 was raised to the control level before
the administration of intravenous or oral aminophylline.
However they reported an increase in baseline resting
ventilation and a consequent fall in PAC02 following
aminophylline. Since no such increase in resting
ventilation was observed in this study, it was not
necessary to increase PETC02 to the baseline placebo
level and unlikely that the lack of a change in the
response after theophylline was due to a change in
PAco2.
Adenosine has been shown to specifically stimulate the
carotid body chemoreceptors in anaesthetised cats
(McQueen and Ribeiro 1981, 1983). Maxwell et al (1986)
demonstrated an increase in resting normoxic ventilation
and hypoxic ventilatory response in six normal subjects
after adenosine infusion. They attributed this increase
in the hypoxic ventilatory response to peripheral
chemoreceptor stimulation. As theophylline acts
centrally as an adenosine antagonist, thus stimulating
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ventilation, then any effect of theophylline is likely
to be due to an imbalance in the opposing and
interacting peripheral and central adenosine mechanisms
and may therefore account for the disparity of published
results.
This study has been unable to demonstrate any effect
of oral theophylline upon the hypoxic ventilatory
response expressed either as the VEinst/Sa02
relationship or as the model gain parameters. As only
four subjects demonstrated plasma theophylline levels
within the therapeutic range, the lack of any consistent
effect of theophylline upon the hypoxic ventilatory
response may be due to the small number of subjects
studied. Further studies are required with the plasma
theophylline level well into the therapeutic range (ie.
15-20 ugml-"'") in order to confirm or refute previous
work suggesting the central action of oral theophylline
as a stimulant of the hypoxic ventilatory response.
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CHAPTER 8: FAMILIAL ASPECTS OF THE HYPOXIC VENTILATORY
RESPONSE
I INTRODUCTION
In man, the hypoxic and hypercapnic ventilatory drives
to breathing vary widely between healthy individuals
(Hirshman et al 1975) and the intensity of the drive may
be important in the pathogenesis of chronic obstructive
pulmonary disease (COPD). It was suggested by Dornhorst
(1955) that patients suffering from COPD may be divided
into two groups: the "pink puffers" who have relatively
normal arterial blood gas tensions, and the "blue
bloaters" who have low Pa02, high PaC02, cor pulmonale
and pulmonary hypertension. The two types of COPD cannot
be distinguished by the degree of emphysema or the
extent of airways obstruction (Thurlbeck 1976). Both
Flenley et al (1970) and Bradley et al (1979) have shown
that patients with the "blue and bloated" form of COPD
had a low hypoxic ventilatory drive.
Various studies suggest that the intensity of the
hypoxic ventilatory drive is partly determined
genetically. Scoggin et al (1978) compared the
ventilatory response to progressive isocapnic hypoxia in
16 non-athletic, healthy parents and siblings of 5
successful long-distance endurance athletes to those of
34 non-athletic controls. They found that the hypoxic
ventilatory drive was decreased to a similar extent in
the runners and their families when compared to the
control subjects and concluded that familial factors
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make a major contribution to the decreased hypoxic
ventilatory drive observed in long-distance runners.
Several groups have investigated the familial aspects
of hypoxic ventilatory drive by studying pairs of
identical and nonidentical twins. Leitch et al (1975)
measured the ventilatory responses to hypoxia and
hypercapnia in one pair of identical twin athletes
trained to a similar high degree and found the responses
to be virtually identical. Collins et al (1978) measured
the ventilatory response to progressive isocapnic
hypoxia and hyperoxic hypercapnia at rest in 12 pairs of
identical and 12 pairs of nonidentical twins. They found
a significant correlation for hypoxic ventilatory drive
for identical twin pairs but not for nonidentical twin
pairs which were independent of body size, blood PC02
and pH. No such correlation was found for the
ventilatory response to hyperoxic hypercapnia.
To investigate whether the genetically determined
intensity of the ventilatory response to hypoxia
determines the severity of hypoxaemia in COPD, Kawakami
et al (1982a) compared the Pa02 of 25 patients with
stable COPD (air, 9.59 + 1.52 kPa) with the hypoxic
ventilatory response of their 34 sons measured using the
progressive isocapnic hypoxia technique at rest. They
showed that the hypoxic ventilatory drive of the sons
expressed as the parameter A, as defined by Weil et al
(1970), correlated significantly with the Pa02 of the
patients when in stable state, and with the PaC02 and
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PaC02 during an acute exacerbation. They also made
similar comparisons in an age-matched control group of
17 patients with silicosis and their 22 sons and found
that in silicosis, no significant relationships were
observed between patients and sons with respect to
arterial blood gas determinations and the ventilatory
responses, except for PaC02 of patients and hypercapnic
ventilatory response of their sons. They concluded that
familial factors are involved in determining the
arterial blood gases and hypoxic ventilatory response in
COPD, and blunted chemosensitivity to hypoxia may
precede clinically manifest COPD.
The role of familial factors in determining arterial
blood gas values in COPD was confirmed by Fleetham et al
(1984) who showed that an abnormal chemical drive to
breathing was present in patients with COPD which
antedates the development of chronic C02 retention. They
measured the ventilatory and PQ ^ responses to
progressive hypoxia and hypercapnia in 14 patients with
COPD (air, PaC>2 6.93 + 0.81 kPa) and in 23 of their
normal adult offspring and found that the hypoxic
responses in the patients were positively correlated
with the mean hypoxic responses of their offspring but
neither the hypercapnic responses nor the resting
breathing patterns of the patients correlated with those
of their offspring. They also showed that the hypoxic
ventilatory response was lower in offspring of
hypercapnic patients than in offspring of normocapnic
1 62
patients. They concluded that blunt hypoxic responses in
patients with COPD are influenced by familial factors
and may represent a premorbid "risk factor" in the
development of C02 retention in COPD.
It was proposed by Flenley (1978) that the observed
interindividual differences in hypoxic ventilatory drive
were due to differences in peripheral chemosensitivity
to hypoxia. This hypothesis was recently supported by
evidence of large interindividual differences in carotid
sinus nerve responses to hypoxia observed in
anaesthetised cat preparations (Vizek et al 1987).
However, both Kawakami et al (1982a) and Fleetham et al
(1984) used the progressive isocapnic hypoxia technique
which may be susceptible to central depression of
ventilation in certain individuals (Weiskopf and Gabel
1975, Easton et al 1986). The following study aims to
investigate both the specific peripheral chemoreceptor
and central hypoxic ventilatory responses by using both
transient and short duration steady state isocapnic
hypoxia techniques.
The aims of this study therefore were:
a) to determine the relationship between the Pa02 of
patients with COPD and the peripheral and/or central
hypoxic ventilatory drive of their offspring.
b) to determine whether the spectrum of responses in the
offspring differed from those of an age and sex matched




The 24 patients with chronic obstructive pulmonary
disease (COPD) were recruited from those attending the
Department's clinic. Arterial blood gas tensions were
measured when they were all in a stable condition (no
exacerbation of COPD for at least 3 weeks) and showed a
wide range of arterial blood gas tensions (Pa02 5.12-
9.49 kPa, PaC02 4.9-12.0 kPa, on air), and severity of
airways obstruction (FEV-^ 12-43 %pred, table 8a).
Arterial blood samples for gas tensions and pH were
obtained by direct puncture of the brachial artery.
Samples were analysed in triplicate within 10 minutes of
withdrawal using a Radiometer ABL II automatic gas
analyser. The electrodes were calibrated automatically
every two hours using high and low pH buffer solutions,
and 02 and C02 mixtures prepared by the analyser from
primary gases. In addition, the analyser was calibrated
manually twice weekly against blood tonometered with gas
mixtures of known P02 and PC02. Thirty nine of their
offspring were initially recruited. Four were
subsequently withdrawn from the study as two were found
to have abnormal lung function, one had mitral valve
disease and one had rheumatoid arthritis. The 35
offspring of these patients were all first generation
sons and daughters and their anthropomorphic and normal
lung function details are given in Table 8b and Appendix
table 22. The offspring group consisted of 20 males and
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15 females (aged 18 to 47 years) and 19 of the group
were cigarette smokers. Of the offspring group there
were 16 single offspring, 5 pairs of siblings and 3
groups of three siblings.
Twenty six control subjects were studied who were sex
and age-matched (to within 3 years) with the offspring
group and whose parents had no history of COPD. They
were recruited from friends or spouses of the offspring
group and all had normal lung function. The control
subjects anthropomorphic and lung function details are
given in Table 8b and Appendix table 23. None of the
control group were withdrawn from the study due to
abnormal lung function or on medical grounds. The
control group consisted of 15 males and 11 females (aged
19 to 50 years) and 5 of this group were cigarette
smokers. All 26 control subjects came from different
families.
Similar measurements were made in both groups. All
subjects fasted for at least one hour before the hypoxic
ventilatory response study and none were taking any
medication (including the contraceptive pill) at the
time of the study.
After the measurement of hypoxic ventilatory drive a
10ml venous blood sample was taken from 33 of the
offspring and all 26 of the control group for
determination of haemoglobin and carboxyhaemoglobin
levels by co-oximetry using an Instrumentation
Laboratory 282 co-oximeter.
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Table 8a Summary of the lung function and arterial
blood gas details of the patients
n 24
sex 10 M; 14 F
age (years) 68 (59-80)
FEV-l (%pred) 23 (12-43)
FVC (%pred) 53 (22-85)
FEV^FVC (%) 32 (13-67)
Pa02 (air, kPa) 7.01 (5.12-9.49)
PaC02 (air, kPa) 6.95 (4.90-8.70)
Values are given as mean and range
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Table 8b Summary of anthropmorphic and lung function
details of the offspring and control groups
Offspring Controls
n 35 26
sex 20 M; 15 F 15 M; 11 F
age (years) 35 (18-47) 33 (19-50)
height (m) 1.72 (1.58-1.85) 1.73 (1.59-1.84)
weight (kg) 71 (53-98) 70 (51-91)
FEV^ (%pred) 94 (77-112) 97 (80-112)
FEV-j/FVC (%) 81 (61-93) 81 (69-92)
TLC (%pred) 96 (71-115) 97 (78-124)
RV/TLC (%) 28 (21-41) 26 (18-56)
TLCO (%pred) 80 (64-102) 92 (60-120)
Values are given as mean and range
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ii) Protocol
The subjects walked on a level treadmill at speeds of
0.92 to 1.55ms-1 which had previously been selected to
produce a VC>2 of about 12mlmin-1kg-1 for each
individual. They initially walked for 10 minutes
breathing room air to establish steady state gas
exchange. Mixed expired gas was collected between 5-7
and 7.15-9.15 minutes after the start of exercise, and
from 5-7 minutes after the last step change hypoxic
stimulus for calculation of VC>2, VCC>2, VE and R to
confirm steady state conditions.
The ventilatory response was measured first to
transient hypoxia and then to step change hypoxia.
iii) Transient hypoxia
Inspired gas was abruptly changed during an expiration
from room air to 1% 02 in N2 for 1-3 breaths to cause a
fall in Sa02 to between 80-90%. Inspired gas was then
returned to room air during an expiration. The transient
hypoxic stimulus was repeated at 2 minute (or at least
40 breath) intervals until at least three acceptable
stimuli were given (Sa02 falling to between 80-90%). A
maximum of 6 transient hypoxic stimuli were given during
each study. Isocapnia was maintained by the addition of
CC>2 close to the Hans-Rudolph valve in the inspiratory
limb of the circuit to keep PETC02 constant.
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iv) Step change hypoxia
Following the last transient hypoxic stimulus the
subjects breathed room air for at least 3 minutes. The
ventilatory response to two levels of step change
hypoxia (Fj02 0.15 and 0.12) were then studied. Inspired
gas was abruptly changed during an expiration from room
air to 1% 02 in N2 for one breath. In the subsequent
expiration, inspired gas was changed to 15% 02 for the
remainder of the 3 minute period. The subjects then
breathed room air for at least 5 minutes. Inspired gas
was then abruptly changed during an expiration to 1% 02
in N2 for two breaths followed by 12% 02 for the
remainder of the 3 minute period. Inspired gas was then
returned to room air during an expiration. Isocapnia was
maintained during the onset and duration of hypoxia by
the addition of C02 close to the Hans-Rudolph valve in
the inspiratory limb of the circuit to keep PE,pC02
constant.
v) Analysis
For each subject the results of the transient hypoxic
stimuli were pooled and the response expressed as the
slope of the VEinst/Sa02 relationship as described in
Chapter 3. The results for the step change hypoxic
stimuli were also pooled and the response expressed as
the slope of the linear regression relationship between
VEinst and Sa02 for 10 breaths before and all breaths
during each 3 minute period of hypoxia.
For each subject, unique parameters describing the
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ventilatory response to both transient and step change
hypoxia were derived using the mathematical model. For
subjects in whom the ventilatory response to transient
hypoxia could not be measured, a double weighting was
applied to the start of each of the periods of step
change hypoxia for parameter estimation by the
mathematical model.
Baseline normoxic PETC02 was calculated as the mean of
20 breaths before the first transient stimulus, 20
breaths before each of the step change hypoxic stimuli
and 20 breaths, five minutes after the end of the last
hypoxic period. The mean PETC02 during transient
hypoxia was calculated for all breaths used in the
analysis of the ventilatory response. The mean PETC02
during step change hypoxia was calculated for 10 breaths
before each and all breaths during both 3 minute periods
of hypoxia.
Correlations between variables were assessed using
least squares linear regression analysis. Baseline
PETC02 was compared with that during transient and step
change hypoxia for each subject using the Kruskal-Wallis
one way analysis of variance method. The Pa02 of the
patients was related by stepwise multiple regression
analysis in order to assess the combined effect of
several variables, including body surface area, weight,
V02 , VC02, VE, slopes of VEinst/Sa02 and model
parameters. The results from the 26 age and sex matched
pairs of control and offspring subjects were compared
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ing the Wilcoxon signed rank test.
171
Ill RESULTS
i) Offspring of patients with COPD
Values for baseline normoxic VE, V02 and VC02 for each
subject are given in Appendix table 24. The mean V02 was
0.85 lmin-1 (s.d. 0.2 lmin-1,range 0.52 to 1.43 lmin-1),
and when expressed per kg body weight was 11.9
mlmin-1kg-1 (s.d. 1.8mlmin-1kg-1, range 8.6 to 16.2
— 1 —1
mlmm kg ). The RQ value was below 1.0 in all but five
subjects (subjects 1,11,19,26,27) in whom it ranged from
1.06 to 1.10. For each individual, there was no
significant difference between baseline PETC02 and the
mean values during either transient or step change
hypoxia, and the standard deviation of PETC02 about the
mean during hypoxia ranged from 0.08 to 0.36kPa
(Appendix table 25). There was also no significant
difference between the mean lowest Sa02 in response to
either transient or step change hypoxia in an individual
(table 8.1).
A response to transient hypoxia could not be measured
in three subjects for technical reasons. The slope of
the VEinst/Sa02 slope ranged -0.24 to -2.36 lmin_1%-1,
and in response to step change hypoxia ranged +0.37 to
_ _ . — "I — 1
-1.75 1mm % (table 8.2). In one subject (subject
11), minute ventilation fell during step change hypoxia,
resulting in a positive VEinst/Sa02 slope. For the group
of patients with COPD, no correlation could be
demonstrated between the Pa02 on air, and either FEV1 or
the FEV1/FVC ratio. The Pa02 of the patients did not
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correlate with the ventilatory response to transient
hypoxia of their offspring expressed as the VEinst/Sa02
relationship (Fig 8.1). Expression of the VEinst/Sa02
slope in response to either transient or step change
hypoxia per body surface area did not alter the
significance of the relationships with the patients Pa02
values. However, the Pa02 of the patients did correlate
(p<0.01) with the ventilatory response to step change
hypoxia of their offspring expressed as the slope of the
VEinst/Sa02 relationship (Fig 8.1). The values assigned
to the model parameters ranged from -1.45 to 4.17
lmin~^%~^ for gain 1, from -1.83 to 3.85 lmin-"^-1
for gain 2, and from 1 to 588 sec for tau 2. A negative
value was required for the inhibition parameter, I in
— 1 — 1
two subjects (range -0.05 to -0.26 (lmm ) ) and a
positive value in 15 subjects (range 0.08 to 0.62
(lmin-"*") ) . Sigma was required in 14 subjects and
ranged from 0.11 to 3.92%. The individual values for all
parameters are given in table 8.3. The Pa02 of the
patients did not correlate with the values for gain 1
derived in their offspring (Fig 8.2), but did correlate
with the values for gain 2 (p<0.05, Fig 8.2). Stepwise
multiple regression analysis showed that the Pa02 of the
patients was best predicted by a combination of both
gain 1 and gain 2 of their offspring (p<0.01) as
described by the equation:
Pa02 (patient) = (0.35+0.14) gain 2 + (0.30+0.15) gain 1
+ (6.08+0.35)
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Table 8.1 Mean Sa02 of the transient hypoxic stimuli
(trans) and lowest 12% 02 step change Sa02





































































Table 8.2 VEinst/Sa02 slopes for transient and step
cnange hypoxia for offspring and control
subjects.
OFFSPRING CONTROLS
Subj ect transient step transient step
number
1 -2 .36 -0.73 -0.73 -0.66
2 -0.97 -0.68 -1.18 -0. 52
3 - -1. 10 -1.98 -1.00
4 -1.89 -1.75 -1.12 -0.41
5 -0.87 -1. 10 -1.24 -0.74
6 -0.24 -0.31 -0.87 -1. 12
7 -1.28 -0.37 -1. 04 -1. 10
8 -0.75 -0 .80 -1. 14 -1. 04
9 -0 .43 -0.48 -0. 14 -0. 18
10 - -0.79 -0.93 -0.44
11 -0 . 42 +0.37 -0. 68 -0 . 62
12 -2 . 07 -0 .89 -0 . 67 -0.81
13 -1. 15 -1.71 -0.81 -0. 44
14 -1.40 -0.54 - -1.21
15 -0 . 53 -0.36 -0 .93 -1. 14
16 -0 .83 -0.30 - -1. 59
17 -0 .44 -0.33 -1.06 -0 . 88
18 -0. 56 -0.20 -1. 62 -1.25
19 -1.52 -1.18 -0. 52 -0. 08
20 -0.73 -0.51 -0.74 -0.81
21 -1.48 -0.96 -1.80 -0 . 49
22 -0.94 -1.21 -1. 14 -1.23
23 -0.71 -1.06 - -0 . 27
24 -0.76 -0 . 95 CO01 -0.30
25 -0.85 -0.37 1 o 4^ -0. 62
26 -1. 64 -0.93 -0 . 69 -0.74
27 - -0 . 58
28 -0.92 -0. 61
29 -0.49 -0 . 37
30 -0.78 -1.22
31 -0.29 -0.21
32 -0 . 60 -0.32
33 -0.39 -0 . 08
34 -0.46 -0.33
35 -0 .90 -0.92
* 1 __ "1
VEinst/Sa02 slopes expressed as 1mm %
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1 1.95 * 3 0.01 *
2 1. 56 * 14 -0.16 *
3 1.41 * 209 1.38 *
4 2.70 * 31 1.34 *
5 1.48 * 36 3 . 85 0. 17
6 2 . 95 0. 09 1 0.71 *
7 -1.45 * 2 2 . 55 *
8 1.96 * 4 -0.44 *
9 -0.51 0. 17 1 1. 00 k
10 0. 56 * 182 2 .42 k
11 -1. 02 * 588 1. 52 *
12 2 .75 0.23 50 1.79 k
13 1.43 k 46 3 .26 k
14 0.96 * 50 0. 04 0 . 20
15 0.80 k 159 0.71 0 .20
16 0.70 0.08 75 0 . 98 0.72
17 0.71 * 256 1.82 *
18 0.45 0.41 28 2.31 3 . 92
19 2 . 54 * 180 0.45 0 . 50
20 1. 01 * 32 1.38 0.23
21 3 . 55 0. 19 16 2 . 45 k
22 2 . 89 0 . 18 4 2 . 48 k
23 4 . 17 0.21 37 2 . 97 k
24 1.41 0.22 58 2 . 85 k
25 1.31 -0 . 05 40 1. 82 0 .22
26 1. 99 * 173 1. 03 0 .29
27 1.95 0 . 08 56 3 . 13 0 . 11
28 1.59 -0.26 93 3 . 59 0 . 53
29 0.83 0 . 62 240 0 k
30 2 . 13 0.45 27 0. 18 k
31 0.51 0.52 204 0. 04 k
32 0 .49 0 . 10 28 0. 88 0 . 34
33 0 . 49 * 43 3 . 78 0.25
34 -0 . 06 0 . 18 40 3 .31 0.24
35 1.86 * 318 -1.83 k
* represents parameter not required to produce the model
of best fit.
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ThePaOpoft patientsisplottedgain tthypoxicv tilatoryresponse,expressed asthemodelparameters,g in1(l fhandpanel)gain2(righth dpa el)ofth ir offspring.Eachpo tre esentsthgaiv lued ivedrind dualsubject.T PaC>2ofthepati ntsdidnotcorrelatewi hgain1butdidcorrelatew hhg in2 valuesoftheiroffspring(<0.08).
ii) Control subjects
Values for baseline normoxic V£, V02 and VC02 in
individual subjects are given in Appendix table 24. The
mean V02 was 0.79 lmin-1 (s.d. 0.17 lmin-1, range 0.50
to 1.19 lmin-1), and when expressed per kg body weight
—1—1 .—1—1
was 11.2 mlmin kg (s.d. 1.6 mlmm kg , range 9.6 to
17.0 mlmin-1kg-1. The RQ value was less than 1.0 in all
subjects. For each individual there was no significant
difference between the mean baseline normoxic PETC02 and
the mean values during either transient or step change
hypoxia, and the standard deviation of PETC02 about the
mean during hypoxia ranged from 0.09 to 0.32kPa
(Appendix table 26) . There was also no significant
difference between the mean lowest Sa02 in response to
either transient or step change hypoxia in an individual
(table 8.1).
A response to transient hypoxia could not be measured
in three subjects for technical reasons. The slope of
the VEinst/Sa02 relationship in response to transient
hypoxia ranged from -0.14 to -1.98 lmin-1%-1, and in
response to step change hypoxia ranged from -0.08 to
-1.59 lmin-1%-1 (table 8.2). The values assigned to the
model parameters ranged from 0.24 to 3.94 lmin-1%-1 for
gain 1, -2.27 to 3.09 lmin-1%-1 for gain 2, and 1 to
367 sec for tau 2. A negative value was required for the
inhibition parameter I in 4 subjects (range -0.48 to
-0.06 (lmin-1)-1), and a positive value in 14 subjects
(range 0.04 to 0.91 (Imin-1)-1). Sigma was required in
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15 subjects and ranged from 0.14 to 0.83 %. The
individual values for all model parameters are given in
table 8.4.
iii) Comparison of Offspring and Controls
The nine offspring subjects who were not age and sex-
matched with control subjects demonstrated hypoxic
ventilatory response (expressed as either VEinst/Sa02
slopes or model gain parameters) throughout the range of
the 26 subjects for whom suitable control subjects were
available. The two groups were correctly age-matched, as
shown by no significant difference between the ages of
the offspring and control groups. The two groups of
subjects exercised at similar exercise levels as there
• •
was no significant difference between V02 or V02/kg.
There was no significant difference between the hypoxic
ventilatory response of offspring and control groups
expressed as transient hypoxia VEinst/Sa02 slope, step
change hypoxia VEinst/Sa02 slope, gain 1 or gain 2 (Figs
8.3 to 8.6).
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1 0.88 * 137 2 . 56 0. 34
2 3 . 37 0.42 3 0.67 *
3 2 . 54 0. 04 51 1. 18 0.29
4 2.87 0.11 10 2 .83 0. 14
5 1.83 * 110 1. 66 0.52
6 2 . 50 0.26 18 2 .20 *
7 2.01 0.30 27 2 . 00 *
8 2.29 -0.11 155 2 . 54 0. 83
9 0.24 * 38 3 . 09 0 . 42
10 1.42 0.06 5 2 .83 0.30
11 2.40 0.50 11 1. 16 *
12 1.25 -0.48 256 2 . 22 0 . 79
13 1.44 * 367 -2 . 27 *
14 1. 59 0. 17 38 2 .85 *
15 2 . 06 * 80 2 . 17 0 . 22
16 2.77 * 46 1.29 *
17 3 . 10 0.64 23 1.99 *
18 2 . 59 -0.06 216 2 . 65 0.23
19 1.68 0. 65 26 1.43 0 .23
20 0.95 -0. 17 32 2 . 94 0.76
21 3 . 94 0. 09 1 2.21 0. 17
22 1.66 * 81 2 . 99 *
23 0.30 inO 183 0. 62 0 . 55
24 0.45 * 245 2 . 11 0 . 63
25 3 .26 0.91 39 1. 68 *
26 2 . 22 0. 17 17 1.76 *
* represents parameter not required to produce the model
of best fit.
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Fig 8.3 : Comparison of Vginst/SaC^ slopes in
response to transient hypoxia in age and sex-matched
pairs of offspring and control subjects.
Each point represents the Vginst/SaC^ slope for each
offspring (left side) or control (right side) subject
in response to transient hypoxia. Each age and sex-
matched pair of offspring and control subjects are
joined by a line. There was no statistical difference
between the ventilatory response to transient hypoxia
of the two groups of subjects.
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Fig 8.A : Comparison of Vginst/SaC^ slopes in response
to step change hypoxia in age and sex-matched pairs of
offspring and control subjects.
Each point represents the Vginst/Sa02 slope for each
offspring (left side) or control subject (right side)
in response to step change hypoxia. Each age and sex-
matched pair of offspring and control subjects are
joined by a line. There was no statistical difference
between the ventilatory response to step change hypoxia
of the two groups of subjects.
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Fig 8.5 : Comparison of gain 1 values in age and sex-
matched pairs of offspring and control subjects.
0J
Offspring Confrols
Each point represents the gain 1 value for each offspring
(left hand side) or control subject (right hand side).
Each age and sex-matched pair of offspring and control
subjects are joined by a line. There was no statistical
difference between the gain 1 values for the two groups
of subjects.
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Fig 8.6 : Comparison of gain 2 values in age and sex-
matched pairs of offspring and control subjects.
Each point represents the gain 2 value for each offspring
(left side) or control subject (right side). Each age
and sex-matched pair of offspring and control subjects are
joined by a line. There was no statistical difference
between the gain 2 values for the two groups of subjects.
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IV DISCUSSION
This study has shown that the Pa02 of patients with
COPD, when in a stable state and breathing air,
correlated with estimates of the hypoxic ventilatory
response measured in their first generation offspring.
These results confirm previous findings (Kawakami et al
1982a, Fleetham et al 1984). Furthermore, there was no
significant difference between the intensity of the
hypoxic ventilatory response measured in the offspring
subjects and that recorded in a group of age and sex-
matched control subjects whose parents did not have
COPD.
Patients with the "blue and bloated" form of COPD have
been shown to have blunted hypoxic ventilatory responses
whereas an intact response has been reported in patients
with the "pink and puffing" form of the disease (Flenley
et al 1970, Bradley et al 1979) . This led to the
hypothesis that a genetically determined (Scoggin et al
1978) low premorbid ventilatory response may predispose
an individual with COPD to develop severe hypoxaemia
(Flenley 1978) . The correlation between the Pa02 of
patients with COPD and estimates of the hypoxic
ventilatory response in their offspring found in both
this and previous studies (Kawakami et al 1982a)
supports this hypothesis.
No previous attempts have been made to determine
whether the spectrum of hypoxaemia in COPD can be
explained by the wide normal variation in the hypoxic
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ventilatory response. Kawakami et al (1982a) found a
significant relationship between the Pa02 of 25 patients
with COPD and the hypoxic ventilatory response of their
34 sons whereas no correlation could be detected between
the PaC>2 of 17 patients with silicosis and the response
of their 22 sons. They did not, however compare the
hypoxic ventilatory rsponses of the two offspring
groups. In this study, the hypoxic ventilatory response
values obtained for both the offspring and control
subjects fell within the normal range measured using a
rebreathing technique by Rebuck and Campbell (1974).
This, coupled with the fact that there was no
significant difference between the responses recorded in
the offspring and the age and sex-matched control
subjects, implies that the offspring reflect the normal
variability and are not a sub-group of the population
with abnormally low responses. Thus the degree of
hypoxaemia developed in COPD appears to be related to
the genetically determined premorbid intensity of the
hypoxic ventilatory response.
In spite of the significant correlation between the
Pa02 of the patients and the hypoxic ventilatory
response of their offspring, this relationship only
accounted for approximately 25% of the variance in the
degree of hypoxaemia of the patients. Several
experimental factors may have contributed to the
unexplained variance. The subjects were not requested to
fast for a specified time before each study. Thus in
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some individuals the response may have been affected by
eating (Zwillich et al 1977) or drinking coffee
(Lakshminarayan et al 1970). However, these effects were
probably minimal as the subjects would have abstained
from food or beverages for at least one hour prior to
the study. A more significant effect may have resulted
from the fact that the hypoxic ventilatory response was
measured on only one occasion in each subject, and not
all subjects were studied at the same time of day. The
hypoxic ventilatory response varies both within and
between days (Sahn et al 1977) and the single
measurement may not represent the true value. However,
as discussed in Chapter 4, even though the extent of the
between-day variability was 19 to 45 %, between-
subject differences were apparent. Furthermore, 15 of
the 35 offspring subjects were females aged between 18
and 47 years. In women, the hypoxic ventilatory response
has been shown to be 43% greater in the luteal phase
compared with the follicular phase of the cycle (White
et al 1983) and significantly less than in men. Hormonal
differences will therefore have influenced the
correlation between patients' Pa02 and offspring hypoxic
ventilatory response to an unknown extent. However,
there was no difference between the male and female
hypoxic ventilatory responses in this study, and as
discussed in Chapter 4, the ventilatory responses of the
female subjects studied were no less reproducible than
those of the male subjects.
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The hypoxic ventilatory response was measured during
exercise so that an adequate transient hypoxic stimulus
could be obtained with only 2-3 breaths of 1% 02 in N2 .
However, use of exercise may have contributed to the
variance for two reasons. Firstly, PETC02 was assumed to
equal PaC02 and this may not be correct. However, as
discussed in Chapter 4, Jones et al (1966) and Whipp and
Wasserman (1969) have shown that at mild to moderate
exercise levels, as in this study, the differences
between PETC02 and PaC02 are small and probably
contribute little to the variation in hypoxic
ventilatory response. Secondly, the hypoxic ventilatory
response is potentiated by exercise (Weil et al 1972,
Martin et al 1978) and the degree of potentiation may
vary between subjects. However, in this study the level
of exercise was similar in all subjects expressed as the
V02/kg and expression of the hypoxic ventilatory
response per m body surface area did not change the
significance of the relationship with the patients'
Pa02. Also, as shown in Chapter 7, mild exercise at this
level caused similar degrees of potentiation in all
subjects. Therefore, whilst small differences in
potentiation between subjects may have contributed to
the unexplained variance, the observed correlation
between the Pa02 of the patients and the hypoxic
ventilatory response of their offspring is unlikely to
be due to the degree of exercise potentiation in each
individual.
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Another source of variability was that only one parent
with COPD contributed to the genetic make-up of each
offspring subject. In some cases the hypoxic ventilatory
responses of siblings were almost identical whereas in
other families, the responses were diverse. However,
Collins et al (1978) showed that the hypoxic ventilatory
response was almost identical between pairs of
homozygous twins but not between pairs of heterozygous
twins.
The major difficulty in interpreting these results and
those of similar studies (Kawakami et al 1982a) arises
from the selection of the Pa02 of the patients. In this
study, a single Pa02 value was taken for each patient
when they were in a stable state breathing air. However,
little is documented on the natural history of the
development of hypoxaemia. Middleton et al (1979)
reported a mean annual decline in Pa02 of only 0.02 kPa
in 85 patients with stable COPD. This would account for
a fall of only 0.4 kPa on average in an individual
patient assuming a twenty year history of the disease
which would have little effect on the observed
correlation. The steady age-related decline in Pa02 of
0.4-0.5 kPa per decade (Mellemgaard et al 1966, Sorbini
et al 1968) would also have had little effect between
subjects on the single Pa02 values used for each patient
as 21 of the 24 patients were aged between 60 and 75
years. Middleton et al (1979) also found that hypoxaemic
patients with COPD suffer a terminal rapid decline in
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Pa02, possibly due to pathological changes in the lungs.
It is unlikely that the values selected for any of the
patients in this study were affected by this terminal
fall, since the value selected was within 0.5 kPa of the
previous measurement made within the preceding twelve
months. However, the interpretation assumes that
patients become, and remain, either "pink puffers" or
"blue bloaters". Factors other than the hypoxic
ventilatory response may also reduce the Pa02 in COPD.
The degree of airways obstruction may affect the Pa02
although no correlation could be demonstrated in this
study between the degree of airways obstruction (FEV-^ or
FEV-j_/FVC) and the Pa02 breathing air, therefore the
extent of airways obstruction was not the major factor
governing the Pa02. Wagner et al (1977) demonstrated
different VA/Q patterns in patients with the "pink and
puffing" and "blue and bloated" forms of COPD but showed
that the measurement was not definative. Thus some of
the variability of the Pa02 measurements may be due to
ventilation-perfusion inequalities of the COPD patients.
Also, the reduced hypoxic ventilatory response in
patients with COPD may have developed as a result of the
chronic hypoxaemia due to peripheral chemoreceptor
adaptation. Such peripheral chemoreceptor adaptation is
thought to occur in high-altitude natives during the
first two years of life probably due to an irreversible
desenSitisation of the peripheral chemoreceptor response
to hypoxia (Sorensen and Severinghaus 1968, Weil et al
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1981). Further information is therefore required
regarding the natural history of the disease before the
degree of hypoxaemia due to a blunted hypoxic
ventilatory response or other factors can be
established.
Finally, the initial hypothesis proposed that, since
the increase in ventilation in response to hypoxia is
mediated by the peripheral carotid bodies (Lugliani
1971), individual differences in the premorbid
peripheral chemoreceptor sensitivity were responsible
for determining the severity of hypoxaemia in COPD
(Flenley et al 1978). Such individual variation in the
carotid chemoreceptor sensitivity has been demonstrated
in cats (Vizek et al 1987) , but is difficult to
quantitate in humans. Previous studies comparing the
PaC>2 of patients with COPD to the hypoxic ventilatory
response of their offspring have used the progressive
isocapnic hypoxia method (Scoggin et al 1978, Collins et
al 1978, Kawakami et al 1982a, Fleetham et al 1984)
which may cause central depression of ventilation in
some subjects (Weil and Zwillich 1976, Easton et al
1986) . This study has shown that the Pa02 of the
patients was best predicted by a combination of the
gains of the two equations of the mathematical model. If
the equation with the fast time constant quantifies the
peripheral chemoreceptor response whilst the slow time
constant equation reflects a combination of peripheral
and central activity, then the results suggest that some
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central regulation, possibly central depression of
ventilation, may also be involved in determining the
PaC>2 in COPD. Although central depression of ventilation
has been demonstrated in conscious humans (Easton et al
1986, 1988), the variability in the normal population
has not been assessed. Investigation of the effect of
prolonged hypoxia, similar to that described by
Anthonisen's group (Easton and Anthonisen 1988b; Easton
et al 1986, 1988) both in the offspring of patients with
COPD and in age and sex-matched control subjects, as
used in this study, would help to elucidate the role of
central hypoxic depression of ventilation in the
pathogenesis of the "blue and bloated" form of COPD.
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SUMMARY AND CONCLUSIONS
A computer based two-compartment mathematical model has
been used to analyse the dynamic ventilatory response to
hypoxia and to quantitate both peripheral and central
components of the response. The model consists of two
linear differential equations (I and II) in parallel;
both using the fall in Sa02 as the input, with the
summed output (I + II) giving the rise in VE during
hypoxia above that in normoxic exercise. Equation I has
a fast time constant (< 3 sec) and equation II has a
slower time constant (> 3 sec). Each equation
incorporates a time constant and a gain. Non-linearities
also included are a "saturating effect" which reduces
the gain of equation II as Sa02 falls, and "inhibition"
or "potentiation" of the gain of equation I as the
output of equation II increases. The model was derived
empirically to fit the hypoxic ventilatory responses of
ten subjects to transient and step change hypoxia at one
particular exercise level.
The aims of this project were to assess the
repeatability of the mathematical model parameter values
obtained in an individual, to investigate the
physiological interpretation of the model structure and
to use the model to study the role of the hypoxic
ventilatory response in determining the severity of
hypoxaemia developed by patients with chronic
obstructive pulmonary disease.
In order to assess the effects of physiological
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changes upon the model parameter estimation,
reproducibility of the model parameter estimation, the
effect of the rate of onset of an hypoxic stimulus, the
effect of increasing exercise level and the effect of
the adenosine antagonist theophylline upon the hypoxic
ventilatory response were studied.
The hypoxic ventilatory response expressed either as
the VEinst/Sa02 relationship or as the mathematical
model parameters was measured ten times in four normal
subjects over a period of at least ten weeks and was
reproducible with no significant within-subject
differences, but with significant between-subject
differences present. Also, the model gain 1 and gain 2
parameters significantly correlated with the VEinst/Sa02
relationship in response to step change hypoxia for each
subject, suggesting that these parameters reflect the
intensity of the hypoxic ventilatory response.
Therefore, the model parameters are reproducible within
a subject and allow identification of differences in the
hypoxic ventilatory response between individuals.
No effect could be demonstrated of the rate of onset
of an hypoxic stimulus (rate of onset range 17-50 sec)
upon the hypoxic ventilatory response measured as the
VEinst/Sa02 relationship or as the model parameters. An
increase in the VEinst/Sa02 relationship in response to
step change hypoxia as the level of exercise rose and
also a concomitant increase in the model gain parameters
were demonstrated. This increase in the model gain
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parameters indicates that they are capable of reflecting
physiological changes. The increase in the hypoxic
ventilatory response may be due to increased peripheral
chemosensitivity, increased muscle afferent activity or
circulating chemical mediators such as noradrenaline
acting centrally. Further studies are necessary to
investigate the mechanism of ventilatory stimulation
during exercise, such as measurement of noradrenaline
levels in the blood before, during and after hypoxic
exercise, and investigation of the effect of a lack of
muscle afferent activity in patients with spinal cord
lesions upon the hypoxic ventilatory response.
The ventilatory stimulant theophylline which acts
centrally as an adenosine antagonist had no consistent
effect upon the hypoxic ventilatory response whether
*
expressed as the V^inst/SaC^ relationship or as the
model gain parameters. However, only six subjects were
studied, and in two of them the plasma theophylline
level was outside the therapeutic range. Further studies
are therefore required with greater numbers of subjects
and therapeutic levels of theophylline to investigate
the effect of theophylline on the model parameters.
Previous work had suggested that the hypoxaemia seen
in patients with the "blue and bloated" form of COPD
develops as a result of diminished peripheral
chemoreceptor mediated ventilatory drive and this may be
an inherited characteristic, which exists premorbidly.
However, the Pa02 of patients with COPD studied
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correlated with the hypoxic ventilatory response of
their offspring measured as the VEinst/Sa02 relationship
to step change hypoxia, or as a combination of both gain
1 and gain 2 parameters. If gain 1 represents the
peripheral response, and gain 2 the combined peripheral
and central response, then both peripheral and central
mechanisms of the hypoxic ventilatory response may be
inherited and a low premorbid ventilatory response may
make an individual susceptible to the "blue and bloated"
form should COPD develop. The hypoxic ventilatory
responses of the group of offspring subjects (expressed
as either the VEinst/Sa02 relationship or as the model
gain parameters) fell within the normal wide range of a
group of age and sex-matched control subjects whose
parents did not have COPD. Thus the responses of the
offspring group demonstrated the variability of the
normal population and did not form a distinct group with
abnormally low responses. These results support the
hypothesis that a genetically determined pre-morbid
intensity of the hypoxic ventilatory response partly
determines the Pa02 in COPD.
Further work is necessary to conclusively determine
the physiological mechanisms reresented by each of the
model components, such as using the specific peripheral
chemoreceptor stimulant almitrine or inducing central
depression of ventilation with prolonged hypoxia. It is
also necessary to determine to what extent the severity
of hypoxaemia developed by patients with COPD is due to
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blunted peripheral chemoreceptor sensitivity or central
depression of ventilation in response to hypoxia by
investigating the variability of the intensity of
central hypoxic depression within a normal population
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We have developed a mathematical model to describe the
dynamic ventilatory response to hypoxia. The ventilatory
response to both transient and step change hypoxic
stimuli were measured in 11 normal subjects during
*
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moderate exercise (Vq2 0.96 +■ 0.08 1 mm ) . The
simplest model which adeguately described the responses
in all subjects consisted of two linear differential
equations (1 and 2) in parallel; both using the fall in
arterial oxygen saturation as input, and with the
outputs summed (1+2) to give the rise in ventilation.
Equation 1 had a fast time constant (<3 sec) , and
equation 2 a slow time constant. Non-linear terms
included were a) a "saturating" effect, similar to that
described by the Michaelis-Menten equation, reducing
gain 2 as oxygen saturation falls, and b) "inhibition"
or "potentiation" of gain 1 as the output of equation 2
increased. Repeated measurements in four subjects showed
that parameter estimation was reproducible in an
individual. The model gives a more precise description
of the hypoxic ventilatory response than the linear
ventilation/oxygen saturation relationship.
Index Terms: hypoxic ventilatory control, mathematical




Wide individual variation in the carotid body mediated
hypoxic ventilatory drive (18) has been shown in normal
subjects (22). Studies in humans (3,15) and animals (26)
suggest that this may arise from genetic differences in
the carotid chemoreceptor sensitivity to hypoxia. It has
been proposed that this inherited sensitivity to hypoxia
may relate to the pathogenesis of the two forms of
chronic obstructive pulmonary disease; those individuals
with genetically low drives developing the "blue and
bloated" syndrome characterised by hypoxemia, C02
retention, pulmonary hypertension, and right heart
failure, and those with brisk drives tending to become
"pink and puffing" with relatively well preserved
arterial blood gas tensions (10), despite similar
severity of airflow obstruction. Patients with the "blue
and bloated" syndrome have a poor prognosis (28), so
that identification of individuals at risk, either
premorbidly or at an early stage of their disease, may
aid in their clinical management.
Conventional methods of assessing hypoxic ventilatory
drive using either steady state (17) or progressive
isocapnic hypoxia (29) may underestimate the peripheral
chemoreceptor response as central depression of
ventilation may result from the relatively prolonged
hypoxia (7). To overcome this, transient hypoxic
(8,12,16,25) or hyperoxic (5,11) methods have been used.
A good correlation has been shown between the responses
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to transient and to progressive isocapnic stimuli (25).
However we have found that, during moderate exercise,
the response to transient hypoxic stimuli expressed as
the linear relationship between minute ventilation and
ear (arterial) oxygen saturation (21) did not accurately
reflect chemoreceptor activity alone (1). Furthermore,
the relationship between minute ventilation and oxygen
saturation in response to rapid onset, short duration
transient stimulus was less than to slower onset, more
prolonged hypoxia, and the two responses could not be
described adequately by a single linear system (27).
Mathematical models have been used to describe the
ventilatory response to 02 (23 ) and C02 ( 2,13,24) .
However, modelling techniques have not previously been
used to investigate the dynamics of the hypoxic
ventilatory controller. We have therefore developed a
mathematical model to relate minute ventilation to
oxygen saturation. This was systematically developed to
fit the observed responses of normal subjects to both
transient and more prolonged hypoxia. The model
parameters give a more precise description of the
individual's response to hypoxia than the simple linear
relationship between ventilation and oxygen saturation
allowing investigation of the physiological mechanisms




The 11 subjects (7M,4F; age 21-40 years) were drawn from
laboratory staff who had no previous history of
cardiovascular or respiratory disease, and who were
taking no current medication. All had a normal FEV1,
lung volumes, and DLCO. The model was developed from
results in subjects 1-10 and repeated measurements were
subsequently made in subjects 1,6,10 and 11. All were
non-smokers except for subject 1, who occasionally
smoked cigarettes. The subjects fasted for at least four
hours prior to a study. They each gave informed consent
to the study after the nature and purpose had been
explained. The study was approved by the Ethics of
Medical Research Sub-Committee of the Lothian Health
Board.
Measurements of Ventilatory Variables
The subjects breathed through a mouthpiece and custom
built two-way respiratory valve with a total deadspace
of 100 ml. The valve had two inspiratory ports operated
by a remote control switch which allowed for rapid
change of inspired gas without the subject's knowledge.
Inspiratory and expiratory flows were recorded with
separate pneumotachographs (Fleisch no. 2), and
expiratory flow integrated to give expiratory tidal
volume. Expired gas passed via the pneumotachograph
through a 3.2 litre mixing chamber to a Parkinson Cowan
CD4 gas meter modified to give a digital electrical
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output of expired volume. Inspiratory and end-tidal P02
(PETq2) and PC02 (PETC02) were measured at the lips by a
mass spectrometer (VG Medical Spectralab-M, Middlewich,
England, U.K.) previously calibrated using five gas
mixtures of known 02, C02, N2 and Argon concentrations.
The inspiratory and end-tidal gas concentrations were
calculated from the concentrations of the four gases
summed to 100% and adjusted for barometric pressure,
after allowing for the delay in the mass spectrometer
response which was measured prior to each study. Ear
oxygen saturation (Sa02; Hewlett Packard 47201A ear
oximeter), and heart rate (Hewlett Packard 78351A ECG
monitor) were monitored throughout the study. Signals
from the pneumotachographs, CD4 gas meter, thermistor in
the expiratory line, mouth pressure micromanometer
(Furness Controls Ltd) to determine end-expiration, mass
spectrometer, and ECG monitor were sampled on-line by a
PDP 11/23 computer (Digital Equipment Corporation). The
integrated expiratory flow signal was calibrated against
the output of the CD4 gas meter every 10 litres. Custom
written programs provided breath-by-breath outputs of
respiratory frequency (fR), tidal volume (Vt; 1/min
BTPS), instantaneous minute ventilation (VEinst = Vt x
fR; 1/min BTPS), and inspiratory and end-tidal gas
concentrations.
• ♦
Oxygen consumption (VQ2) and C02 output (VC02), both
expressed as 1 min-^ STPD, were calculated over two
minute periods using minute ventilation measured with
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the dry gas meter, and 02 and C02 concentrations of
mixed expired gas sampled simultaneously from the
mixing chamber. Oxygen concentration was measured with a
Servomex 02 analyzer (model 570A), and C02 with a Gould
capnograph (Mark III), both previously calibrated with
four gas mixtures of known 02 and C02 concentrations.
Ventilatory responses to hypoxia were measured during
moderate steady state exercise on a level treadmill
(Woodway ELG2). The subjects walked at a speed
(approximately 3 mph) which raised V02 to about 1 1/min.
Ventilatory Responses to Transient and Step Change
Hypoxia
Ten subjects were each studied on one occasion. The
subjects exercised for two 45 minute periods separated
by 30 minutes rest. The ventilatory response to
transient hypoxia was measured during the first period
of exercise and to step change hypoxia during the second
period. For each exercise period, the subjects initially
walked for 11 minutes breathing room air to establish
steady state conditions. Duplicate measurements of Vq2
and VC02 were made after seven minutes of exercise, and
repeated two minutes after both the third and the final
transient hypoxic stimulus, and five minutes after the
final step change hypoxic stimulus.
A transient hypoxic stimulus was produced by changing
the inspired gas from room air to 100% nitrogen during
an expiration. The subjects took between one and three
breaths of 100% N2 in order to reduce SaQ2 to
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approximately 85%. The inspired gas was then returned to
room air during expiration. The transient hypoxic
stimulus was repeated six times, separated by at least
60 breaths of room air (Fig 1).
A step change hypoxic stimulus was produced by
changing the inspired gas from room air to 15% 02 during
expiration. Hypoxia was maintained for three minutes.
The inspired gas was then changed back to room air for
six minutes. The step change hypoxic stimulus was then
repeated using an inspired concentration of 12% 02,
which reduced Sa02 to approximately 85%. After a further
six minutes breathing room air this sequence of step
change stimuli was repeated (Fig 1). Isocapnia was
maintained initially by priming the hypoxic gas mixture
with an appropriate concentration of C02, and thereafter
by adjusting the inspired C02 concentration so as to
keep PETc02 constant at the normoxic level during the
hypoxia. However, no attempt was made to maintain
isocapnia after the return to room air.
Variables were compared using Wilcoxon's test for
paired data.
Repeatability Studies
Four subjects were studied on ten occasions at the same
time of day at least one week apart. Subjects 1,10 and
11 were studied on ten consecutive weeks and subject 6
over a period of 34 weeks. A modified protocol was used
for these studies. Each individual walked on a level
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treadmill at the same speed (approximately 3 mph) for
all ten studies. They initially walked for 9 minutes
breathing room air. Duplicate measurements of VQ2 and
VC02 were made after five minutes of exercise, and five
minutes after the second step change hypoxic stimulus.
Transient hypoxic stimuli were repeated four times, each
separated by 40 breaths of room air. After the fourth
transient stimulus, the subjects continued to walk
breathing room air for three minutes. The responses to
15% and 12% 02 step changes in inspired gas were then
measured once only at each level of hypoxia. The onset
of the step change hypoxic stimuli was also modified to
produce a fall in SaQ2 which approximated more closely
to a square wave. The inspired gas was initially changed
from room air to 1% 02 in N2 for one breath before
changing to 15% 02 mixture, and from room air to 1% 02
in N2 for two breaths before changing to 12% 02.
Isocapnia was maintained during transient hypoxia, and
during the onset and duration of the step change hypoxic
stimuli by addition of C02 to the inspired air so that
PETc02 was kept constant.
The mean PETC02 during transient hypoxia was compared
to the mean normoxic baseline level using Wilcoxon's
test for paired data. Other comparisons were made using
Friedman's Analysis of Variance.
Development of the Model
The simplest model structure relating VEinst to SaQ2 was
sought which would use the minimum number of parameters
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and which would adequately describe the experimental
data from all subjects. The Sa02 recorded by the ear
oximeter was assumed to be an accurate measure of the
hypoxic stimulus (with all other ventilatory stimuli
assumed constant), and VEinst was assumed to be a
measure of the response. The model structure also had to
be compatible with a proportional relationship between
VEinst and Sa02 during steady state isocapnic hypoxia as
implied by previous observations during rebreathing
(21) . For all models, the fall in SaQ2 during hypoxia
(S) , where S = SaQ2(normoxia) - Sa02(t), was taken as
the input. The output of the model (Vcalc) , was
calculated and compared to the experimentally recorded
rise in VEinst. The details of the computer program are
given in the Appendix.
The complexity of model was increased progressively in
the order 1) a linear differential equation, 2) a non¬
linear differential equation, 3) various arrangements of
two linear differential equations, and 4) two linear
differential equations with non-linear terms, until a
structure was found which adequately fitted all
experimental data. At each stage, the best fit to the
data was found, and the process stopped at the level
when the addition of further terms did not yield a
statistically significant decrease in the residual
deviations of VEinst from the values for ventilation
calculated by the model. A decrease on addition of one
new parameter was considered to be significant if the
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quantity:
F = (RSSbefore - RSSafter)
(RSSafter/(n-(p+l))
was greater than the 5% level of Snedecor's F
distributed with 1 and (n-(p+l)) degrees of freedom,
where RSSfaefore and RSSafter were the residual sum of
squares before and after inclusion of the additional
parameter, p was the original number of parameters, and
n was the number of data points being fitted. This is a




There was no significant difference in the normoxic
steady state levels of V£, VQ2, VCQ2, or PETCQ2 between
the two periods of exercise (Table 1) . During transient
hypoxia PETC02 fell significantly (P<0.01) from a mean
baseline of 42 + 3 mmHg to a mean lowest value of 37 +4
mmHg. The largest standard deviation about the mean for
PETQQ2 during step change hypoxia was 1.4 mmHg. The mean
lowest SaQ2 in response to the repeated transient
hypoxic stimuli (range 76 - 87 mmHg) was not
significantly different from the mean lowest SaQ2 in
response to the 12% 02 step change stimuli (range 75 -
89 mmHg).
Model Development Results
The simplest model used was a single linear differential
equation as illustrated in Fig 2. In the steady state
(i.e. dV/dt = 0) the equation reduces to:
V = GS
thus fulfilling the criterion that in steady state
isocapnic conditions VEinst is proportional to SaQ2,
while the differential equation includes time as a
variable to allow dynamic analysis. Applying this
equation, parameters giving a good fit between Vcalc and
VEinst in response to transient hypoxia underestimated
the increase in response to step change hypoxia (Fig 2),
whereas those giving a good fit for step change hypoxia
overestimated the response to transient hypoxia. This
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confirms that the ventilatory response to the two types
of hypoxic stimuli cannot be described adequately by a
single linear system (27).
Two non-linear terms were then added into the single
linear differential equation. The first allowed the gain
to change at a threshold of S, dS/dt, Vcalc, or
dVcalc/dt. The second allowed the gain of the equation
to "saturate" in a way analogous to the Michaelis-Menten
equation by replacing the gain G with the term G/(S +
r). In no case was a significantly better fit obtained.
Various forms of interaction of two linear
differential equations were then investigated. These
included a) arrangement in series with the output of one
being the input of the other, and with the output of the
second equation forming the overall output, and b)
arrangement in parallel with both differential equations
receiving the same input with the output of both being
either summed or multiplied to give the overall output.
The best fit was consistently obtained using two
equations in parallel with both outputs summed (Fig 3)
with Equation 1 having a fast time constant ( 1 <3 sec)
and Equation 2 having a slow time constant ( 2) . The
slow time constant resulted in a slow return of Vcalc to
baseline after the return to normoxia. Since isocapnia
was not maintained during the recovery from hypoxia good
agreement between Vcalc and V£inst could not be expected
here. The output (Y2) of the equation with the slow time
constant was therefore set to zero when S < 2%, which
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eliminated the slow recovery in Vcalc. This was
necessary to limit the weighting given to the recovery
period during the fitting process. Even after
elimination of the slow recovery, this model did not
adequately describe all data.
Finally, simple non-linear terms were added to the two
differential equations. These included the "saturating"
effect (described above) in either equation, changes in
the gain of one equation dependent on the output of the
other (simulating inhibition or potentiation) , and the
introduction of time delays in different parts of the
equations.
The Final Model
The simplest model which adequately described the
experimental data in all subjects is shown in Fig 4. The
time constant of equation 1 (71; Fig 4) was found to be
fast (< 3 sec) and was therefore arbitrarily set to 0.1
sec since the time constant of the ear oximeter (1.6
seconds; 6) prevented this parameter from being
measureable. Equation 2 had a long time constant (7 2)
and its gain was allowed to saturate as described above.
Finally, the output of equation 1 was "inhibited"
(positive parameter I) or "potentiated" (negative
parameter I) by the output of equation 2.
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Parameter Estimation in 10 Normal Subjects
The parameters giving the best fit between the model
output and the experimental data are summarized in Table
2. In each case the addition of further parameters did
not result in a significantly improved fit. In three of
the 10 subjects only the 3 parameters Gl, G2, and T2
were needed (Fig 5, subject 4) . In the remaining
subjects, the parameter r was also needed in three (Fig
5, subjects 5,10), a positive I parameter ("inhibiting"
effect) was needed in two, and a negative I parameter
("potentiating" effect) in a further three subjects (Fig
5, subject 3). In one subject both the parameters r and
a negative I were also required.
Repeatability in Four Subjects
Normoxic baseline values for VE, V02, vco2' and PETC02
(Table 3) were not significantly different on different
days in an individual. The PETC02 did not change
significantly from normoxic baseline during transient
hypoxia, and the largest standard deviation about the
mean during step change hypoxia was 1.7 mmHg.
Gain 1, gain 2 and T2 varied between days within an
individual (Fig 6) but these differences were not
significant. The coefficients of variation ranged from
21-34% for gain 1, from 20-45% for gain 2, and from 75-
121% for T2. There was a significant difference
(PcO.OOl) between subjects for gains 1 and 2 but not for
T 2. The absolute values of the non-linear terms I and r
varied between days in an individual (Fig 6) . However
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the parameter I tended to be consistently either
positive (inhibition) or negative (potentiation) within
an individual (Fig 6), with a positive value needed for
all 10 measurements in subjects 1 and 11, and with a
negative value needed on eight occasions in subject 6
and nine occasions in subject 10. The parameter r was
consistently needed in subject 10 and on only one
occasion in subject 1. In subjects 6 and 10, r was
needed on four and six occasions respectively (Fig 6).
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DISCUSSION
To explore the apparent differences in the hypoxic drive
to ventilation as measured using transient or step
change hypoxic stimuli, we have developed a mathematical
model based on two linear differential eguations and
incorporating non-linear terms to describe the dynamic
relationship between VE and Sa02 during both types of
stimulus. This model provided a consistently better fit
to the data than models based on a single differential
equation, with or without non-linear terms, and of other
combinations of two differential equations with and
without non-linear terms. The model depends upon
several assumptions. Arterial oxygen saturation was
taken as a measure of the stimulus and V£inst as the
output. The Pq2 within the carotid glomus is considered
to be the stimulus to the peripheral arterial
chemoreceptors (9) , but end-tidal P02 cannot be used as
index of the stimulus to the chemoreceptors since it
will not accurately reflect arterial p02 during the
rapid changes of the inspired gas from room air to 100%
nitrogen. While SaQ2 is not the actual chemoreceptor
stimulus, it is related to arterial PQ2 (and thus to
carotid glomus Pq2^' anc* provides the only available
non-invasive measure of arterial oxygenation since the
response time of transcutaneous PQ2 electrodes would be
inadequate to follow the rapid changes.
Although ventilation is a linear function of SaQ2
during rebreathing (21), we are concerned with
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describing the relationships during rapid changes in
Sa02• Use of two linear differential equations in
parallel with different time constants for each equation
yields an output which is intrinsically non-linear, but
which approximates to a linear model in steady state
conditions (ie. SaQ2 remaining constant for a period of
at least twice the slow time constant) . The non-linear
terms needed to describe the response in some subjects
distort this long-term appearance of linearity, although
the output with "saturating" effect appears to be
approximately linear at high levels of stimulus. Our
model has been developed to describe our observations in
studies using stimuli lasting up to 3 minutes. It may
therefore be less adequate during more prolonged
hypoxia.
A further assumption was that arterial ?co2 was
constant and equal to end-tidal PC02* End-tidal PC02 ^as
been directly compared with simultaneously measured
PaCo2 an normal subjects at rest and on exercise (4,14)
showing a small positive PETC02_Paco2 difference as
tidal volume increases during exercise. However there
are insufficient data to allow the application of a
reliable empirical correlation to calculate Paco2 (the
presumed other stimulus to ventilation) in our studies.
During the onset and plateau of the step change hypoxic
stimuli we adjusted the inspired C02 concentration so as
to keep end-tidal Pco2 constant. Possible inadequate
control of ?aco2 was disregarded in the model . The
21 6
PETc02 was allowed to fall during the return to
breathing room air with a resultant reduction in V£inst
at this time. This phase of the response is reflected
in the model by setting the output of the slow time
constant equation to zero as the Sa02 returns to its
baseline.
Assessing the goodness of fit of the model to the data
poses problems. A perfect fit is clearly impossible due
to the uncertainty in measuring both stimulus (SaQ2) and
response (V^inst). The uncertainty in the response can
be estimated as measurement errors are small compared
with the easily measured random physiological variation
in VEinst. However, the uncertainty in the stimulus
cannot be assessed due to problems in measuring Sa02.
The time constant of the HP4710A ear oximeter in the
fast mode is 1.61 seconds (6) and the oximeter only
provides integer output values. In some subjects SaQ2
fell by only 2 or 3% when breathing 15% oxygen, so that
this restriction to integer values could conceal an
error of up to 50%. Furthermore, the time course of the
measured SaQ2 is distorted by averaging the readings
within each breath, and this distortion is worse during
transient stimuli when the true nadir values may be
lost. As the size of these experimental inaccuracies
cannot be assessed, the standard chi-squared "goodness
of fit" test cannot be used quantitatively. The residual
sum of squares method which was used to assess goodness
of fit does not give an absolute measure as it depends
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upon the variability in Vginst at any given Sa02 ,
which may differ between normoxia and hypoxia. However
it allows the goodness of fit between one model or set
of parameters and another to be compared objectively. We
have therefore shown that the final model fitted the
data statistically better than all the simpler models
tested, and at least as well as the more complex ones
studied.
Many different structures were studied during the
development of the model. We consider that the final
model is the simplest using the approach adopted.
Although there may be other combinations of terms which
would give an equally good or better fit it is likely
that this would be at the expense of greater complexity
and hence greater parameter uncertainty. Even with the
simplest model the complexity precludes unique
estimation of all parameters, and the parameters found
may not necessarily be the best possible. Ideally, the
parameters derived for an individual from one set of
data should be confirmed by data from a different set of
stimuli. This was done implicitly when we used a reduced
data set to derive the model initially (see Appendix)
with subsequent application of the model to the full
data sets. Furthermore, the repeated studies confirm the
value of the model and suggest that it gives a
quantitative and reproducible measure of hypoxic
ventilatory control in normal subjects. The between-day
differences in the estimated parameters are compatible
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with the previous reported day-to-day variablity in the
hypoxic ventilatory response in an individual (22) . The
differences may therefore reflect physiological changes
such as variations in blood pH which has been shown to
account partly for the between-day variability in the
ventilatory response to hypoxia (22). The greater
between-subject compared to within-subject variability
in the gains suggests that the model is capable of
quantifying genetically-determined individual
differences in hypoxic ventilatory control (3).
Finally, however, it must be emphasised that the form
of the model was developed empirically on a purely
mathematical basis without consideration of possible
underlying physiological mechanisms. Physiological
interpretation of the model must be treated with
caution. It is tempting to ascribe the components of the
response described by the differential equation with the
fast time constant to the activity of the carotid
chemoreceptor, and that with the longer time constant to
a central "controller", but further studies are needed




The program (written in Fortran IV and assembler on a
DEC PDP 11/73) allowed for any arrangement of one or two
differential equations, with or without the non-linear
terms described above. An input file contained a
sequence of values for an individual of Sa02, time and
VEinst, including both step change and transient events.
To reduce processing time, only 15 normoxic breaths
before and after each period of hypoxia were included in
the file. A standard Runge-Kutta integration routine
(20) was used to calculate values of ventilation for a
given set of equation parameters, and the parameters
were adjusted to minimize the sum of weighted squared
differences between the calculated and observed
ventilation using the "Simplex" method (20) . The
weighting prevented the fitting process being biased
towards the step changes (due to their greater number of
experimental points contributing to the sum of squares)
by multiplying the squared differences during step
changes by the factor W, where
W = sum of durations of transients
sum of durations of steps
To allow the use of delays within the model and
compensation for the delay in response of the ear
oximeter (about 2 sec), the Sa02 was interpolated to one
second intervals within the program using the method of
Lagrange (19).
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During development of the model, a reduced data set
consisting of the response to three transient and two
step change hypoxic stimuli (one 15% 02 and one 12% 02
stimulus) for a subject was used to reduce computing
time. The best fit was then confirmed on the full data
set and adjusted if necessary.
When estimating model parameters using the final
model, a fit was made initially without either of the
non-linear terms, and was repeated using first the
"saturating" effect, and then the inhibition term. At
each stage a significant improvement in fit was sought.
If this did not occur then the parameter values from the
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TABLE 1
Ventilation and gas exchange during normoxic steady state
exercise in 10 normal subjects.
Subject Period 1 Period 2
No. (Transient Hypoxia) (Step Change Hypoxia)
VE V02 VC02 PETC02 VE V02 VC02 PETC02
lnin-1 lnin-1 lnin-1 nmHg lnin-1 lnin-1 lnin-^ mnHg
1 22.9 0.98 0.84 44 23.1 0.93 0.30 44
2 26.3 0.39 0.84 38 27.1 0.92 0.38 33
3 22.5 1.04 0.84 44 25.2 1.14 0.97 42
4 19.4 1.01 0.84 46 19.2 0.99 0.33 45
5 22.2 0.95 0.30 41 22.6 0.95 0.73 41
6 27.9 1.04 0.90 39 23.1 1.07 0.92 38
7 29.5 0.96 0.94 41 23.4 0.99 1.01 43
8 19.7 0.90 0.77 43 22.0 0.96 0.83 40
9 24.0 0.93 0.84 42 21.6 0.95 0.81 42
10 20.7 0.30 0.69 38 21.1 0.78 0.68 38
Mean 23.6 0.95 0.33 42 23.3 0.97 0.35 41
SD 3.5 0.07 0.07 3 3.2 0.09 0.10 3
Fccrnote : V£, minute ventilation (1 min-" BTPS) ; V0~ oxygen
ccr.sumpticn (1 min-1 STPD) ; VC02 carbon dioxide output (1 nin-1
STPD); PETC02, end-tidal Pco2 (mmHg).
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TABLE 2




Equation 1 Equation 2
G1 I >-2 G2 r
1 3.0 - 0.001 15 3 . 0 0.1
2 0.6 * 70 3.2 •k
3 1.3 - 0.015 8 4 . 8 :k
4 0.1 * 20 1. 8 •k
5 1.0 * 70 11. 0 0.26
6 9.0 - 0.014 15 10 . 0 ★
7 3.0 0.05 15 0 . 8 *
3 0.7 * 16 1.3 *
9 0.9 0.009 8 3 . 4 ★
10 1.7 * 30 12 . 0 0.3
itnote: Gl: gain of equation 1 (1 min-H-i)
I: parameter describing "inhibi tion" (posi tive vali
or "potentiation" (negative value) of gain 1
(1 min-1)-1
V2: time constant of equation 2 (sec)
G2: gain of equation 2 (without r, 1 min~-% -1; with
1 min-1)
r: parameter describing "saturating" effect acting on
G2 (%)




Mean ventilation and gas exchange during normoxic steady state
exercise for 10 repeated studies in four subjects.
Subject VE Vq2 vC02 petC02
No-

























Foornote: V£, r.inute ventilation (1 nin-1 BTPS); VQ2, oxygen
consumption (1 min-1 STPD); VC02, carbon dioxide




Figure 1: Breath-by-breath measurements of VEinst (upper
trace), SaQ2 (middle trace), and end-tidal Pqq2 (l°wer
trace) in one subject showing the responses to transient
and step change hypoxic stimuli. Hypoxic stimuli
consisting of 2 breaths of 100% N2, given at times
indicated by the arrows, caused a transient fall in Sa02
and brief rise in VEinst. Step change stimuli, produced
by changing the inspired gas abruptly to either 15 or
12% 02, caused a slower onset, sustained fall in Sa02
*
accompanied by a gradual and maintained rise in VEinst.
End-tidal PETC02 fell slightly during the response to
the transient stimulus, but was maintained constant at
the normoxic baseline level during the onset and
duration of the step change hypoxic stimuli.
Figure 2: A. Schematic representation of the model
consisting of a single linear differential equation.
B. Comparison of the model output, Vcalc (upper trace,
and dotted line in the lower trace), and the
experimentally recorded VEinst (solid line, lower trace)
in response to three transient and two step change (FIq2
0.15 and 0.12) hypoxic stimuli in one subject. The model
output tended to overestimate the response to transient
hypoxia and underestimate the response to step change
hypoxia.
Figure 3: A. Schematic representation of the
model consisting of two linear differential equations in
228
parallel with both outputs summed (Y1 + Y2).
B. Comparison of the model output, ^calc, and the
experimentally recorded Vginst, illustrated as in Fig 2.
The model did not adequately describe the response to
all hypoxic stimuli, tending to underestimate the
response to the 15% 02 step change stimulus, and with
the slow time constant of equation 2 resulting in a slow
return in Vcalc to baseline after the return to
normoxia.
Figure 4: A. Schematic representation of the final model
consisting of two linear differential equations in
parallel, with both outputs summed and incorporating two
non-linear terms describing i) "inhibition" (positive I)
or "potentiation" (negative I) of gain of equation 1
(Gl) by the output of equation 2 (Y2) , and ii) allowing
the gain of equation. 2 to "saturate" by replacing G2
with G2/(S + r). The slow recovery in Vcalc on return to
normoxia was eliminated by setting the output of
equation 2 (Y2) to zero when S < 2%.
B. Comparison of the model output, Vcalc, and the
experimentally recorded VEinst, illustrated as in Fig 2,
showing a close fit between the model output and the
experimentally recorded response to transient and step
change hypoxic stimuli with elimination of the slow
recovery in Vcalc on removal of the hypoxic stimulus.
Figure 5: Illustration of the model output giving the
best fit to the experimentally recorded V£inst in four
229
subjects. For each subject the model output (Vcalc,
upper trace and dotted line in middle trace) , and
breath-by-breath measurements of VEinst (middle trace)
and Sa02 (lower trace) are shown. In subject 4 only the
parameters Gl, G2 and ?"2 were needed to give the best
fit, whereas a negative I parameter ("potentiation") was
also needed in subject 3, and r needed in subjects 5 and
10.
Figure 6: Histograms of the estimated parameters Gl,
G2, I, r and *T2 measured on 10 occasions in each of four
subjects. The units given for G2 of 1 min-1 %-1 apply to
those cases where r was not required; for those cases
where r was needed the units for G2 are 1 min-1.
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Mean Sa02 of the transient hypoxic stimuli
(trans) and lowest 12% C>2 step change Sa02











































































Transient hypoxic stimuli slopes of response




































































Step change hypoxic stimui slopes of response











































Model parameter gain 1 values for each
subject given for each study day (lmin
Subject
1 2 3 4
1.55 2.54 3.54 5.31
1.94 2 . 64 3 . 67 3.31
1.74 3.48 4.33 2.58
0.77 3.57 3 . 37 3.03
1.18 2 . 00 3 .82 3 . 53
1.87 5. 19 3.37 2 .17
0.96 3.27 5.44 2 . 69
1.09 1.93 3.25 2.21
1.73 3 . 11 5.24 3 .49
1.75 1.99 4 . 17 2 .78
1.46 2.97 4 . 02 3 . 11
0.42 0.99 0.78 0.91
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Table 8 Model parameter inhibition values for each
subject given for each study day ((lmin-1)-1)
Subject
Study
day 1 2 3 4
1 -0.19 0. 04 * 0.44
2 -0.09 0. 12 -0.18 0.82
3 -0.20 0. 56 0.20 0.21
4 -0.26 0. 63 -0.22 0.59
5 -0.21 0. 03 -0.31 0. 19
6 -0.14 0.96 -0. 06 0.30
7 -0. 17 0. 13 -0.42 0.26
8 0.02 0. 07 -0.21 0. 11
9 -0. 01 0. 09 -0.24 0.43
10 -0. 08 0. 11 -0. 05 0. 15
where * represents parameter not required by model of
best fit
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Table 9 Model parameter time constant of equation 2,




day 1 2 3 4
1 34 51 24 4
2 24 51 15 158
3 28 26 180 11
4 14 50 145 20
5 90 50 48 3
6 45 50 95 37
7 29 12 272 14
8 56 50 40 129
9 180 50 307 15
10 167 170 197 67
mean 67 56 132 46
s. d. 60 42 105 55
co.of var. 90% 75% 79% 121%
where co. of var. represents the coefficient of
variation
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Table 10 Model parameter gain 2 values for each
subject for each study day
Subject
Study
day 1 2 3 4
1 10.28 1.18 3 . 64 0.96
2 10.08 3 . 01 2.01 2 . 37
3 8 . 34 1.18 2.97 1.74
4 11. 63 1.14 2.20 1.31
5 9.99 3 . 64 2 . 32 0.76
6 10.08 1. 89 1.82 2 . 84
7 11. 39 2 . 12 1.42 1.25
8 5.43 3.76 2.26 2 . 27
9 7 . 89 1.87 0.99 1.43
10 8 . 82 2 . 03 1. 04 1.67
mean 9 .39 2 . 18 2 . 07 1.66
s. d. 1.84 0 . 98 0 . 82 0 . 66
Units for gain 2 if sigma also included are lmin-1%-1,
or if sigma not required to produce the model of best
fit then lmin-1.
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Table 11 Model parameter saturating effect, sigma
values for each subject for each study day (%)
Subject
Study
day 1 2 3 4
1 1.70 0.29 * *
2 1.23 0. 05 1. 02 *
3 1.73 * 0.51 *
4 1.35 * * *
5 1.63 0.21 0. 47 *
6 1. 59 0. 05 * *
7 1. 68 * * *
8 0.24 * 0.46 0 . 18
9 0 .25 0.49 * *
10 0 .49 0. 19 * *





































































































































































































































































































































































































































































































































































































































































85.18±0.2146+ .0950 15--.22+0.175.5 . 04 8 95.48+0.103 .2860 955 0. 25.53+0.0749 164 56 .
Table 17 Lowest Sa02 values during hypoxia at rest and
at each exercise level during step change
hypoxia for each subject
Exercise level
Subject Rest 1 2 3 4
number Sa00 Sa00 Sa00 Sa0o Sa09
<%? (%) (%) (%) (%)
1 87 89 87 85 -
2 84 89 87 85 -
3 83 84 84 81 -
4 82 78 82 77 -
5 84 84 83 80 -
6 81 83 84 77 -
7 82 89 85 81 87
8 82 87 81 - -
9 83 82 82 83 -
mean 83 85 84 81
s. d. 2 4 2 3
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3.75 1.95 1.95 3.60 4.40 3.75
1.56 2.07 1.36 1.00 1.19 1.29
6.1 9.0 4.2 7.4 7.7 6.6
0.18 0.20 0.10 0.22 0.22 0.19
0.15 0.15 0.10 0.19 0.20 0.17
17.7 22.0 14.5 15.7 12.7 13.7
0.38 0.45 0.33 0.51 0.64 0.53
5.57 4.82 5.74 4.85 5.77 5.06
3.60 1.70 2.35 3.60 4.60 3.80
0.51 0.20 0.29 0.27 0.19
8.6 7.0 5.5 8.0 9.1 7.6
0.23 0.17 0.13 0.20 0.24 0.22
0.23 0.14 0.12 0.19 0.22 0.18
18.2 16.0 14.7 15.2 14.9 14.8
0.96 0.39 0.35 0.54 0.67 0.58
5.54 4.93 5.35 4.48 4.76 5.35
Table 20 Steady state exercise ventilation and gas





vo2 vco2 vE vo2 vco2
1 20.4 0.83 0.84 20.9 0.79 0.79
2 21.7 0.79 0.66 20.7 0.70 0. 58
3 17. 0 0.47 0.46 15.2 0. 53 0. 48
4 15.8 0. 62 0.53 19 . 0 0 . 65 0. 57
5 20.2 0.77 0.72 22.5 0.88 0.76
6 16.2 0.63 0. 54 17 . 6 0. 67 0 . 56
VE expressed as lmin 1 BTPS, V02 and VC02 as lmin 1
STPD.
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Table 21 Baseline normoxic exercise Petco2 values
(base) and those during transient (trans) and
step change hypoxia (step) for each subject
taking placebo or theophylline
PLACEBO THEOPHYLLINE
Subject base trans step base trans step
number
1 5.71 5.85 5.92 5.50 5.47 5.50
+0.49 +0.33 +0.25 +0.17 +0.23 +0.16
2 5.33 5.31 5.22 5.17 5.11 5.13
+0.15 +0.16 +0.11 +0.12 +0.17 +0.12
3 5.20 - 5.18 5.14 5.03 5.21
+0.37 - +0.18 +0.17 +0.18 +0.10
4 5.02 5.05 4.97 4.49 4.56 4.50
+0.14 +0.22 +0.14 +0.15 +0.10 +0.12
5 5.95 5.79 5.89 4.96 4.89 4.99
+0.21 +0.31 +0.16 +0.14 +0.22 +0.17
6 5.18 5.06 5.19 5.31 5.11 5.20
+0.15 +0.21 +0.13 +0.17 +0.23 +0.12
254






















































































































































































































































































































































































































bj( mb( 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34




















































































































































































































































































































































































































































































































































































































































































bj< intx 16 17 18 19 20 21 22 23 24 25 26
Tahlo
23










































































































































































































Table 24 Baseline normoxic values for ventilation and
gas exchange for offspring and control groups
OFFSPRING CONTROLS
Subj ect vo2 vco2 vE vo2 vco2
number
1 28 . 9 0.99 1. 09 16.8 0 .76 0.70
2 22 . 4 0.94 0.90 19 . 8 0 . 68 0 . 58
3 27 . 2 1.14 1. 10 30.0 1. 19 1. 19
4 25.8 0.92 0.75 20.3 0 .75 0 .75
5 23 . 1 0.92 0.74 18. 2 0. 66 0 . 63
6 19 . 0 0 . 67 0. 63 19 . 7 0. 66 0 . 53
7 25.4 0.90 0.81 19 . 5 0.71 0. 60
8 18 . 0 0 . 63 0.63 26.0 1. 07 1. 06
9 24 . 3 0.93 0.93 13 . 8 0 . 50 0.40
10 21.1 0 .97 0.95 23.5 0.99 0 .86
11 29 . 1 0 . 99 1.05 18 . 6 0 .75 0 .70
12 25 . 1 0. 92 0.86 18 . 2 0 . 61 0 . 52
13 32 . 2 1.43 1.22 20.4 0 .79 0 .74
14 20 . 5 0.92 0.83 17.7 0. 50 0.45
15 17 . 0 0 . 56 0.47 24 . 1 0 . 85 0 .80
16 16 . 0 0 . 52 0 .49 24 . 2 0.96 0.81
17 21.0 0 .76 0 . 65 19 . 3 0 .76 0.71
18 18 . 8 0 . 60 0. 54 18 . 5 0 .82 0 . 69
19 21.4 0 . 63 0 . 67 20.3 0.71 0 . 69
20 16 . 1 0.57 0.50 23.1 0.81 0 . 69
21 30.8 1.20 1.03 22 . 3 0 . 88 0. 88
22 24 . 7 0 . 89 0.79 26.1 1. 09 0 .84
23 20.0 0.81 0.74 16 . 4 0 . 69 0 . 52
24 21.3 0.93 0.89 16. 9 0 . 68 0.61
25 29 . 0 0.93 0. 97 19 . 3 0 . 69 0 . 57
26 20.8 0 . 68 0.74 21.0 0.84 0 .79
27 21.4 0 . 88 0.96
28 17 . 4 0.71 0.63
29 19 . 5 0 . 79 0 . 77
30 26 . 0 0 . 89 0 . 90
31 15 . 7 0 . 55 0.46
32 32 . 5 1. 09 1. 07
33 26.9 0 . 93 0. 87
34 21.3 0.86 0. 74
35 18 . 4 0 . 67 0 . 60

























































































5.3 3 +0.3 0
5.64+0.19
6.13+0.23
4 . 84 +0.14
5 . 12 +0.13
5 .81+0.12
4 .82 +0.17
4 . 47 +0.20
5. 07 +0.16
4 . 88 +0.14
5 . 03 +0.21
5 . 47+0.21
5 . 88 +0.25
4 .90+0.34
4 . 82 +0.22
6 . 18 +0.25

































4 . 87 + 0 . 14
5.06+0.09
4.91+0.18
6 . 02 + 0 . 22
4 . 9 5+ 0 .. 2 0
5 .29 +0.26
5.04+0.08
4 . 90+ 0 . 14













































































5 . 24 + 0 .27
5.49+0.09




































ADAMS, L. FRANKEL, H. GARLICK, J. GUZ, A. MURPHY, K.
SEMPLE, S.J.G. The role of spinal cord transmission in
the ventilatory response to exercise in man; J. Physiol.
1984a: 355: 85-97
ADAMS, L. GARLICK, J. GUZ, A. MURPHY, K. SEMPLE,
S.J.G. Is the voluntary control of exercise in man
necessary for the ventilatory response?; J. Physiol.
1984b: 355: 71-83
ADAMS, E.M. SWANSON, G.D. WEIL, J.V. On the
assessment of the hypoxic ventilatory response. From
Modelling and control of breathing, 1983. Ed. B.J. Whipp
and D.M. Wiberg, Elsevier Science Publishing Co. p46-53
AIRLIE, M.A.A. FLENLEY, D.C. WARREN, P.M. Effect of
almitrine on hypoxic ventilatory drive measured by
transient and progressive isocapnic hypoxia in normal
men; Clin. Sci. 1989: 77: 431-437
ALFES, H. KINDLER, J. KNOCHE, H. MATTHIESSEN, D.
MOLLMAN, H. PAGNICCO, R. The biogenic amines in the
carotid body; Prog. Histochem. Cytochem. 1977: 10: 1-69
ALLY, A.I. NAKATSU, K. Adenosine inhibition of
isolated rabbit ileum andd antagonism by theophylline;
J. Pharmacol. Exp. Ther. 1976: 199: 208-215
ANDERTON, J.L. HARRIS, E.A. SLAWSON, K.B. The
repeatability of ventilatory responses to excess of
carbon dioxide and lack of oxygen; Quart. J. Exptl.
Physiol. 1964: 49: 43-51
ASMUSSEN, E. NIELSON, M. Ventilatory response to C02
during work at normal and at low oxygen tensions; Acta.
Physiol. Scand. 1957: 39: 27-35
ASMUSSEN, E. NIELSON, M. Pulmonary ventilation and
effect of oxygen breathing in heavy exercise; Acta.
Physiol. Scand. 1958: 43: 365-378
BELVILLE, J.D. WHIPP, B.J. KAUFMAN, R.D. SWANSON,
G.D. AQLEH, K.A. WASSERMAN, K. Central and peripheral
chemoreflex loop gain in normal and carotid-body
resected subjects; J. Appl. Physiol. 1979: 46: 843-853
BERGER, A.J. Distribution of carotid sinus nerve
afferents to solitary tract nuclei of the cat using
transganglionic transport of horseradish peroxidase;
Neurosci. Lett. 1979: 14: 153-158
262
BERGER, A.J. MITCHELL, R.A. SEVERINGHAUS, J.W. Medical
progress: Regulation of respiration; N. Eng. J. Med.
1977: 297: 92-97, 138-143, 194-201
BERTHON-JONES, M. SULLIVAN, C.E. Ventilatory and
arousal responses to hypoxia in sleeping humans; Am.
Rev. Resp. Dis. 1982: 125: 632-639
BERTHOLON, J.F. CARLES, J. EUGENE, M. LABEYRIE, E.
TEILLAC, A. A dynamic analysis of the ventilatory
response to carbon dioxide inhalation in man. J.
Physiol. 1988: 398: 423-440
BERTHOLON, J.F. EUGENE, M. LABEYRIE, E. TEILLAC, A. A
dynamic analysis of the ventilatory response to hypoxia
in man. J. Physiol. 1989: 408: 473-492
BEST, C.H. TAYLOR, N.B. Physiological basis of medical
practice, 11th edition, 1985. Ed. J. B. West, Williams
and Wilkins, Baltimore.
BHATTACHARYYA, K.N. CUNNINGHAM, D.J.C. GOODE, R.C.
HOWSON, M.G. LLOYD, B.B. Hypoxia, ventilation, PC02 and
exercise; Resp. Physiol. 1970: 9: 329-347
BILLIET J.J. Normal Tco values for healthy women; J.
Phys. (Paris) 1963: 55
BISCOE, T.J. MILLAR, R.H. Effect of inhalation
anaesthetics on carotid body chemoreceptor activity; Br.
J. Anaesth. 1968: 40: 2012
BISCOE, T.J. PURVES, M.J. Factors affecting the carotid
chemoreceptor and cervical sympathetic activity with
special reference to passive hindlimb movements; J.
Physiol. (Lond.) 1967: 190: 425-441
BISGARD, G.E. MITCHELL, R.A. HERBERT, D. A. Effects of
dopamine, norepinephrine and 5-hydroxytryptamine on the
carotid body of the dog; Resp. Physiol. 1979: 37: 61-80
BLACK, A.M.S. McCLOSKEY, D.I. TORRANCE, R.W. The
response of carotid body chemoreceptors to sudden
changes of hypercapnic and hypoxic stimuli; Resp.
Physiol. 1971: 13: 36-49
BLACK, A.M.S. TORRANCE, R.W. Respiratory oscillations
in chemoreceptor discharge in the control of breathing;
Respir. Physiol. 1971: 13: 221-237
BRADLEY, C.A. FLEETHAM, J.A. ANTHONISEN, N.R.
Ventilatory control in patients with hypoxaemia due to
obstructive lung disease; Am. Rev. Resp. Dis. 1979:
120: 21-29
263
BRIGGS, H. Physical exertion fitness and breathing; J.
Physiol. 1920: 54: 292-318
BUCHFUHRER, M.J. HANSEN, J.E. ROBINSON, T.E. SUE,
D.Y. WASSERMAN, K. WHIPP, B.J. Optimising the exercise
protocol for cardiopulmonary assessment. J. Appl.
Physiol. 1983: 55: 1558-1564
BURROWS, B. FLETCHER, C.M. HEARD, B.E. JONES, N.L.
WOOTLIFF, J.S. The emphysematous and bronchial types of
chronic airways obstruction; Lancet 1966: i: 830-835
BUTCHER, R.W. SUTHERLAND, E.W. Adenosine 3',5'-
phosphate in biological materials; purification and
properties of 3',5'-nucleotide phosphodiesterase and use
of this enzyme to characterize adenosine 3',5'-phosphate
in human urine; J. Biol. Chem. 1962: 237: 1244-1250
CALERESU, F.R. CIRIELLO, J. Projections to the
hypothalamus from buffere nerves and nucleus tractus
solitarius in the cat; Am. J. Physiol. 1980: 239:R130-
R136
CALVERLEY, P.M.A. MIDDLETON, W. BRASH, H.M. WRAITH,
P.K. FLENLEY, D.C. Do human arterial chemoreceptors
respond to transient changes in C02 tension during
exercise?; Clin. Sci. 1974: 56: 36p
CASABURI, R. A dynamic model of the respiratory
controller; PhD dissertation, 1972, Troy, N.Y.:
Rensselaer Polytechnic Institute, University Microflm
Abstr. 72-18, 272.
CHERNIACK, N.S. EDELMAN, N.H. LAHIRI, S. Hypoxia and
hypercapnia as respiratory stimulants and depressants;
Resp. Physiol. 1970: 11: 113-116
CHIODI, H. DILL, D.B. CONSOLAZIO, F. HORRATH, S.M.
Respiratory and circulatory responses to acute carbon
monoxide poisoning; Am. J. Physiol. 1941: 134: 684-693
CHRISTENSEN, N.J. GALBO, H. HANSEN, J.F. HESSE, B.
RICHTER, E.A. TRAP-JENSEN, J. Catecholamines and
exercise; Diabetes 1979; 28: 58-62
CLANCY, L.J. CRITCHLEY, J.A.J.H. LEITCH, A.G. KIRBY,
B.J. UNGAR, A. FLENLEY, D.C. Arterial catecholamines
in hypoxic exercise in man; Clin. Sci. Mol. Med. 1975:
49: 503-506
COHEN, M.I. Discharge patterns of brain stem
respiratory neurones during Hering-Breuer reflex evoked
by lung inflation; J. Neurophysiol. 1969: 32: 356-374
264
COLLINS, D.D. SCOGGIN, C.H. ZWILLICH, C.W. WEIL, J.V.
Hereditary aspects of decreased hypoxic response; J.
Clin. Invest. 1978: 62: 105-110
COLQUHOUN, D. Lectures on Biostatistics, Clarendon
Press, Oxford, 1971
COTES, J.E. Lung Function, 1st Edition, Blackwell,
Oxford, 1965
COTES, J.E. Lung Function, 4th Edition, Blackwell,
Oxford, 1979
CRAPO, R.O. MORRIS, A.H. CLAYTON, P.D. Lung volumes in
healthy non-smoking adults; Bull. Europ. Physiopath.
Resp. 1982: 18: 419-425
CRAPO, R.O. MORRIS, A.H. GARDNER, R.M. Reference
spirometric values using techniques and equipment that
meet ATS recommendations; Am. Rev. Resp. Dis. 1981:
123: 659-664
CUMMINS, A.R.C. ALISON, J. JACOBI, M.S. IYAWE, V.I.
SAUNDERS, K.B. Ventilatory sensitivity to inhaled
carbon dioxide around the control point during exercise;
Clin. Sci. 1986: 71: 17-22
CUNNINGHAM, D.J.C. Some quantitative aspects of the
regulation of human respiration in exercise; Br. Med.
Bull. 1963: 19: 25-30
CUNNINGHAM, D.J.C. The patterns of alveolar carbon
dioxide and oxygen: the effects of various oscillations
on breathing in man; Scientific Basis of Medicine Annual
Reviews, 1972: 332-362
CUNNINGHAM, D.J.C. The control system regulating
breathing in man; Quart. Rev. Biophysics. 1974: 64: 433-
483
CUNNINGHAM, D.J.C. HEY, E.N. PATRICK, J.M. LLOYD,
B.B. The effect of noradrenaline infusion on the
relation between pulmonary ventilation and the alveolar
POo and PCO^ in man; Ann. N.Y. Acad. Sci. 1963: 109:
765-770
CUNNINGHAM, D.J.C. PATRICK, J.M. LLOYD, B.B. The
respiratory response of man to hypoxia; in Oxygen in the
Animal Organism. Ed. F. Dickens and E. Neil. Elmsford
N.Y. Pergammon Press, 1964: 277-293
CUSHLEY, M.J. TATTERSFIELD, A.E. HOLGATE, S.T.
Inhaled adenosine and guanine on airway resistance in
normal and asthmatic subjects; Br. J. Clin. Pharmacol.
1983: 15: 161-165
265
DALY, J.W. BRUNS, R.F. SNYDER, S.H. Adenosine
receptors in the central nervous system: relationship to
the central actions of methylxanthines; Life Sciences
1981: 28: 2083-2097
DALY, M. De B. LAMBERTSON, C.J. SCHWEITZER, A.
Observations on the volume of blood flow and oxygen
utilisation of the carotid body in the cat; J. Physiol.
(Lond). 1954: 125: 67-89
DAVIDSON, A.C. CAMERON, I.R. The effect of acute
hypoxia on subsequent cardiorespiratory responsiveness
in normal man; Bull. Eur. Physiopathol. Respir. 1983:
19: 32-33
DAVIES, R.O. LAHIRI, S. Absence of carotid
chemoreceptor response during hypoxic exercise in the
cat; Resp. Physiol. 1973: 18: 92-100
DeCASTRO, F. Sur la structure et 1'innervation du sinus
carotidien de l'homme et les mammiferes: nouveax faits
sur 1'innervation et la fonction du glomus caroticum;
Trav. Lab. Rech. Biol. Univ. Madr. 1928: 25: 330-380
DeCORT, S.C. HILL, J.E. WARREN, P.M. The ventilatory
response to transient hypoxia is not limited by the
resultant hypocapnia in normal subjects; Clin. Sci.
1988: 74: A13
DeCORT, S.C. WARREN, P.M. MCQUEEN, D.S. The
chemoreceptor response to hypoxia is independent of the
rate of onset of stimulus both before and after
almitrine; Clin. Sci. 1987: 73: suppl. 17, 35-36p
DEJOURS, P. La regulation de la ventilation au cours de
1'exercise musculaire chez l'homme; J. de Physiol.
(Paris) 1953: 51: 163-261
DEJOURS, P. Control of respiration by arterial
chemoreceptors; Ann. New York Acad. Sci. 1963: 109: 682-
695
DEJOURS, P. Approaches to the study of arterial
chemoreceptors; in Arterial Chemoreceptors, Ed. R.W.
Torrance, Blackwell, Oxford, 1968: 41-49
DEJOURS, P. GIRARD, F. LABROUSSE, Y. RAYNAUD, Y.
Stimulus oxygene chemoreflexe de la ventilation a basse
altitude chez l'homme- Au cours de l'exercise
musculaire; J. de Physiol. (Paris) 1957a: 49: 120-124
DEJOURS, P. LABROUSSE, Y. RAYNAUD, Y. TEILLAC, A.
Stimulus oxygene chemoreflexe de la ventilation a basse
altitude (50m) chez l'homme; J. de Physiol. (Paris)
1957b: 49: 115-120
266
DEJOURS, P. LABROUSSE, Y. RAYNAUD, Y. TEILLAC, A.
Stimulus oxygene de la ventilation au repos et au cours
de l'exercise musculaire, a basse altitude (50m) chez
l'homme; Rev. Franc. Etudes Clin, et Biol 1958: III:
103-123
DOEKEL, R.C. ZWILLICH, C.W. SCOGGIN, C.H. KRYGER,
M.H. WEIL, J.V. Clinical semi-starvation: depression of
hypoxic ventilatory response; N. Engl. J. Med. 1976:
295: 358-361
DORNHORST, A.C. Respiratory insufficiency; Lancet 1955:
1: 1185-1187
DOUGLAS, N.J. Control of ventilation during sleep;
Clinics in Chest Medicine 1985: 6: 563-575
DOUGLAS, N.J. BRASH, H.M. WRAITH, P.K. CALVERLEY,
P.M.A. LEGGETT, R.J.E. McELDERRY, L. FLENLEY, D.C.
Accuracy, sensitivity to carboxyhaemoglobin and speed of
response of the Hewlett-Packard 47201A ear oximeter; Am.
Rev. Resp. Dis. 1979: 119: 311- 313
DOUGLAS, N.J. WHITE, D.P. PICKETT, C.K. Respiration
during sleep in normal man; Thorax 1982: 37: 840-844
DOWELL, A. R. HEYMAN, A. SEIKER, H.O. TRIPATHY, K.
Effect of aminophy11ine on respiratory center
sensitivity in Cheyne-Stokes respiration and in
pulmonary emphysema; N. Engl. J. Med. 19 65; 273: 144 7-
1453
DUNCAN, G. JOHNSON, R.H. LAMBIE, D.G. Role of sensory
nerves in the cardiovascular and respiratory changes
with isometric forearm exercise in man; Clin. Sci. 1981;
60: 145-155
DUTTON, R.E. HODSON, W.A. DAVIES, D.G. FENNER, A.
Effect of the rate of rise of carotid body PC02 on the
time course of ventilation; Respir. Physiol. 1967:
3: 367-379
DUTTON, R.E. SMITH, E.J. GHATAK, P.K. DAVIES, D.G.
Dynamics of the respiratory controller during carotid
body hypoxia; J. Appl. Physiol. 1973: 35: 844-850
EASTON, P.A. ANTHONISEN, N.R. Ventilatory response to
sustained hypoxia after pretreatment with aminophylline;
J. Appl. Physiol. 1988a: 64: 1445-1450
EASTON, P.A. ANTHONISEN, N.R. Carbon dioxide effects
on the ventilatory response to sustained hypoxia; J.
Appl. Physiol. 1988b: 64: 1451-1456
267
EASTON, P.A. SLYKERMAN, L.J. ANTHONISEN, N.R.
Ventilatory response to sustained hypoxia in normal
adults; J. Appl. Physiol. 1986: 61: 906-911
EASTON, P.A. SLYKERMAN, L.J. ANTHONISEN, N.R.
Recovery of the ventilatory response to hypoxia in
normal adults; J. Appl. Physiol. 1988: 64: 521-528
EDELMAN, N.H. CHERNIACK, N.S. LAHIRI, S. RICHARDS, E.
FISHMAN, A.P. The effects of abnormal sympathetic
nervous function upon the ventilatory response to
hypoxia; J. Clin. Invest. 1970: 49: 1153-1165
EDELMAN, N.H. EPSTEIN, P.E. LAHIRI, S. CHERNAIACK,
N.S. Ventilatory response to transient hypoxia and
hypercapnia in man; Respir. Physiol. 1973: 17: 302-314
ELDRIDGE, F.L. KILEY, J.P. MILLHORN, D.E. Respiratory
responses to medullary hydrogen ion changes in cats:
Different effects of respiratory and metabolic acidoses;
J. Physiol. (Lond) 1985: 358: 285-297
ELDRIDGE, F.L MILLHORN, D.E. WALDROP, T.G. KILEY,
J.P. Mechanism of respiratory effects of
methylxanthines; Respir. Physiol. 1983: 53: 239-261
EVENSON, M.A. WARREN, B.L. Serum theophylline analysis
by high-pressure liquid chromatography ; Clin. Chem.
1976: 22: 851-855
EYZAGUIRRE, C. LEWIN, J. Chemoreceptor activity of the
carotid body of the cat; J. Physiol. (Lond) 1961:
159: 222-237
EYZAGUIRRE, C. ZAPATA, P. Perspectives in carotid body
research; J. Appl. Physiol. 1984: 57: 931-957
FLEETHAM, J.A. ARNUP, M.E. ANTHONISEN, N.R. Familial
aspects of ventilatory control in patients with chronic
obstructive pulmonary disease; Am. Rev. Resp. Dis. 1984:
129': 3-7
FLENLEY, D.C. Clinical hypoxia: causes, consequences
and correction; Lancet 1978: 1: 542-546
FLENLEY, D.C. BRASH, H. CLANCY, L. COOKE, N.J.
LEITCH, A. G. MIDDLETON, W. WRAITH, P.K. Ventilatory
response to steady-state exercise in hypoxia in humans;
J. Appl. Physiol. 1979: 46: 438-446
FLENLEY, D.C. COOKE, N.J. KING, A.J. LEITCH, A. G.
BRASH, H.M. The hypoxic drive to breathing during
exercise in normal man and in hypoxic patients with
chronic bronchitis and emphysema; Bulletin de Physio-
Pathologie Respiratoire, 1973: 9: 689-691
268
FLENLEY, D.C. FRANKLIN, D.H. MILLER, J.S. The hypoxic
drive to breathing in chronic bronchitis and emphysema;
Clin. Sci. 1970: 38: 503-518
FLENLEY, D.C. MILLAR, J.S. Ventilatory response to
oxygen and carbon dioxide in chronic respiratory
failure; Clin. Sci. 1967: 33: 319-334
FLENLEY, D.C. WARREN, P.M. Ventilatory responses to 02
and CC>2 during exercise; Ann. Rev. Physiol. 1983: 45:
415-426
FORSTER, H.V. DEMPSEY, J.A. BIRNBRAUM, M.L. REDDEN,
W.G. THODEN, J. GROVER, R.F. RANKIN, J. Effect of
chronic exposure to hypoxia an ventilatory response to
C02 and hypoxia; J. Appl. Physiol. 1971: 31: 586-592
FOX, I.H. KELLY, W.N. The role of adenosine and 2'-
deoxyadenosine in mammalian cells; Ann. Rev. Biochem.
1978: 47: 655-686
FREDHOLM, B.B. SYDBOM, A. The anti-allergic actions of
theophylline due to antagonism at the adenosine
receptor; Agents and Actions 1980: 10: 145-147
GABEL, R.A. KRONENBERG, R.S. SEVERINGHAUS, J.W. Vital
capacity breaths of 5% or 15% C02 in N2 or 02 to test
carotid chemosensitivity; Resp. Physiol. 1973: 17: 195-
208
GABEL, R. A. WEISKOPF, R.B. Ventilatory interaction
between hypoxia and [H+] at chemoreceptors of man; J.
Appl. Physiol. 1975: 39: 292-296
GEORGOPOULOS, D. HOLTBY, S.G. BEREZANSKI, D.
ANTHONISEN, N.R. Aminophylline effects on ventilatory
response to hypoxia and hyperoxia in normal adults; J.
Appl. Physiol. 1989: 67: 1150-1156
GERHARDT, T. MCCARTHY, J. BANCALARI, E. Effects of
aminophylline on ventilation and metabolic rate in
premature infants with apnea; Pediatr. Res. 1977: 11:
533
GOULD, G. A. AIRLIE, M.A.A. BRASH, H.M. WRAITH, P.K.
WARREN, P.M. FLENLEY, D.C. The "on-phase" of
ventilatory response to transient hypoxia to assess
carotid chemoreceptor mediated ventilatory drive during
exercise; Clin. Sci. 1985: 68: suppl. 11, p62
GRODINS, F.S. BUELL, J. BART, A.J. Mathematical
analysis and digital simulation of the respiratory
control system; J. Appl. Physiol. 1967: 22: 260-276
269
GUGGER, M. MOLLOY, J. GOULD, G.A. WHYTE, K.F. RAAB,
G.H. SHAPIRO, C.M. DOUGLAS, N.J. Ventilatory and
arousal responses to added inspiratory resistance during
sleep; Am. Rev. Resp. Dis. 1989, in press
GUZ, A. Regulation of respiration in man; Ann. Rev.
Physiol. 1975: 37: 303-323
GUZ, A. NOBLE, N.L.M. WIDDICOMBE, J.G. TRENCHARD, D.
MUSHIN, W.W. Peripheral chemoreceptor block in man;
Resp. Physiol. 1966: 1: 38-40
HALL, A.M. HEYWOOD, C. COTES, J.E. Lung function in
healthy British women; Thorax 1979: 34: 359-365
HATCHER, J.D. CHIU, L.K. JENNINGS, D.B. Anaemia as a
stimulus to aortic and carotid chemoreceptors in the
cat; J. Appl. Physiol. 1973: 44: 696-702
HEDEMARK, L.L. KRONENBERG, R.S. Ventilatory and heart
rate responses to hypoxia and hypercapnia during sleep
in adults; J. Appl. Physiol. 1982: 53: 307-312
HESS, A. CASSADY, I. Efferent fibres from the brainstem
neurones in the rat carotid sinus nerve; Soc. Neurosci.
1983: A9: 978
HESS, A. ZAPATA, P. Innervation of the cat carotid
body: normal and experimental studies; Fed. Proc. 1972:
31: 1365-1382
HESSE, B. KANSTRUP, I.L. CHRISTENSEN, N.J. INGEMANN-
HANSEN, T. HALKJAER-KRISTENSEN, J. PETERSEN, F.B.
Reduced norepinephrine response to dynamic exercise in
human subjects during O2 breathing; J. Appl. Physiol.
1981: 51: 176-171
HEYMANS, C. BOUCKAERT, J.J. Sinus carotidienne et
reflexes respiratoires: Compte Rend. Soc. de Biol. 1930:
103: 498-500
HEYMANS, C. BOUCKAERT, J.J. DAUTREBANDE, L. Sinus
carotidien et reflexes respiratoires: sensibilite des
sinus carotidiens aux substances chimiques. Action
stimulante respiratoire reflexe de sulfure, de sodium du
cyanure, de potassium, de la nicotine et de la lobeline;
Arch. Int. Pharmacodyn. Ther. 1931: 40: 54-91
HEYMANS, C. NEIL, E. Reflexogenic areas of the
cardiovascular system; London, Churchill, 1958
HICKHAM, J.B. PRYOR, W.W. PAGE, E.B. ATWELL, R.J.
Respiratory regulation during exercise in unconditioned
subjects; J. Clin. Invest. 1951: 30: 503-516
270
HILLS, M. ARMITAGE, P. The two-period cross-over
clinical trial; Br. J. Clin. Pharm. 1979: 8: 7-20
HIRSHMAN, C.A. McCULLOUGH, R.E. WEIL, J.V. Normal
values for hypoxic and hypercapnic ventilatory drives in
man; J. Appl. Physiol. 1975: 38: 1095-1098
HORNBEIN, T.F. ROOS, A. Effect of mild hypoxia on
ventilation during exercise; J. Appl. Physiol. 1962:
17: 239-242
HORROBIN, D.F. MANKU, M.S. FRANKS, D.J. HAMET, P.
Methyl xanthine phosphodiesterase inhibitors behave as
prostaglandin antagonists in a perfused rat mesenteric
artery preparation; Prostoglandins 1977: 13: 33-40
HUBERT, H.B. FABSITZ, R.R. FEINLEIB, M. GWINN, C.
Genetic and environmental influences on pulmonary
function in adult twins; Am. Rev. Resp. Dis. 1982:
125: 409-415
HUDGEL, D.W. WEIL, J.V. Asthma associated with
decreased hypoxic ventilatory drive; Ann. Intern. Med.
1974: 80: 622-625
JAHAVERI, S. TEPPEMA, L.J. EVERS, J.A.M. Effects of
aminophylline on hypoxaemia-induced ventilatory
depression in the cat; J. Appl. Physiol. 1988: 64: 1837-
1843
JENNETT, S. WALKER, G. Effect of brief hypoxia on
subsequent ventilatory response in healthy people; J.
Physiol. 1984: 350: 38
JONES, N.L. McHARDY, G.J.R. NAIMATH, A. CAMPBELL,
E.J.M. Physiological dead space and alveolar-arterial
gas pressure differences during exercise; Clin. Sci.
1966: 31: 19-29
JONES, N.L. ROBERTSON, D.G. KANE, J.W. Difference
between end-tidal and arterial PC02 in exercise; J.
Appl. Physiol. 1979: 47: 954-960
KAO, F.F. MEI, S.S. The central multiplicative
interaction of P02 and PC02 on ventilation; in The
Regulation of Respiration during sleep and anaesthesia.
Ed. R.S. Fitzgerald, J. Gautier and S. Lahiri. New York
Plenum Press, 1978: p403-414
KAWAKAMI, Y. IRIE, T. KISHI, F. ASANUMA, Y. SHIDA,
A. YOSHIKAWA, T. KAMISHIMA, K. HASEGAWA, H. MURAO,
M. Familial aggregation of abnormal ventilatory control
and pulmonary function in chronic obstructive pulmonary
disease; Eur. J. Respir. Dis. 1981: 62: 56-64
271
KAWAKAMI, Y. IRIE , T. SHIDA, A. YOSHIKAWA, T.
Familial factors affecting arterial blood gas values and
respiratory chemosensitivity in chronic obstructive
pulmonary disease; Am. Rev. Resp. Dis. 1982a: 125: 420-
425
KAWAKAMI, Y. YOSHIKAWA, T. SHIDA, A. ASANUMA, Y.
Control of breathing in young twins; J. Appl. Physiol.
1982b: 52: 537-542
KEPRON, W. CHERNIACK, R.M. The ventilatory response to
hypercapnia and hypoxaemia in chronic obstructive lung
disease; Am. Rev. Resp. Dis. 1973: 108: 843-850
KING, A.J. COOKE, N.J. LEITCH, A.G. FLENLEY, D.C.
The effects of 30% oxygen on the respiratory response to
treadmill exercise in chronic respiratory failure; Clin.
Sci. 1973: 44: 151-162
KIRBY, T.P. AIRLIE, M.A.A. WRAITH, P.K. HILL, J.E.
DeCORT, S.C. CARSON, E.R. FLENLEY, D.C. WARREN, P.M.
Modelling the dynamic ventilatory responses to hypoxia
in normal subjects; J. Appl. Physiol, in press
KNOWLTON, G.C. LARRABEE, M.G. A unitary analysis of
pulmonary volume receptors; Am. J. Physiol. 1946: 147:
100-114
KOEPCHEN, H.P. Uber die Wirkung von Cortison und
Testosteron aug die Atmung; Pfleugers Arch. 1953:
257: 144-154
KOEPCHEN, H.P. LOTSCHKE, G.C. LOESCHKE, H.H. Uber die
Wirkung von Adrenocorticotropem Hormon auf die
Lungenventilation des Menschen; Pfleugers Arch. 1954:
258: 475-480
KOLBEK, R.C. SPIER, W.A. CARRIER, G.O. BRANSOME, E.D.
Apparent irrelevance of cyclic nucleotides to the
relaxation of tracheal smooth muscle induced by
theophylline; Lung 1979: 156: 173-183
KRONENBERG, R.S. DRAGE, C.W. Attenuation of the
ventilatory and heart rate responses to hypoxia and
hypercapnia with aging in normal man; J. Clin. Invest.
1973: 52: 1812-1819
KRONENBERG, R. HAMILTON, F.N. GABEL, R. HICKEY, R.
READ, D.J.C. SEVERINGHAUS, J.W. Comparison of three
methods for quantitating respiratory response to hypoxia
in man; Resp. Physiol. 1972: 16: 109-125
272
LAGERCRANTZ, H. YAMAMOTO, Y. FREDHOLM, B.B.
PRABHAKAR, N.R. VON EULER, C. Adenosine analogues
depress ventilation in rabbit neonates. Theophylline
stimulation of respiration via adenosine receptors?;
Pediatr. Res. 1984: 18: 387-390
LAHIRI, S. DELANEY, R.G. Stimulus interaction in
responses of carotid body chemoreceptor single afferent
fibers; Respir. Physiol. 1975: 24: 249-266
LAHIRI, S. EDELMAN, N.H. Peripheral chemoreflexes in
the regulation of breathing of high altitude natives;
Resp. Physiol. 1969: 6: 375-385
LAKSHMINARAYAN, S. SAHN, S.A. WEIL, J.V. Effect of
aminophylline on ventilatory responses in normal man;
Am. Rev. Resp. Dis. 1978,117: 33-38
LARRABEE, M.G. HODES, R. Cyclic changes in the
respiratory centres, revealed by the effects of afferent
impulses; Am. J. Physiol. 1948: 155: 147-164
LEBOWITZ, M.D. KNUDSON, R.J. BURROWS, B. Family
aggregation of pulmonary function measurements; Am. Rev.
Resp. Dis. 1984: 129: 8-11
LEE, L-Y. MILLHORN, H.T. Central ventilatory responses
to 02 and C02 at three levels of carotid chemoreceptor
stimulation; Resp. Physiol. 1975: 25: 319-333
LEITCH, A.G. CLANCY, L. FLENLEY, D.C. Maximal oxygen
uptake, lung volume and ventilatory response to carbon
dioxide and hypoxia in a pair of identical twin
athletes; Clin. Sci. Mol. Med. 1975: 48: 235-238
LEITCH, A.G. CLANCY, L. FLENLEY, D.C. Measurement of
the hypoxic drive to breathing at rest and on exercise
using transient, progressive and steady-state hypoxic
methods in normal subjects; Clin. Sci. Mol. Med. 1976:
51: 12p
LLOYD, B.B. JUKES, M.G.M. CUNNINGHAM, D.J.C. The
relationship between alveolar oxygen pressure and the
respiratory response to carbon dioxide in man; Quart. J.
Expt. Physiol. 1958: 43: 214-227
LOESCHKE, H.H. Central chemosensitivity and the reaction
theory; J. Physiol. (Lond). 1982: 332: 1-24
LUGLIANI, R. WHIPP, B.J. SEARD, C. WASSERMAN, K.
Effect of bilateral carotid resection on ventilatory
control at rest and during exercise in man; N. Eng. J.
Med. 1971: 285: 1105-1111
273
LUNDBERG, D.B. BREESE, G.R. MUELLER, R.A.
Aminophylline may stimulate respiration in rats by
activation of dopaminergic receptors; J. Pharmacol. Exp.
Ther. 1981: 217: 215-221
MARGENAU, H. MURPHY, G.M. The Mathematics of Physics
and Chemistry; 2nd Ed; London; D. Van. Nostrand Co. ;
1956, 467-519
MARTIN, B.J. WEIL, J.V. SPARKS, K.E. McCULLOUGH, R.E.
GLOVER, R.F. Exercise ventilation correlates positively
with ventilatory chemoresponsiveness; J. Appl. Physiol.
1978: 45: 557-564
MASSON, R.G. LAHIRI, S. Chemical control of breathing
during hypoxia and exercise; Resp. Physiol. 1974: 22:
241-262
MAXWELL, D.L. FULLER, R.W. NOLOP, K.B. DIXON, C.M.S.
HUGHES, J.M.B. Effects of adenosine on ventilatory
responses to hypoxia and hypercapnia in humans; J. Appl.
Physiol. 1986: 61: 1762-1766
McDONALD, D.M. MITCHELL, R.A. The innervation of glomus
cells, ganglion cells and blood vessels in the rat
carotid body: A quantitative ultrastructural study; J.
Neurocytol. 1975: 4: 177-230
McFADDEN, E.R. Circadian rhythms; Am. J. Med. 1988: 85:
2-5
MCQUEEN, D.S. EYZAGUIRRE, C. Effects of temperature on
carotid chemoreceptor and baroreceptor activity; J.
Neurophysiol. 1974: 37: 1287-1296
McQUEEN, D.S. RIBEIRO, J.A. Effect of adenosine on
carotid chemoreceptor activity in the cat; Br. J.
Pharmacol. 1981: 74: 129-136
McQUEEN, D.S. RIBEIRO, J.A. On the specificity and
type of receptor involved in carotid body chemoreceptor
activation by adenosine in the cat; Br. J. Pharmacol.
1983: 80: 347-354
MELLEMGAARD, K. Alveolar-arterial oxygen difference:
size and components in normal man; Acta. Physiol. Scand.
1966: 67: 10-20
MIDDLETON, H.C. PEAKE, M.D. HOWARD, P. Hypoxaemia in
chronic obstructive bronchitis; Thorax 1979: 34: 213-
216
274
MILLHORN, D.E. ELDRIDGE, F.L. KILEY, J.P. WALDROP,
T.G. Prolonged inhibition of respiration following
acute hypoxia in glomectomized cats; Resp. Physiol.
1984: 57: 331-340
MILLHORN, D.E. ELDRIDGE, F.L. WALDROP, T.G. Prolonged
stimulation of respiration by a new central neural
mechanism; Resp. Physiol. 1980: 41: 87-103
MITCHELL, R.A. LOESCHKE, H.H. MASSION, W.H.
Respiratory responses mediated through superficial
chemosensitive areas on the medulla; J. Appl. Physiol.
1963: 18: 523-533
MIYAMURA, M. YAMASHINA, T. HONDA, Y. Ventilatory
responses to C02 rebreathing at rest and during exercise
in untrained subjects and athletes; Jap. J. Physiol.
1976: 26: 245-254
MOORE, L.G. ZWILLICH, C.W. BATTAGLIA, J.D. COTTON,
E.K. WEIL, J. V. Respiratory failure associated with
familial depression of ventilatory response to hypoxia
and hypercapnia; N. Eng. J. Med. 1976: 295: 861-865
MORGAN, N. CAMERON, I. The respiratory response to
behavioural and metabolic stimulation; Clin. Sci. 1984:
67: 61p
MOUNTAIN, R. ZWILLICH, C.W. WEIL, J.V. Hypoventilation
in obstructive lung disease. The role of familial
factors; N. Eng. J. Med. 1978: 298: 521-525
MUELLER, R.A. LUNDBERG, D.B. BREESE, G.R. Alteration
of aminophyl1ine-induced respiratory stimulation by
perturbation of biogenic amine systems; J. Pharmacol.
Exp. Ther. 1981: 218: 593-599
NATALINO, M.R. ZWILLICH, C.W. WEIL, J.V. Effects of
hyperthermia on hypoxic ventilatory response in normal
man; J. Lab. Clin. Med. 1977: 80: 564-572
NIEL, E. O'REGAN, R.G. Efferent and afferent impulse
activity recorded from few-fibre preparations of
otherwise intact sinus and aortic nerves; J. Physiol.
(Lond). 1971: 215: 33-47
NIELSON, M. SMITH, H. Studies on the regulation of
respiration in acute hypoxia; Acta. Physiol. Scand.
1951: 24: 293-313
O'REGAN, R.G. Control of carotid body chemoreceptors by
autonomic nerves; Ir. J. Med. Sci. 1977: 146: 199-205
275
O'REGAN, R.G. Responses of carotid body chemosensory
activity and blood flow to stimulation of sympathetic
nerves in the cat; J. Physiol. (Lond). 1981: 315: 81-98
OTIS, A.B. Quantitative relationships in steady-state
gas exchange; Handbook of Physiology 1964: 3: 681-698
PATRICK, J.M. HOWARD, A. The influence of age, sex,
body size and lung size on the control and pattern of
breathing during C02 inhalation in Caucasians; Resp.
Physiol. 1972: 16: 337-350
PITTS, R.F. The function of components of the
respiratory complex; J. Neurophysiol. 1942: 5: 407
POLSON, J.B. KRZANOWSKI, J.J. GOLDMAN, A.L.
SZENTIVANYI, A. Inhibition of human pulmonary
phosphodiesterase activity by therapeutic levels of
theophylline; Clin. Exp. Pharmacol. Physiol. 1978:
5: 535-539
PRESS, W.H. FLANNERY, B.P. TEUKOLSKY, S.A.
VETTERLING, W.T. Numerical Recipies. The Art of
scientific Computing; Cambridge; Cambridge University
Press; 1986, 274-334, 547-577
RAHN, H. FENN, W.O. A graphical analysis of the
respiratory Gas Exchange; Am. Physiol. Soc. Washington
D.C. 1955
READ, D.J.C. A clinical method for assessing the
ventilatory response to C02 ; Aust. Ann. Med. 1967:
16: 20-32
REBUCK, A.S. CAMPBELL, E.J.M. A clinical method for
assessing the ventilatory response to hypoxia; Am. Rev.
Resp. Dis. 1974: 109: 345-350
REBUCK, A.S. KANGALEE, M. PENGELLY, L.D. CAMPBELL,
E-.J.M. Correlation of 'Ventilatory responses to hypoxia
and hypercapnia; J. Appl. Physiol. 1973: 35: 173-177
REBUCK, A.S. WOODLEY, W.E. Ventilatory effects of
hypoxia and their dependence on PC02 ; J. Appl. Physiol.
1975: 38: 16-19
REDGATE, Z.S. GELLHORN, E. Respiratory activity and
the hypothalamus; Am. J. Physiol. 1958: 193: 189-194
REGENSTEINER, J.G. WOODARD, W.D. HAGERMAN, D.D. WEIL,
J.V. PICKETT, C.K. BENDER, P.R. GRINDLAY MOORE, L.
Combined effects of female hormones and metabolic rate
on ventilatory drives in women; J. Appl. Physiol. 1989:
66: 808-813
276
REYNOLDS, W.J. MILLHORN, H.T. Transient ventilatory
response to hypoxia with and without controlled alveolar
PC02; J. Appl. Physiol. 1973: 35: 187-196
RUFFIN, R.E. NEWHOUSE, M.T. Dipyridamole - is it a
bronchodilator?; Eur. J. Resp. Dis. 1981: 62: 123-126
RYBAK, B. Continuous control of intravascular PCO and
reflexogenic effects of carbon dioxide on the pulmo-
cardio-vascular system in situ; in Carbon Dioxide and
Metabolic Regulations. Ed. G. Nahas and K.E. Schaefer,
Springer Verlag, New York, 1974: 196-203
SAHN, S.A. ZWILLICH, C.W. DICK, N. McCULLOUGH, R.E.
LAKSHMINARAYAN, S. WEIL, J.V. Variability of
ventilatory responses to hypoxia and hypercapnia; J.
Appl. Physiol. 1977: 43: 1019-1025
SAMPSON, S.R. Effects of mecamyline on responses of
carotid body chemoreceptors in vivo to physiological and
pharmacological stimuli; J. Physiol. (Lond) 1971a: 212:
655-666
SAMPSON, S.R. Mechanism of efferent inhibition of
carotid body chemoreceptors in the cat; Brain Res.
1971b: 45: 266-270
SANDERS, J.S. BERMAN, T.M. BARTLETT, M.M. KRONENBERG,
R.S. Increased hypoxic ventilatory drive due to
administration of aminophylline in normal men; Chest
1980: 78: 279-282
SARHAN, N.A.S. LEANING, M.S. SAUNDERS, K.B. CARSON,
E.R. Development of a complex model: breathing and its
control in man; Biomed. Meas. Infor. Contr. 1988: 2: 81-
100
SAUNDERS, K.B. BALI, H.N. CARSON, E.R. A breathing
model of the respiratory system: the controlled system;
J..Theor. Biol. 1980: 84: 135-161
SAUNDERS, N. A. HEILPERN, S. REBUCK, A.S. Relation
between personality and ventilatory response to carbon
dioxide in normal subjects: A role in asthma?; Brit.
Med. J. 1972: 1: 719-721
SCOGGIN, C.H. DOEKEL, R.D. KRYGER, M.H. ZWILLICH,
C.W. Familial aspects of decreased hypoxic ventilatory
drive in endurance athletes; J. Appl. Physiol. 1978:
44: 464-468
SERGEANT, A.J. ROULEAU, M.Y. SUTTON, J.R. JONES, N.L.
Ventilation in exercise studied with circulatory
occlusion ; J. Appl. Physiol. 1981: 50: 718-723
277
SEVERINGHAUS, J.W. Blood gas calculator; J. Appl .
Physiol. 1966: 21: 1108-1116
SEVERINGHAUS, J. BAINTON, C.R. CARCELEN, A.
Respiratory insensitivity to hypoxia in chronically
hypoxic man; Resp. Physiol. 1966: 1: 308-334
SHAW, R.A. SCHONFELD, S.A. WHITCOMB, M.E. Progressive
and transient hypoxic ventilatory drive tests in normal
subjects; Am. Rev. Resp. Dis. 1982: 126: 37-40
SMITH, W.K. The representation of respiratory movements
in the cerebral cortex; J. Neurophysiol. 1938: 1: 55-68
SNYDER, S.H. KATIMS, J.J. ANNAU, Z. BRUNS, R.F.
DALY, J.W. Adenosine receptors and behavioural actions
of methylxanthines; Proc. Natl. Acad. Sci. 1981:
78: 3260-3264
SORBINI, C.A. GRASSI, V. SOLINAS, E. MUIESON, G.
Arterial oxygen tension in relation to age in healthy
subjects; Respiration 1968: 25: 3-13
SORENSEN, S.C. CRUZ, J.C. Ventilatory response to a
single breath of C02 in 02 in normal man at sea level
and high altitude; J. Appl. Physiol. 1969: 27: 186-190
SORENSEN, S.C. SEVERINGHAUS, J.W. Irreversible
respiratory insensitivity to acute hypoxia in man born
at high altitude; J. Appl. Physiol. 1968: 25: 217-220
ST. JOHN, W.M. WANG, S.C. Response of medullary
respiratory neurons to hypercapnia and isocapnic
hypoxia; J. Appl. Physiol. 1977: 43: 812-821
SUTTON, F.D. ZWILLICH, C.W. CREAGH, C.E. PIERSON,
D.J. WEIL, J. V. Progesterone for the treatment of
Pickwickian syndrome; Ann. Intern. Med. 1975: 83: 476-
479
SWANSON, G.D. WHIPP, B.J. KAUFMAN, R.D. AQLEH, K. A.
WINTER, B. BELLVILLE, J.W. Effect of hypercapnia on
hypoxic ventilatory drive in normal and carotid body-
resected man; J. Appl. Physiol. 1978: 45: 971-977
TENNEY, S.M. OU, L.C. Ventilatory response of
decorticate and decerebrate cats to hypoxia and C02;
Respir. Physiol. 1977: 29: 81-92
TEPPEMA, L.J. BARTS, P.W.J.A. FOLGERING, H.T. EVERS,
J.A.M. Effects of respiratory and (isocapnic) metabolic
acid-base disturbances on medullary extracellular fluid
pH and ventilation in cats; Resp. Physiol. 1983: 53:
379-395
278
THURLBECK, W.M. Major problems in pathology; Ed. J. L.
Bennington, Philadelphia 1976
TOBIN, M.J. MADOR, M.J. GUENTHER, S.M. LODATO, R.F.
SACKNER, M.A. Variability of resting respiratory drive
and timing in healthy subjects; J. Appl. Physiol. 1988:
65: 309-317
TURNER, E.A. Cerebral control of respiration; Brain,
1954: 77: 448-486
UNGAR, A. BOUVEROT, P. The ventilatory responses of
conscious dogs to isocapnic oxygen tests. A method of
exploring the central component of respiratory drive and
its dependence on 02 and C02 ; Resp. Physiol. 1980:
39: 183-197
VERNA, A. U1trastructural localisation of post¬
ganglionic sympathetic nerve endings in the rat carotid
body; in Arterial Chemoreceptors, Proceedings of the
sixth International Meeting. Ed. C. Belmonte, D. Acker
and S. Fidone. Leicester University Press, 1981: 336-343
VIZEK, M. PICKETT, C.K. WEIL, J.V. Interindividual
variation in hypoxic ventilatory response: potential
role of carotid body; J. Appl. Physiol. 1987: 63: 1884-
1889
WAGNER, P.D. DANTZKER, D.R. DUECK, R. CLAUSEN, J.L.
WEST, J.B. Ventilation-perfusion inequality in chronic
obstructive pulmonary disease; J. Clin. Invest. 1977:
59: 203-216
WARREN, P.M. AIRLIE, M.A.A. DeCORT, S.C. KIRBY, T.P.
WRAITH, P.K. FLENLEY, D.C. The ventilatory response to
hypoxia in humans is a function of the rate of change of
the stimulus. Am. Rev. Resp. Dis. 1987:135: A369
WARREN, P.M. CALVERLEY, P.M.A. LEITCH, A.G.. WRAITH,
P.K. BRASH, H.M. FLENLEY, D.C. Comparison of 3
techniques for assessing hypoxic drive in normal
subjects; Clin. Sci. 1984: 66: p42
WARREN, P.M. KIRBY, T.P. WRAITH, P.K. CARSON, E.R.
AIRLIE, M.A.A. DeCORT, S.C. HILL, J.E. FLENLEY, D.C.
Dynamic analysis of the ventilatory response to hypoxia
in normal subjects using a two-compartment mathematical
model; Am. Rev. Resp. Dis. 1989: 139: A228
WASSERMAN, K. WHIPP, B.J. KOYAL, S.N. CLEARY, M.G.
Effect of carotid body resection on ventilatory and
acid-base control during exercise; J. Appl. Physiol.
1975: 39: 354-358
279
WEIL, J.V. BYRNE-QUINN, E. SODAL, I.E. FILLEY, G.F.
GROVER, R.F. Acquired attenuation of chemoreceptor
function in chronically hypoxic man at high altitude; J.
Clin. Invest. 1971: 50: 186-195
WEIL, J.V. BYRNE-QUINN, E. SODAL, I.E. FRIESON, W.O.
UNDERHILL, B. FILLEY, G.F. GROVER, R.F. Hypoxic
ventilatory drive in normal man; J. Clin. Invest.
1970:49: 1061-1071
WEIL, J.V. BYRNE-QUINN, E. SODAL, I.E. KLINE, J.S.
McCULLOUGH, R.E. FILLEY, G.F. Augmentation of
chemosensitivity during mild exercise in normal man; J.
Appl. Physiol. 1972: 33: 813-819
WEIL, J.V. ZWILLICH, C.W. Assessment of ventilatory
response to hypoxia: methods and interpretation; Chest
1976: 70: 124-128
WEINBERGER, M. HENDELES, L. Theophylline for chronic
asthma: rationale for treatment, product selection and
dosage schedule; in Jonkman et al, Sustained release
theophylline in the treatment of chronic respiratory
airways obstruction, 1984, Excerpta Medica, Amsterdam
WEISKOPF, R.B. GABEL, R. A. Depression of ventilation
during hypoxia in man; J. Appl. Physiol. 1975: 39: 911-
915
WHIPP, B.J. DRYSDALE, D.B. CUNNINGHAM, D.J.C.
PETERSEN, E.S. The interaction of peripheral and
intercranial respiratory drive in man studied by
transients; Bull. Eur. Physiopathol. Resp. 1976: 14:
254-255
WHIPP, B.J. WASSERMAN, K. Alveolar-arterial gas tension
differences during graded exercise; J. Appl. Physiol.
1969: 27: 361-365
WHIPP, B.J. WASSERMAN, K. Carotid bodies and
ventilatory control dynamics in man; Fed. Proc. 1980:
39: 2668-2673
WHITE, D.P. DOUGLAS, N.J. PICKETT, C.K. WEIL, J.V.
ZWILLICH, C.W. Sexual influence on the control of
breathing; J. Appl. Physiol. 1983: 54: 874-879
WHITELAW, W. A. DERENNE, J.-Ph. MILIC-EMILI, J.
Occlusion pressure as a measure of respiratory centre
output in conscious man; Resp. Physiol. 1975: 23: 181-
199
WINN, H.R. RUBIO, R. BERNE, R.M. Brain adenosine
concentration during hypoxia in rats; Am. J. Physiol.
1981: 241: 235-242
280
WINSLOW, J.B. Exposition anatomique de la structure du
corps humain; Paris: Desprez and Desessartz p463 (Traite
des Nerfs, Para. 371-373, Amsterdam; Reimprime aux
depens de la Compagnie, 1732: 3: 222
ZWILLICH, C.W. PIERSON, D.J. HOFELDT, F.D. LUFLIN,
E.C. WEIL, J. V. Ventilatory control in myxedema and
hypothyroidism; N. Engl. J. Med. 1975: 292: 622-655
ZWILLICH, C.W. SAHN, S.A. WEIL, J.V. Effects of
hypermetabolism on ventilation and chemosensitivity; J.
Clin. Invest. 1977: 60: 900-906
ZWILLICH, C.W. WEIL, J.V. Increased ventilatory
response to hypoxia and hypercapnia during
thyrotoxicosis; Clin. Res. 1976: 24: 103A
281
glossary
FEV]_ Forced expiratory volume in 1 second (1)
vc Vital capacity (1)
RV Residual volume (1)
FRC Functional residual capacity (1)
tlc Total lung capacity (1)
ERV Expiratory reserve volume (1)
tlco Single-breath carbon monoxide diffusion
(mmol/kPa.min)
factor
raw Airways resistance (kPa.sec)/l
sg_.t ,aw
— 1
Airways specific conductance (kPa.sec)
vtg Thoracic gas volume (1)
BTPS Body temperature and pressure, saturated
STPD Standard temperature and pressure, dry
ve Expired ventilation (lmin-1)
VEinst Instantaneous expired minute ventilation
(lmin-1)
vt Tidal volume (1)
fR
_ -J
Respiratory freguency (breaths mm )
vo2 Oxygen consumption (lmin-1)
vco2
— 1
Carbon dioxide elimination (lmin )
RQ Respiratory exchange ratio (VC02/V02)
Sa02 Arterial oxygen saturation (%)
pi Partial pressure of inspired gas (kPa or mmHg)
PE Partial pressure of end-tidal gas (kPa or mmHg)
PA Partial pressure of alveolar gas (kPa or mmHg)
Pa Partial pressure of arterial gas (kPa or mmHg)
FI Fractional concentration of inspired gas (%)
fe Fractional concentration of expired gas (%)
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